Id,Title,Link
45000,Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726002/
45001,An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851053/
45002,An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100302/
45003,Current clinical status of new COVID-19 vaccines and immunotherapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442597/
45004,A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459021/
45005,"COVID-19 vaccine development: milestones, lessons and prospects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062866/
45006,"Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092649/
45007,Efficacy and safety of COVID‐19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726273/
45008,Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977625/
45009,Application of Traditional Vaccine Development Strategies to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134813/
45010,Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960675/
45011,Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10819631/
45012,Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997755/
45013,"COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569411/
45014,COVID-19 vaccines: The status and perspectives in delivery points of view,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759095/
45015,"Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637516/
45016,COVID-19 vaccines in pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061132/
45017,COVID-19: An Overview of SARS-CoV-2 Variants—The Current Vaccines and Drug Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480030/
45018,SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353927/
45019,An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101866/
45020,"A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445802/
45021,"Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843115/
45022,SARS‐CoV‐2 and its variants of concern including Omicron: A never ending pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111768/
45023,A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047227/
45024,"Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615473/
45025,Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787839/
45026,"SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054865/
45027,"Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016159/
45028,From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805901/
45029,COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461057/
45030,"A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465653/
45031,COVID-19 Vaccine: Between Myth and Truth,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950941/
45032,"SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519814/
45033,Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458178/
45034,Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040368/
45035,"COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301790/
45036,An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938630/
45037,"SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143972/
45038,"COVID-19 Vaccines, Effectiveness, and Immune Responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737588/
45039,COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536649/
45040,"Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473425/
45041,COVID-19 Vaccine Platforms: Challenges and Safety Contemplations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537163/
45042,"An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968612/
45043,A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611209/
45044,Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369331/
45045,"COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916486/
45046,Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566192/
45047,Recent developments in SARS‐CoV‐2 vaccines: A systematic review of the current studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348268/
45048,COVID-19 Vaccines: Current and Future Perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025326/
45049,Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574046/
45050,Covid‐19 vaccines and variants of concern: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646685/
45051,Advances in COVID-19 mRNA vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940982/
45052,The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027942/
45053,Advances in gene-based vaccine platforms to address the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789827/
45054,Comprehensive narrative review of real-world COVID-19 vaccines: viewpoints and opportunities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274757/
45055,Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825346/
45056,The status of COVID-19 vaccines in India: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126226/
45057,COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922043/
45058,"Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732709/
45059,"A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708628/
45060,Nanocarrier vaccines for SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794055/
45061,"‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452662/
45062,A Comprehensive Investigation Regarding the Differentiation of the Procurable COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936379/
45063,Humoral and cellular immunity and the safety of COVID-19 vaccines: a summary of data published by 21 May 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499872/
45064,Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933851/
45065,"COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545698/
45066,The Coming of Age of Nucleic Acid Vaccines during COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134841/
45067,Adaptive immunity to SARS-CoV-2 and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803150/
45068,COVID-19 vaccines and a perspective on Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832054/
45069,Role of COVID-19 Vaccines in SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165056/
45070,Recent developments in the immunopathology of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108124/
45071,Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355161/
45072,Recent advances in respiratory immunization: A focus on COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937028/
45073,"Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905308/
45074,"Reported cases of multisystem inflammatory syndrome in children aged 12–20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864018/
45075,A Narrative Review of COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779282/
45076,Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099545/
45077,"COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569292/
45078,Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486642/
45079,Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349657/
45080,Tracking the COVID-19 vaccines: The global landscape,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101659/
45081,COVID-19 mRNA vaccines: Platforms and current developments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856755/
45082,Vaccination in patients with kidney failure: lessons from COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397175/
45083,What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837315/
45084,Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10739883/
45085,The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623509/
45086,Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965371/
45087,COVID‐19  vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111382/
45088,Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166525/
45089,"Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548286/
45090,What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979618/
45091,The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730674/
45092,"COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082934/
45093,Vaccines against SARS-CoV-2 variants and future pandemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979704/
45094,The Breadth of Bacteriophages Contributing to the Development of the Phage-Based Vaccines for COVID-19: An Ideal Platform to Design the Multiplex Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861788/
45095,COVID-19 vaccine: where are we now and where should we go?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898300/
45096,"COVID-19, post-acute COVID-19 syndrome (PACS, “long COVID”) and post-COVID-19 vaccination syndrome (PCVS, “post-COVIDvac-syndrome”): Similarities and differences",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154064/
45097,Humoral and cellular immune memory to four COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135677/
45098,Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917804/
45099,Immunological considerations for COVID-19 vaccine strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472682/
45100,"COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898934/
45101,Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802525/
45102,COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10810638/
45103,Cureus. 2024 Feb; 16(2): r137. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10897748/
45104,Real-Word Effectiveness of Global COVID-19 Vaccines Against SARS-CoV-2 Variants: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160927/
45105,Efficacy and safety of COVID‐19 vaccines: A network meta‐analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538745/
45106,Application of Traditional Vaccine Development Strategies to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413721/
45107,mSystems. 2023 Mar-Apr; 8(2): e00927-22. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134813/
45108,Immunological mechanisms of vaccine-induced protection against COVID-19 in humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246128/
45109,Covid-19 vaccination in pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363819/
45110,Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607623/
45111,A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436716/
45112,A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323196/
45113,A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337507/
45114,The find of COVID-19 vaccine: Challenges and opportunities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773313/
45115,The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385722/
45116,COVID-19: Vaccines and therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472710/
45117,Vaccine design and delivery approaches for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380485/
45118,"A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343749/
45119,"The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459165/
45120,Fully understanding the efficacy profile of the COVID-19 vaccination and its associated factors in multiple real-world settings,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641184/
45121,COVID-19 Vaccines: Where Did We Stand at the End of 2023?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10893040/
45122,Novel coronavirus mutations: Vaccine development and challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561474/
45123,COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641591/
45124,Clinical development and approval of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935460/
45125,Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513651/
45126,Effectiveness of COVID-19 Vaccines at Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompromised Adults: An Observational Study of Real-World Data Across 10 US States from August-December 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201325/
45127,COVID-19 Animal Models and Vaccines: Current Landscape and Future Prospects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537799/
45128,SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816567/
45129,COVID-19 management landscape: A need for an affordable platform to manufacture safe and efficacious biotherapeutics and prophylactics for the developing countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148927/
45130,Heterologous immunity induced by 1st generation COVID-19 vaccines and its role in developing a pan-coronavirus vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420909/
45131,Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278575/
45132,Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551237/
45133,Development of antibody resistance in emerging mutant strains of SARS CoV‐2: Impediment for COVID‐19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111059/
45134,"COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665991/
45135,RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429941/
45136,Advances in the design and development of SARS-CoV-2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674100/
45137,"An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946785/
45138,"COVID-19 Incidence Proportion as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine Type",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675075/
45139,Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062288/
45140,Nano-Enabled COVID-19 Vaccines – Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029448/
45141,"Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452404/
45142,"Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538893/
45143,Eur J Heart Fail. 2023 Feb 17; 25(3): 443. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117570/
45144,"‘COVID Is Coming, and I’m Bloody Scared’: How Adults with Co-Morbidities’ Threat Perceptions of COVID-19 Shape Their Vaccination Decisions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957419/
45145,"Accelerated COVID-19 vaccine development: milestones, lessons, and prospects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328682/
45146,"Covid-19: virology, variants, and vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951271/
45147,TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828069/
45148,An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669259/
45149,Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049400/
45150,Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451184/
45151,Comparison of Immunogenicity and Reactogenicity of Five Primary Series of COVID-19 Vaccine Regimens against Circulating SARS-CoV-2 Variants of Concern among Healthy Thai Populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051392/
45152,"SARS-CoV-2 Vaccines: Types, Working Principle, and Its Impact on Thrombosis and Gastrointestinal Disorders",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554396/
45153,Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135663/
45154,The Role of Immunity in the Pathogenesis of SARS-CoV-2 Infection and in the Protection Generated by COVID-19 Vaccines in Different Age Groups,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967364/
45155,Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348242/
45156,Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890022/
45157,"Immune response kinetics to SARS-CoV-2 infection and COVID-19 vaccination among nursing home residents—Georgia, October 2020–July 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11020945/
45158,Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092276/
45159,Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201317/
45160,COVID-19 vaccination challenges: A mini-review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302531/
45161,"Two Years into
the COVID-19 Pandemic: Lessons Learned",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380879/
45162,COVID-19 vaccine acceptance and its socio-demographic and emotional determinants: A multi-country cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647027/
45163,Interpretative immune targets and contemporary position for vaccine development against SARS‐CoV‐2: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753271/
45164,The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385234/
45165,"A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015872/
45166,Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385778/
45167,Racing to immunity: Journey to a COVID‐19 vaccine and lessons for the future,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753785/
45168,Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319039/
45169,Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584756/
45170,Super-rapid race for saving lives by developing COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035961/
45171,Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis—implications for public health communications in Australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724587/
45172,Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863502/
45173,Lancet. 2022 Apr 4 ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979561/
45174,Lancet. 2023 25 February-3 March; 401(10377): 644. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949836/
45175,Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126103/
45176,"Intention to get COVID-19 vaccines: Exploring the role of attitudes, subjective norms, perceived behavioral control, belief in COVID-19 misinformation, and vaccine confidence in Northern India",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828102/
45177,Intranasal COVID-19 vaccines: From bench to bed,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785603/
45178,Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590867/
45179,"Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434692/
45180,Coronavirus Disease 2019–COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405836/
45181,"COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220438/
45182,Immunology of SARS-CoV-2 infections and vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429035/
45183,"Recent review of COVID-19 management: diagnosis, treatment and vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549062/
45184,"Understanding the challenges to COVID-19 vaccines and treatment options, herd immunity and probability of reinfection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758618/
45185,"SARS-CoV-2 Variants, Vaccines, and Host Immunity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761766/
45186,Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360027/
45187,COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459551/
45188,Microarray patches enable the development of skin-targeted vaccines against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060128/
45189,"A matter of trust: a qualitative comparison of the determinants of COVID-19 vaccine hesitancy in Taiwan, the United States, the Netherlands, and Haiti",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225662/
45190,"A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952616/
45191,A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10888826/
45192,Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021373/
45193,Pharmaceutical Aspects and Clinical Evaluation of COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095160/
45194,Vaccines for COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597597/
45195,The skin as a critical window in unveiling the pathophysiologic principles of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298003/
45196,"COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935456/
45197,Immune Response to SARS-CoV-2 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312515/
45198,WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882397/
45199,"Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251022/
45200,Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018321/
45201,Coronavirus (SARS-CoV-2): a systematic review for potential vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920137/
45202,The Burden of COVID-19 in Children and Its Prevention by Vaccination: A Joint Statement of the Israeli Pediatric Association and the Israeli Society for Pediatric Infectious Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781684/
45203,SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464065/
45204,Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537111/
45205,"Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015644/
45206,COVID-19: Characteristics and Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909801/
45207,"Potential SARS-CoV-2 vaccines: Concept, progress, and challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006194/
45208,Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801892/
45209,"Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616290/
45210,Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345146/
45211,The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040821/
45212,Animal models for studying coronavirus infections and developing antiviral agents and vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122840/
45213,The Coming of Age of Nucleic Acid Vaccines during COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580386/
45214,mSystems. 2023 Mar-Apr; 8(2): e00928-22. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134841/
45215,Vaccines for the Prevention of Coronavirus Disease 2019 in Older Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633624/
45216,"Meeting Summary: Global Vaccine and Immunization Research Forum, 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938725/
45217,"Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095162/
45218,"A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774670/
45219,nSARS-CoV-2 and COVID-19 Pandemic: From Emergence to Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083482/
45220,Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874888/
45221,COVID-19 Vaccines in Older Adults: Challenges in Vaccine Development and Policy Making,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934735/
45222,mRNA vaccines for COVID-19 and diverse diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935967/
45223,Administration of COVID-19 vaccines in immunocompromised patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316069/
45224,An overview on the treatments and prevention against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906607/
45225,"COVID‐19 and plasma cells: Is there long‐lived protection?
",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350162/
45226,Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025561/
45227,Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyond,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635945/
45228,"COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923340/
45229,PICK-ing Malaysia’s Epidemic Apart: Effectiveness of a Diverse COVID-19 Vaccine Portfolio,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706086/
45230,Current and prospective computational approaches and challenges for developing COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871111/
45231,"The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862168/
45232,A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273573/
45233,"Novel receptor, mutation, vaccine, and establishment of coping mode for SARS-CoV-2: current status and future",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461067/
45234,Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851580/
45235,Nat Commun. 2023; 14: 1581. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031713/
45236,An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor-binding domain vaccine in aged mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176044/
45237,Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733958/
45238,Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569602/
45239,"Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases, in Patients with Cardiac Issues, and in the Healthy Population",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964607/
45240,Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230982/
45241,Immunity after COVID-19 Recovery and Vaccination: Similarities and Differences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322013/
45242,Coronavirus vaccine development: from SARS and MERS to COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749790/
45243,Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892939/
45244,COVID‐19 disease and vaccination in pregnant and lactating women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111214/
45245,An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146241/
45246,Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980688/
45247,"Antibodies against SARS-CoV-2 Alpha, Beta, and Gamma Variants in Pregnant Women and Their Neonates under Antenatal Vaccination with Moderna (mRNA-1273) Vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505142/
45248,"COVID-19 vaccines uptake: Public knowledge, awareness, perception and acceptance among adult Africans",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159554/
45249,A comprehensive review on efficient approaches for combating coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531103/
45250,A global picture: therapeutic perspectives for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884157/
45251,"Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776284/
45252,"Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012513/
45253,A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534788/
45254,Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390046/
45255,Messenger ribonucleic acid vaccines for severe acute respiratory syndrome coronavirus-2 – a review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695521/
45256,COVID-19 Disease in Under-5 Children: Current Status and Strategies for Prevention including Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058749/
45257,Myocarditis associated with COVID-19 and its vaccines - a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596182/
45258,Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861611/
45259,Prerequisite for COVID-19 Prediction: A Review on Factors Affecting the Infection Rate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602751/
45260,Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343072/
45261,Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062302/
45262,A quick scoping review of the first year of vaccination against the COVID-19 pandemic: Do we need more shots or time?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477714/
45263,Post-vaccination outcomes in association with four COVID-19 vaccines in the Kingdom of Bahrain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161761/
45264,Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160920/
45265,Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889515/
45266,Implications for COVID-19 vaccine uptake: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884645/
45267,Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185820/
45268,Contextualizing Wastewater-Based surveillance in the COVID-19 vaccination era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783150/
45269,COVID-19: comprehensive review on mutations and current vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647783/
45270,"COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642873/
45271,Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10974399/
45272,A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302808/
45273,SARS-CoV-2: An Analysis of the Vaccine Candidates Tested in Combatting and Eliminating the COVID-19 Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785262/
45274,"A Comprehensive Review of the Global Efforts on COVID-19 Vaccine
Development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029445/
45275,Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288895/
45276,The first 12 months of COVID-19: a timeline of immunological insights,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958099/
45277,COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294236/
45278,Early clinical trial data and real‐world assessment of COVID‐19 vaccines: Insights from the Society of Infectious Diseases Pharmacists,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662264/
45279,Predictors of COVID-19 vaccine uptake among people who inject drugs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868393/
45280,"Persisting Vaccine Hesitancy in Africa: The Whys, Global Public Health Consequences and Ways-Out—COVID-19 Vaccination Acceptance Rates as Case-in-Point",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697713/
45281,High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4+ and CD8+ memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11007208/
45282,Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscape,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980456/
45283,SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205158/
45284,Defining the risk of SARS-CoV-2 variants on immune protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345323/
45285,"Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study ",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527398/
45286,COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862165/
45287,A Review of Different Vaccines and Strategies to Combat COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145217/
45288,Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210448/
45289,Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021–2022 influenza season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780637/
45290,The impact of maternal SARS-CoV-2 infection and COVID-19 vaccination on maternal-fetal outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595355/
45291,Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359488/
45292,Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645832/
45293,Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953148/
45294,Challenges in Emerging Vaccines and Future Promising Candidates against SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10834093/
45295,Identifying COVID-19 optimal vaccine dose using mathematical immunostimulation/immunodynamic modelling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574467/
45296,The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804231/
45297,"Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377789/
45298,Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419014/
45299,"COVID‐19 vaccinations: The unknowns, challenges, and hopes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015467/
45300,"The barriers, facilitators and association of vaccine certificates on COVID-19 vaccine uptake: a scoping review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537206/
45301,"Trilogy of COVID-19: Infection, Vaccination, and Immunosuppression",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148894/
45302,The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765363/
45303,"Parents' willingness to vaccinate themselves and their children with the booster vaccine against SARS‐CoV‐2: A cross‐sectional study in Puyang city, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874889/
45304,American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014184/
45305,Instructing durable humoral immunity for COVID-19 and other vaccinable diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085459/
45306,COVID-19 vaccination in pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093065/
45307,The intestinal microbiota and improving the efficacy of COVID-19 vaccinations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578005/
45308,"Utilizing nanozymes for combating COVID-19: advancements in diagnostics, treatments, and preventative measures",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283317/
45309,Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID‐19 vaccination: A systematic review and meta‐analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348179/
45310,An update on vaccine status and the role of nanomedicine against SARS‐CoV‐2: A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315735/
45311,Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889026/
45312,"An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865970/
45313,Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604694/
45314,Does COVID-19 Vaccination Warrant the Classical Principle “ofelein i mi vlaptin”?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999356/
45315,Nanomedicine to deliver biological macromolecules for treating COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149150/
45316,The dawn of mRNA vaccines: The COVID-19 case,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008785/
45317,Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006950/
45318,BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113676/
45319,"A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806010/
45320,"Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786601/
45321,Mental Health Issues During and After COVID-19 Vaccine Era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414813/
45322,"COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685956/
45323,The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168478/
45324,An update on the impact of SARS-CoV-2 pandemic public awareness on cancer patients' COVID-19 vaccine compliance: Outcomes and recommendations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354075/
45325,A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119307/
45326,"Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346130/
45327,A perspective on SARS-CoV-2 virus-like particles vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832101/
45328,Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300285/
45329,Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949184/
45330,"Experiences, Enablers, and Challenges in Service Delivery and Integration of COVID-19 Vaccines: A Rapid Systematic Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222130/
45331,Common Demand vs. Limited Supply—How to Serve the Global Fight against COVID-19 through Proper Supply of COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834692/
45332,A qualitative insight into the perceptions and COVID-19 vaccine hesitancy among Pakistani pharmacists,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009959/
45333,The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994064/
45334,Sci Rep. 2022; 12: 6498. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019531/
45335,"Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296253/
45336,Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363466/
45337,Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179012/
45338,COVID-19 vaccination efficacy in numbers including SARS-CoV-2 variants and age comparison: a meta-analysis of randomized clinical trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250750/
45339,Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540924/
45340,A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the frequency and the function of lung-resident memory CD4+ and CD8+ T cells and enhanced protection against COVID-19-like symptoms and death caused by SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10734477/
45341,An overview on inactivated and live‐attenuated SARS‐CoV‐2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102488/
45342,COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115278/
45343,Molecular and Clinical Aspects of COVID-19 Vaccines and Other Therapeutic Interventions Apropos Emerging Variants of Concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734653/
45344,COVID-19 Vaccines: Current Conditions and Future Prospects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533517/
45345,An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402174/
45346,"Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS‐CoV‐2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712136/
45347,A systematic and thematic analysis of the top 100 cited articles on mRNA vaccine indexed in Scopus database,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746518/
45348,Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183699/
45349,A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181264/
45350,High Frequency of COVID-19 Vaccine Hesitancy among Canadians Immunized for Influenza: A Cross-Sectional Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506006/
45351,Recent Advances on Drugs and Vaccines for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673875/
45352,Putative Role of Vitamin D for COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396570/
45353,"COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071852/
45354,"SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364403/
45355,"Update on Covid-19: vaccines, timing of transplant after COVID-19 infection and use of positive donors",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992272/
45356,Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979261/
45357,Vaccine Development against COVID-19: Study from Pre-Clinical Phases to Clinical Trials and Global Use,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402459/
45358,Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057551/
45359,From Emergence to Endemicity: A Comprehensive Review of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617653/
45360,COVID-19 vaccines: Update of the vaccines in use and under development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683840/
45361,Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955234/
45362,Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444935/
45363,"Anti-coronavirus vaccines will not accelerate the transition of humanity to a non-pandemic period, but the pandemic will take fewer victims",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994861/
45364,Conspiracy theories and misinformation about COVID-19 in Nigeria: Implications for vaccine demand generation communications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830779/
45365,Safety & effectiveness of COVID-19 vaccines: A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552389/
45366,Chinese parents’ intentions to vaccinate their children against SARS-CoV-2 infection and vaccine preferences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903901/
45367,"Genomic, immunological, and clinical analysis of COVID‐19 vaccine breakthrough infections in Beijing, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015436/
45368,mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511551/
45369,"SARS-CoV-2, fertility and assisted reproduction",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976972/
45370,Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829820/
45371,Confidence in COVID-19 vaccine effectiveness and safety and its effect on vaccine uptake in Tanzania: A community-based cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088920/
45372,Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998902/
45373,GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243192/
45374,A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020204/
45375,Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058052/
45376,Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697230/
45377,Factors Influencing the Intention and Uptake of COVID-19 Vaccines on the African Continent: A Scoping Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146577/
45378,Global disparities in public health guidance for the use of COVID-19 vaccines in pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882664/
45379,"Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10839970/
45380,Current progress and challenges in the design and development of a successful COVID-19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835609/
45381,mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995030/
45382,The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213067/
45383,"A review on COVID-19 transmission, epidemiological features, prevention and vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047653/
45384,The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870038/
45385,"Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985161/
45386,"Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged at least 75 years during the spring-summer (monovalent vaccine) and autumn-winter (bivalent vaccine) booster campaigns: a prospective test negative case–control study, United Kingdom, 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690860/
45387,"COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431783/
45388,Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005103/
45389,Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005913/
45390,The role of trained immunity in COVID-19: Lessons for the next pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265767/
45391,Current scenario of COVID-19 vaccinations and immune response along with antibody titer in vaccinated inhabitants of different countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343376/
45392,"Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906643/
45393,Analysis of the Protective Efficacy of Approved COVID-19 Vaccines Against Various Mutants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095899/
45394,"SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253265/
45395,Recent and advanced nano-technological strategies for COVID-19 vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015106/
45396,The Impact of Priority Settings at the Start of COVID-19 Mass Vaccination on Subsequent Vaccine Uptake in Japan: One-Year Prospective Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337369/
45397,Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965458/
45398,Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144974/
45399,Vaccine Protection Through Placenta and Breastfeeding: The Unmet Topic in COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203883/
45400,Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462926/
45401,"COVID‐19: A systematic review and update on prevention, diagnosis, and treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906461/
45402,The Vaccine World of COVID-19: India’s Contribution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695423/
45403,Modified mRNA-Based Vaccines Against Coronavirus Disease 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021518/
45404,The way of SARS-CoV-2 vaccine development: success and challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575680/
45405,"A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863680/
45406,The COVID-19 pandemic in children and young people during 2020-2021: A complex discussion on vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763337/
45407,SARS‐CoV‐2 vaccine‐related cutaneous manifestations: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111829/
45408,Current and future nanoparticle vaccines for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602808/
45409,A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941884/
45410,"Understanding the COVID-19 Vaccine Policy Terrain in Ontario Canada: A Policy Analysis of the Actors, Content, Processes, and Context",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143674/
45411,An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282453/
45412,High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579840/
45413,Identifying H1N1 and COVID-19 vaccine hesitancy or refusal among health care providers: a scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173945/
45414,Vaccine Confidence and Hesitancy at the Start of COVID-19 Vaccine Deployment in the UK: An Embedded Mixed-Methods Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632016/
45415,Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134725/
45416,Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948998/
45417,"Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040490/
45418,"Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616523/
45419,"Animal models for COVID-19: advances, gaps and perspectives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261903/
45420,Women's views and experiences of accessing pertussis vaccination in pregnancy and infant vaccinations during the COVID-19 pandemic: A multi-methods study in the UK,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247266/
45421,Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937508/
45422,Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114615/
45423,COVID-19 vaccines: where we stand and challenges ahead,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818063/
45424,FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238652/
45425,Vaccination-Associated Myocarditis and Myocardial Injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171307/
45426,"Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March–October, 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995303/
45427,"Newly Emerged Antiviral Strategies for SARS-CoV-2: From Deciphering Viral Protein Structural Function to the Development of Vaccines, Antibodies, and Small Molecules",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181103/
45428,COVID-19 in children: epidemic issues and candidate vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433085/
45429,After the Storm: Ophthalmic Manifestations of COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837328/
45430,Does a major change to a COVID-19 vaccine program alter vaccine intention? A qualitative investigation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674511/
45431,The impact of non-pharmaceutical interventions on the first COVID-19 epidemic wave in South Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403893/
45432,"COVID-19 vaccine hesitancy in Latin America and Africa: a scoping
review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494688/
45433,mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973374/
45434,"COVID-19: A state of art on immunological responses, mutations, and treatment modalities in riposte",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798670/
45435,SARS-CoV-2 vaccines: Clinical endpoints and psychological perspectives: A literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969448/
45436,"Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240077/
45437,Factors Influencing COVID-19 Vaccine Acceptance in High Income Countries Prior to Vaccine Approval and Rollout: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888412/
45438,SARS-CoV-2 infection and immune responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113164/
45439,An Update on Complications Associated with SARS-CoV-2 Infection and COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612126/
45440,"The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248554/
45441,SARS-CoV-2: vaccinology and emerging therapeutics; challenges and future developments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884156/
45442,Analysis of the protective efficacy of approved COVID-19 vaccines against Omicron variants and the prospects for universal vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10711607/
45443,Nasal sprays for treating COVID-19: a scientific note,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969373/
45444,Next-Generation COVID-19 Vaccines Should Take Efficiency of Distribution into Consideration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034273/
45445,The success of SARS-CoV-2 vaccines and challenges ahead,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279572/
45446,Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993231/
45447,"Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930006/
45448,"Latest updates on SARS-CoV-2 genomic characterization, drug, and vaccine development; a comprehensive bioinformatics review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910145/
45449,Protein-based nano-vaccines against SARS-CoV-2: Current design strategies and advances of candidate vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998285/
45450,Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622998/
45451,Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784226/
45452,"Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113741/
45453,COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992234/
45454,Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043892/
45455,A social ecological approach to identify the barriers and facilitators to COVID-19 vaccination acceptance: A scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529136/
45456,A systematic review and meta-analysis of the global prevalence and determinants of COVID-19 vaccine acceptance and uptake in people living with HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10810755/
45457,Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10754519/
45458,SARS-CoV-2 Vaccines: Where Are We Now?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363243/
45459,Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040362/
45460,How can COVID-19 vaccines benefit people? A study based on the theory of the commons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332236/
45461,"Recurring SARS-CoV-2 variants: an update on post-pandemic, co-infections and immune response",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911975/
45462,SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311925/
45463,SARS-CoV-2 BNT162b2 vaccine–induced humoral response and reactogenicity in individuals with prior COVID-19 disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876462/
45464,Effectiveness of Adapted COVID-19 Vaccines and Ability to Establish Herd Immunity against Omicron BA.1 and BA4-5 Variants of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10747774/
45465,Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993410/
45466,SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553736/
45467,Comprehensive Highlights of the Universal Efforts towards the Development of COVID-19 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611897/
45468,Innovations and development of Covid-19 vaccines: A patent review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539827/
45469,COVID-19 and hepatic injury: cellular and molecular mechanisms in diverse liver cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850933/
45470,Factors associated with COVID-19 vaccination during June–October 2021: A multi-site prospective study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063571/
45471,Leishmaniac Quest for Developing a Novel Vaccine Platform. Is a Roadmap for Its Advances Provided by the Mad Dash to Produce Vaccines for COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874365/
45472,Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724751/
45473,Evolution and Control of COVID-19 Epidemic in Hong Kong,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698160/
45474,Research progress on vaccine efficacy against SARS-CoV-2 variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115786/
45475,"Comprehensive literature review on COVID-19 vaccines and role of
SARS-CoV-2 variants in the pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637774/
45476,A Multidisciplinary Approach to Coronavirus Disease (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228528/
45477,"Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260489/
45478,"Vaccine efficacy against SARS-CoV-2 for Pfizer BioNTech, Moderna, and AstraZeneca vaccines: a systematic review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628441/
45479,"Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11055380/
45480,COVID-19 vaccine hesitancy in Africa: a scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294808/
45481,mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052021/
45482,Immunity to SARS‐CoV‐2 induced by infection or vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447342/
45483,COVID-19 signalome: Potential therapeutic interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744501/
45484,Disease severity during SARS-COV-2 reinfection: a nationwide study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786677/
45485,Antibody responses and SARS-CoV-2 infection after BNT162b2 mRNA booster vaccination among healthcare workers in Japan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296373/
45486,"Vaccination willingness, vaccine hesitancy, and estimated coverage of SARS‐CoV‐2 vaccine among healthcare workers in Tanzania: A call for action",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10750438/
45487,Multiple Sclerosis Patients and Disease Modifying Therapies: Impact on Immune Responses against COVID-19 and SARS-CoV-2 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876554/
45488,Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733686/
45489,mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179023/
45490,"The public’s role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598529/
45491,Adverse Events and Safety of SARS-CoV-2 Vaccines: What’s New and What’s Next,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085443/
45492,Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857405/
45493,Variants of SARS-CoV-2: Influences on the Vaccines’ Effectiveness and Possible Strategies to Overcome Their Consequences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051174/
45494,Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376308/
45495,Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320437/
45496,"A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673752/
45497,Challenges and Recent Advancements in COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059828/
45498,Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11035709/
45499,Multi-omics for COVID-19: driving development of therapeutics and vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627145/
45500,Vaccination is the most effective and best way to avoid the disease of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408370/
45501,Coronavirus Disease 2019 (COVID-19) Pandemic across Africa: Current Status of Vaccinations and Implications for the Future,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504201/
45502,COVID-19: breaking down a global health crisis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129964/
45503,New insights on possible vaccine development against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484811/
45504,A reasoned approach towards administering COVID‐19 vaccines to pregnant women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362094/
45505,The level and determinants of COVID-19 vaccine acceptance in Ghana,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9269973/
45506,Anaphylaxis and Related Events Following COVID‐19 Vaccination: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349886/
45507,"Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923678/
45508,Lancet. 2022 Jun 11; 399(10342): 2190. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183211/
45509,Immunomodulation of COVID‐19 severity by helminth co‐infection: Implications for COVID‐19 vaccine efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926508/
45510,Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269828/
45511,Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799473/
45512,COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359622/
45513,Development of leading first-generation vaccines against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133830/
45514,A systematic review of current status and challenges of vaccinating children against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557115/
45515,"COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact—an updated review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969349/
45516,Infectious disease mRNA vaccines and a review on epitope prediction for vaccine design,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194884/
45517,COVID-19: systemic pathology and its implications for therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692150/
45518,Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212142/
45519,COVID-19 vaccines: Frequently asked questions and updated answers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910656/
45520,"A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426593/
45521,Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10943180/
45522,Assessment of COVID-19 vaccination among healthcare workers in Iraq; adverse effects and hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674125/
45523,Cellular and Molecular Mechanisms of Pathogenic and Protective Immune Responses to SARS-CoV-2 and Implications of COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053541/
45524,Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166166/
45525,"COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874732/
45526,"Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081433/
45527,Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316835/
45528,COVID-19 vaccines: Update of the vaccines in use and under development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217136/
45529,"Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660177/
45530,Limited induction of SARS-CoV-2–specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876428/
45531,COVID-19 Vaccines: An Updated Overview of Different Platforms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687223/
45532,Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016444/
45533,"Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491202/
45534,Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267508/
45535,Recent Update of COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106961/
45536,"Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043613/
45537,"Recombinant protein vaccines, a proven approach against coronavirus pandemics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788321/
45538,T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303130/
45539,"COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013908/
45540,An Appraisal of the Current Scenario in Vaccine Research for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310376/
45541,"Artificial Intelligence-Based Data-Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279074/
45542,Potential treatments of COVID-19: Drug repurposing and therapeutic interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930377/
45543,Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305266/
45544,Influenza virus and SARS-CoV-2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722349/
45545,SARS-CoV-2 Vaccine Development: Current Status,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392072/
45546,Myocarditis Following COVID-19 Vaccine Use: Can It Play a Role for Conditioning Immunization Schedules?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271782/
45547,A review of the potential neurological adverse events of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668235/
45548,Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183637/
45549,"The anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, minimally impacts the endogenous immune response to COVID-19 vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210450/
45550,"Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395427/
45551,Third COVID-19 vaccine dose boosts antibody function in Rwandans with high HIV viral load,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558770/
45552,Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910541/
45553,Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861463/
45554,Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9725157/
45555,COVID-19 vaccines: Considering sex differences in efficacy and safety,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824304/
45556,Zebrafish models of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841970/
45557,"Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436060/
45558,Trajectory of COVID-19 vaccine hesitancy post-vaccination and public’s intention to take booster vaccines: A cross-sectional analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332231/
45559,COVID-19 immunity and vaccines: what a pharmacist needs to know,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388771/
45560,Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286992/
45561,"The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960999/
45562,"Longevity and Neutralizing Capacity of IgG Antibodies against SARS-CoV-2 Generated by the Application of BNT162b2, AZD1222, Convidecia, Sputnik V, and CoronaVac Vaccines: a Cohort Study in the Mexican Population",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927513/
45563,The Effects of COVID-19 Vaccination on Lactating Women: A Systematic Review of the Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024041/
45564,How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386070/
45565,"The COVID-19 Vaccines: Recent Development, Challenges and Prospects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067284/
45566,mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733218/
45567,"COVID-19, Vaccines, and Thrombotic Events: A Narrative Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880092/
45568,Efficacy and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948677/
45569,Recent advances in the vaccine development for the prophylaxis of SARS Covid-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381430/
45570,Considerations for vaccinating children against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373744/
45571,"COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927760/
45572,"Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722419/
45573,Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444584/
45574,Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566665/
45575,Association of SARS-CoV-2 Vaccination or Infection With Bell Palsy: A Systematic Review and Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141297/
45576,The Use of COVID-19 Vaccines in Patients with SLE,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586600/
45577,Acceptance and willingness to pay under the different COVID-19 vaccines: A contingent valuation method,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167635/
45578,A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475528/
45579,An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654464/
45580,Circular RNA vaccines against SARS-CoV-2 and emerging variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971115/
45581,Impact of COVID-19 on male urogenital health: Success of vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316714/
45582,Topics in Antivax and Provax Discourse: Yearlong Synoptic Study of COVID-19 Vaccine Tweets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411425/
45583,Vaccine nationalism and internationalism: perspectives of COVID-19 vaccine trial participants in the United Kingdom,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526520/
45584,"Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542872/
45585,SARS-CoV-2–Specific Vaccine Candidates; the Contribution of Structural Vaccinology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877865/
45586,A Community-Based Participatory Research Approach to Developing and Testing Social and Behavioural Interventions to Reduce the Spread of SARS-CoV-2: A Protocol for the ‘COPAR for COVID’ Programme of Research with Five Interconnected Studies in the Hong Kong Context,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603243/
45587,Could live attenuated vaccines better control COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354792/
45588,Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168935/
45589,"Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901381/
45590,Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237901/
45591,Positive attitudes towards COVID-19 vaccines: A cross-country analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912241/
45592,The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394394/
45593,"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351583/
45594,Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989408/
45595,Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142517/
45596,Indirect Dispersion of SARS-CoV-2 Live-Attenuated Vaccine and Its Contribution to Herd Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055900/
45597,Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828434/
45598,"COVID-19 and pregnancy: clinical outcomes; mechanisms, and vaccine efficacy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371980/
45599,"Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260568/
45600,Misinformation about vaccine safety and uptake of COVID-19 vaccines among adults and 5–11-year-olds in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492517/
45601,Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191606/
45602,The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767501/
45603,Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10974902/
45604,Changes in COVID-19 vaccine acceptance rate among recovered critically Ill patients: A 12-month follow-up study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542446/
45605,Overview of Nonhuman Primate Models of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594265/
45606,The Lancet Commission on lessons for the future from the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539542/
45607,mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813741/
45608,A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675757/
45609,PLoS Pathog. 2022 Nov; 18(11): e1011000. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707784/
45610,Tracking trends in COVID-19 vaccines based on 47 different vaccines: A bibliometric review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416739/
45611,The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271749/
45612,"Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406542/
45613,SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430572/
45614,Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539635/
45615,SARS-CoV-2 and male infertility: from short- to long-term impacts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013302/
45616,Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031022/
45617,Immune-mediated approaches against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355525/
45618,COVID-19 Outcomes and Vaccination in Patients with Spondyloarthritis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124289/
45619,"Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523321/
45620,"COVID-19: Progress in diagnostics, therapy and vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359073/
45621,"Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257064/
45622,Viral targets for vaccines against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747004/
45623,Development of synthetic antigen vaccines for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506811/
45624,"Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481764/
45625,COVID-19 vaccine challenges: What have we learned so far and what remains to be done?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997052/
45626,"COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314268/
45627,A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247891/
45628,Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017870/
45629,Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282104/
45630,Clin Infect Dis. 2021 Aug 6 : ciab687. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436392/
45631,"A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862159/
45632,SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759609/
45633,Effector-Memory B-Lymphocytes and Follicular Helper T-Lymphocytes as Central Players in the Immune Response in Vaccinated and Nonvaccinated Populations against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607383/
45634,"COVID-19: Immunology, Immunopathogenesis and Potential Therapies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919479/
45635,"What Demographic, Social, and Contextual Factors Influence the Intention to Use COVID-19 Vaccines: A Scoping Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431323/
45636,SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680029/
45637,Rapid development of analytical methods for evaluating pandemic vaccines: a COVID-19 perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516068/
45638,Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353007/
45639,Immune response in COVID-19: what is next?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110941/
45640,"Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917454/
45641,Effectiveness and Safety of COVID-19 Vaccine among Pregnant Women in Real-World Studies: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879911/
45642,"Women’s views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: a multi-methods study in the UK",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759061/
45643,Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247969/
45644,"COVID-19 Vaccine Acceptability Among People Experiencing Homelessness in Central Florida and Southern Nevada, March-June 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555610/
45645,"Formulation, Device, and Clinical Factors Influencing the Targeted Delivery of COVID-19 Vaccines to the Lungs",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684852/
45646,Cardiovascular and haematological events post COVID‐19 vaccination: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817142/
45647,"Immunogenicity and efficacy of Ad26.COV2.S, an adenoviral vector–based COVID-19 vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349621/
45648,Marginal effects of public health measures and COVID-19 disease burden in China: A large-scale modelling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538769/
45649,Single‐cell transcriptomic atlas reveals distinct immunological responses between COVID‐19 vaccine and natural SARS‐CoV‐2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350186/
45650,COVID-19 vaccination and liver disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827578/
45651,Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046074/
45652,The COVID-19 pandemic — what have urologists learned?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007269/
45653,Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 Vaccine: a 6-month population-based cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411798/
45654,A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741840/
45655,A review on the induction of host immunity by the current COVID-19 vaccines and a brief non-pharmaceutical intervention to mitigate the pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853290/
45656,Vaccines Against COVID-19: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953736/
45657,SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268159/
45658,Impact of COVID-19 on Cardiovascular Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962056/
45659,Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952855/
45660,COVID-19 Research: Lessons from Non-Human Primate Models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402317/
45661,"COVID-19 vaccines: rapid development, implications, challenges and future prospects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937046/
45662,COVID-19 in patients with hematologic malignancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098396/
45663,"Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220944/
45664,Uncovering the information immunology journals transmitted for COVID-19: A bibliometric and visualization analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670819/
45665,Translating known drivers of COVID-19 disease severity to design better SARS-CoV-2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664555/
45666,"Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585490/
45667,Misinformation of COVID-19 vaccines and vaccine hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366757/
45668,"SARS-CoV-2 pre-exposure prophylaxis: A potential COVID-19 preventive strategy for high-risk populations, including healthcare workers, immunodeficient individuals, and poor vaccine responders",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393547/
45669,The COVID-19 Vaccine and Pregnant Minority Women in the US: Implications for Improving Vaccine Confidence and Uptake,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784552/
45670,Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107063/
45671,"mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10748114/
45672,Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939774/
45673,Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241372/
45674,PLoS Med. 2023 Jul; 20(7): e1004268. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356153/
45675,Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969402/
45676,The Social Ecological Model: A Framework for Understanding COVID-19 Vaccine Uptake among Healthcare Workers—A Scoping Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536505/
45677,"Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999280/
45678,COVID-19 in early 2021: current status and looking forward,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938042/
45679,"Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535431/
45680,"Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639796/
45681,Lancet Infect Dis. 2023 Jan; 23(1): e1. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640201/
45682,A Review of the Progress and Challenges of Developing a Vaccine for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591699/
45683,"Pediatricians’ perceptions, practices, and barriers regarding COVID-19 vaccine for children: A cross-sectional survey in Ontario, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067459/
45684,Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021367/
45685,Humoral immune response after COVID-19 infection or BNT162b2 vaccine among older adults: evolution over time and protective thresholds,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990277/
45686,Influences of social media usage on public attitudes and behavior toward COVID-19 vaccine in the Arab world,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481138/
45687,Serosurveillance among urban slum and non-slum populations immunized with COVID-19 vaccines in Bangladesh,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10804132/
45688,Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595936/
45689,"Persistent Health Issues, Adverse Events, and Effectiveness of Vaccines during the Second Wave of COVID-19: A Cohort Study from a Tertiary Hospital in North India",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319407/
45690,Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712944/
45691,"COVID-19 Vaccination in Korea: Past, Present, and the Way Forward",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723191/
45692,Effects of SARS-CoV-2 Vaccines on Sperm Quality: Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10702876/
45693,SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894219/
45694,Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960567/
45695,Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082173/
45696,Immunological Study of Combined Administration of SARS-CoV-2 DNA Vaccine and Inactivated Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228235/
45697,Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788580/
45698,Better Understanding Adult COVID-19 Vaccination Hesitancy and Refusal: The Influence of Broader Beliefs about Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180283/
45699,"COVID-19 Vaccination in Cancer Patients: A Review
Article",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459453/
45700,The Immunopathobiology of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632753/
45701,"mRNA vaccines for infectious diseases: principles, delivery and clinical translation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386155/
45702,Nat Rev Drug Discov. 2021; 20(11): 880. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895108/
45703,A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020838/
45704,"Adenoviral-vectored next-generation respiratory mucosal
vaccines against COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172971/
45705,"Emerging trends of edible vaccine therapy for combating human diseases especially COVID‐19: Pros, cons, and future challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347755/
45706,Perspectives About Modulating Host Immune System in Targeting SARS-CoV-2 in India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921795/
45707,"Development of variant‐proof severe acute respiratory syndrome coronavirus 2, pan‐sarbecovirus, and pan‐β‐coronavirus vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538210/
45708,Do we miss rare adverse events induced by COVID-19 vaccination?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589063/
45709,Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085771/
45710,"COVID-19 vaccine hesitancy among people living with HIV in a low-resource setting: A multi-center study of prevalence, correlates and reasons",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946883/
45711,Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523127/
45712,"Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334936/
45713,Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173604/
45714,Behavioural Determinants of COVID-19-Vaccine Acceptance in Rural Areas of Six Lower- and Middle-Income Countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875839/
45715,COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238037/
45716,COVID‐19 vaccines: what do we know so far?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420457/
45717,"A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094131/
45718,"Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226031/
45719,Real-World Effectiveness of SARS-CoV-2 Vaccine Booster in Hemodialysis Patients with COVID-19 Receiving Molnupiravir,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967999/
45720,Overview of Nucleocapsid-Targeting Vaccines against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10747980/
45721,"Surveillance for Multisystem Inflammatory Syndrome in US Children Aged 5–11 Years Who Received Pfizer-BioNTech COVID-19 Vaccine, November 2021 through March 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563003/
45722,"COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911532/
45723,"Effectiveness of a nationwide COVID-19 vaccination program in Mexico against symptomatic COVID-19, hospitalizations, and death: a retrospective analysis of national surveillance data",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918316/
45724,COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556541/
45725,Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769538/
45726,The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine: A Retrospective Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855786/
45727,SARS-CoV-2 in immunocompromised individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468314/
45728,COVID-19 vaccination intention and hesitancy: Mistrust on COVID-19 vaccine benefit a major driver for vaccine hesitancy among healthcare workers; a cross-sectional study in North India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351420/
45729,"The Coronavirus pandemic – 2022: Viruses, variants & vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839804/
45730,Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342588/
45731,"COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126225/
45732,"Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613973/
45733,Effectiveness and Efficacy of Vaccine on Mutated SARS-CoV-2 Virus and Post Vaccination Surveillance: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777947/
45734,Factors Influencing the Acceptance of COVID-19 Vaccines in a Country with a High Vaccination Rate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145438/
45735,COVID-19 Vaccine Effectiveness: A Review of the First 6 Months of COVID-19 Vaccine Availability (1 January–30 June 2021),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951318/
45736,Development of virus‐like particles‐based vaccines against coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537895/
45737,"Smart Nanostructured Materials for SARS-CoV-2 and Variants Prevention, Biosensing and Vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775677/
45738,"Effects of vaccination, new SARS-CoV-2 variants and reinfections on post-COVID-19 complications",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372538/
45739,Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025068/
45740,"Association of BNT162b2 Vaccine Third Dose Receipt With Incidence of SARS-CoV-2 Infection, COVID-19–Related Hospitalization, and Death Among Residents of Long-term Care Facilities, August to October 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250055/
45741,ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307634/
45742,"COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459904/
45743,Advanced Vaccine Design Strategies against SARS-CoV-2 and Emerging Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951973/
45744,Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542941/
45745,Defending against SARS-CoV-2: The T cell perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911802/
45746,Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494270/
45747,"A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957225/
45748,Role of genomics in combating COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894692/
45749,Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953067/
45750,COVID-19 Vaccination Effectiveness in the General Population of an Italian Province: Two Years of Follow-Up,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459219/
45751,Effectiveness of COVID-19 vaccines and their challenges (Review),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524740/
45752,Characterization of the First SARS-CoV-2 Isolates from Aotearoa New Zealand as Part of a Rapid Response to the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877023/
45753,Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863418/
45754,COVID-19 vaccine effectiveness and variants in Nepal: study protocol for a test-negative case–control study with SARS-CoV-2 genetic sequencing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123857/
45755,A comprehensive insight on the challenges for COVID-19 vaccine: A lesson learnt from other viral vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245239/
45756,"Immunogenicity, effectiveness, safety and psychological impact of COVID-19 mRNA vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359511/
45757,Reported Adverse Effects and Attitudes among Arab Populations Following COVID-19 Vaccination: A Large-Scale Multinational Study Implementing Machine Learning Tools in Predicting Post-Vaccination Adverse Effects Based on Predisposing Factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955470/
45758,A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752025/
45759,COVID-19 Vaccines for Adults and Children with Autoimmune Gut or Liver Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781431/
45760,Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778858/
45761,"Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537675/
45762,Perspectives on RNA Vaccine Candidates for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044912/
45763,"Assessment of the Immune Response in Patients with Insulin Resistance, Obesity, and Diabetes to COVID-19 Vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383449/
45764,SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817149/
45765,Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651100/
45766,Clinical progress of therapeutics and vaccines: Rising hope against COVID-19 treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008982/
45767,COVID-19: Coronavirus Vaccine Development Updates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785583/
45768,Insights into new-onset autoimmune diseases after COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108562/
45769,"Current Therapeutics for COVID-19, What We Know about the Molecular Mechanism and Efficacy of Treatments for This Novel Virus",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319826/
45770,Immune interference in effectiveness of influenza and COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154574/
45771,Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579910/
45772,Wuhan to World: The COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042280/
45773,A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576135/
45774,Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904156/
45775,mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10783604/
45776,Conditionality of COVID-19 vaccine acceptance in European countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806150/
45777,Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687542/
45778,Challenges and prospects of COVID‐19 vaccine development based on the progress made in SARS and MERS vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461374/
45779,Modelling optimal vaccination strategies against COVID-19 in a context of Gamma variant predominance in Brazil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527216/
45780,A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326230/
45781,Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159263/
45782,COVID-19 Vaccines: An Overview of Different Platforms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869214/
45783,"Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589856/
45784,Nat Rev Gastroenterol Hepatol. 2023; 20(3): 195. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836328/
45785,"Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502079/
45786,Adv Drug Deliv Rev. 2022 Oct; 189: 114501. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413842/
45787,Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10928100/
45788,Misinformation About COVID-19 Vaccines on Social Media: Rapid Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359307/
45789,Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2–induced lung exudative vasculitis and predicts COVID-19 severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388124/
45790,Vaccine and vaccination as a part of human life: In view of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646257/
45791,"Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265248/
45792,Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527104/
45793,Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919858/
45794,"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099315/
45795,Lancet. 2021 17-23 July; 398(10296): 212. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285114/
45796,Intention to vaccinate against COVID-19 and adherence to non-pharmaceutical interventions against COVID-19 prior to the second wave of the pandemic in Uganda: a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163003/
45797,SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212873/
45798,Maternal COVID-19 Vaccination and Its Potential Impact on Fetal and Neonatal Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617890/
45799,Vaccines (Basel). 2022 Nov; 10(11): 1925. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697509/
45800,Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552678/
45801,A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329957/
45802,SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942461/
45803,"Immunity, endothelial injury and complement-induced coagulopathy in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570423/
45804,Vaccines platforms and COVID-19: what you need to know,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537331/
45805,Facilitators and barriers to COVID-19 vaccine uptake among women in two regions of Ghana: A qualitative study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385066/
45806,Immune Response to COVID-19 and mRNA Vaccination in Immunocompromised Individuals: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132351/
45807,Immunogenicity of SARS-CoV-2 vaccines in patients with cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345889/
45808,The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337479/
45809,Vaccine based on folded RBD‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111473/
45810,Role of the Microbiome in the Pathogenesis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009446/
45811,The immunology of SARS-CoV-2 infections and vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670910/
45812,Immunology of SARS-CoV-2 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182659/
45813,Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733302/
45814,Mucosal delivery of nanovaccine strategy against COVID-19 and its variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676163/
45815,"COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842412/
45816,COVID-19 Vaccination Hesitancy among Healthcare Workers—A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227837/
45817,Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431281/
45818,Severe COVID-19 versus multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032586/
45819,An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547679/
45820,Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576691/
45821,Studying SARS-CoV-2 vaccine hesitancy among health professionals in Tunisia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004208/
45822,"Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571424/
45823,Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906453/
45824,"Pregnancy and COVID-19: prevention, vaccination, therapy, and beyond",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771011/
45825,Current and Emerging Knowledge in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846833/
45826,Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974059/
45827,The Reassessed Potential of SARS-CoV-2 Attenuation for COVID-19 Vaccine Development—A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146402/
45828,The Willingness of Elderly Taiwanese Individuals to Accept COVID-19 Vaccines after the First Local Outbreak,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032573/
45829,"SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876838/
45830,Immunobiology and immunotherapy of COVID‐19: A clinically updated overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675260/
45831,"Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial ",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520577/
45832,BMJ. 2023; 382: p2193. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518699/
45833,COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677491/
45834,Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595377/
45835,"Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and immunity after natural SARS-CoV-2 infection—A comparative study from Novi Sad, Serbia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809561/
45836,Hybrid and vaccine‐induced immunity against SAR‐CoV‐2 in MS patients on different disease‐modifying therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538694/
45837,Ann Clin Transl Neurol. 2023 Feb; 10(2): 297. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930418/
45838,Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699414/
45839,Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574042/
45840,Brief review on repurposed drugs and vaccines for possible treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905377/
45841,Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622386/
45842,"Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229378/
45843,"Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053562/
45844,A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317023/
45845,Hesitancy toward vaccination against COVID-19: A scoping review of prevalence and associated factors in the Arab world,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443971/
45846,"Prevalence of risk behaviors and correlates of SARS-CoV-2 positivity among in-school contacts of confirmed cases in a Georgia school district in the pre-vaccine era, December 2020–January 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759220/
45847,"COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381432/
45848,An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173993/
45849,Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897647/
45850,Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576507/
45851,Predictors of second COVID‐19 booster dose or new COVID‐19 vaccine hesitancy among nurses: A cross‐sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878136/
45852,The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981974/
45853,Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968608/
45854,"General publics’ perception toward COVID-19 vaccines in Afghanistan, 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339775/
45855,COVID-19 vaccines for children and adolescents in Africa: aligning our priorities to situational realities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844950/
45856,"Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767775/
45857,"Immediate Hypersensitivity Reactions Induced by COVID-19 Vaccines: Current Trends, Potential Mechanisms and Prevention Strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219714/
45858,"Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682370/
45859,Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611039/
45860,SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835786/
45861,"COVID-19 vaccine acceptance, hesitancy, and associated factors among medical students in Sudan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989287/
45862,COVID-19 mRNA vaccine protects against SARS-CoV-2 Omicron BA.1 infection in diet-induced obese mice through boosting host innate antiviral responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970285/
45863,Predictors of COVID-19 vaccine hesitancy in Chad: A cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846328/
45864,A Guide to COVID‐19: a global pandemic caused by the novel coronavirus SARS‐CoV‐2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283703/
45865,"A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179092/
45866,"Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959423/
45867,Safety of COVID-19 Vaccines: Spotlight on Neurological Complications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502976/
45868,A systematic review on mucocutaneous presentations after COVID‐19 vaccination and expert recommendations about vaccination of important immune‐mediated dermatologic disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111423/
45869,Coronavirus Disease-2019 Vaccine Hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729588/
45870,Major Insights in Dynamics of Host Response to SARS-CoV-2: Impacts and Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424194/
45871,Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647069/
45872,A systematic review assessing the effectiveness of COVID-19 mRNA vaccines in chronic kidney disease (CKD) individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732501/
45873,COVID-19 vaccine perceptions in the initial phases of US vaccine roll-out: an observational study on reddit,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899002/
45874,The Race for COVID-19 Vaccines: The Various Types and Their Strengths and Weaknesses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207585/
45875,Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333977/
45876,Analyses of reported severe adverse events after immunization with SARS-CoV-2 vaccines in the United States: One year on,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610110/
45877,COVID-19 Vaccination Responses with Different Vaccine Platforms in Patients with Inborn Errors of Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574808/
45878,Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931657/
45879,Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523015/
45880,Warp Speed for Coronavirus Disease 2019 (COVID-19) Vaccines: Why Are Children Stuck in Neutral?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543330/
45881,Misinformation and COVID-19 vaccine hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659512/
45882,Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724446/
45883,"A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767042/
45884,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723445/
45885,Lancet. 2021 9-15 January; 397(10269): 98. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808126/
45886,COVID-19 Therapeutic Potential of Natural Products,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254072/
45887,The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385870/
45888,Prevalence and factors associated with COVID-19 vaccine acceptance in Zambia: a web-based cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994469/
45889,"Beliefs, barriers and hesitancy towards the COVID-19 vaccine among Bangladeshi residents: Findings from a cross-sectional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398020/
45890,Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824221/
45891,Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781318/
45892,"The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humans",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939769/
45893,Addressing COVID-19 vaccine hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225513/
45894,An update on host immunity correlates and prospects of re-infection in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787841/
45895,"The Chemokines CXC, CC and C in the Pathogenesis of COVID-19 Disease and as Surrogates of Vaccine-Induced Innate and Adaptive Protective Responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416781/
45896,Towards a population-based threshold of protection for COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673730/
45897,SARS-CoV-2 vaccine candidates in rapid development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993188/
45898,Immunogenicity and Effectiveness of Primary and Booster Vaccine Combination Strategies during Periods of SARS-CoV-2 Delta and Omicron Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607825/
45899,COVID-19 Vaccines: Adenoviral Vectors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795482/
45900,Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885691/
45901,Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444709/
45902,Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095229/
45903,Cell Rep Med. 2021 Jul 20; 2(7): 100354. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253687/
45904,COVID-19 vaccine uptake and its associated factors among Palestinian healthcare workers: Expectations beaten by reality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098917/
45905,COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553271/
45906,"Evaluation of Conspiracy Beliefs, Vaccine Hesitancy, and Willingness to Pay towards COVID-19 Vaccines in Six Countries from Asian and African Regions: A Large Multinational Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694922/
45907,Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260046/
45908,On the road to ending the COVID-19 pandemic: Are we there yet?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908885/
45909,"Parents’Attitudes, Their Acceptance of the COVID-19 Vaccines for Children and the Contributing Factors in Najran, Saudi Arabia: A Cross-Sectional Survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414087/
45910,Dynamical modelling of viral infection and cooperative immune protection in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501599/
45911,Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2.2 in China: A case–control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088971/
45912,"COVID-19, Myocarditis and Pericarditis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171304/
45913,Coronavirus Disease 2019 Vaccinations in Patients With Chronic Liver Disease and Liver Transplant Recipients: An Update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257133/
45914,From the environment to the cells: An overview on pivotal factors which affect spreading and infection in COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236413/
45915,Therapeutic Approaches to the Neurologic Manifestations of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302225/
45916,Clinical Syndromes Related to SARS-CoV-2 Infection and Vaccination in Pediatric Age: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673592/
45917,COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410227/
45918,The COVID-19 vaccine development: A pandemic paradigm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127526/
45919,Advances in Next-Generation Coronavirus Vaccines in Response to Future Virus Evolution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785936/
45920,Treatments for COVID-19: Lessons from 2020 and new therapeutic options,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598952/
45921,Adverse Events following Immunization with COVID-19 Vaccines: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398801/
45922,"Investigating Virological, Immunological, and Pathological Avenues to Identify Potential Targets for Developing COVID-19 Treatment and Prevention Strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563267/
45923,"Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709697/
45924,A comprehensive review on potential therapeutics interventions for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677683/
45925,The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390120/
45926,Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886553/
45927,Current view on novel vaccine technologies to combat human infectious diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661323/
45928,Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806161/
45929,A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628444/
45930,NPJ Vaccines. 2022; 7: 150. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684560/
45931,"Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012893/
45932,Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519339/
45933,Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253687/
45934,"The Application
of Biomaterials for the Vaccine, Treatment, and Detection of SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851365/
45935,"The SARS-CoV-2 Antibodies, Their Diagnostic Utility, and Their Potential for Vaccine Development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412318/
45936,Innovative vaccine platforms against infectious diseases: Under the scope of the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527590/
45937,Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July–December 2020),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634074/
45938,COVID-19 vaccine literacy: A scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026896/
45939,Measures to Increase Immunogenicity of SARS-CoV-2 Vaccines in Solid Organ Transplant Recipients: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10748337/
45940,"Aggregating human judgment probabilistic predictions of the safety, efficacy, and timing of a COVID-19 vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882426/
45941,State of the art in epitope mapping and opportunities in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987558/
45942,"Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January–March 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434543/
45943,Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968619/
45944,Acceptance or Rejection of the COVID-19 Vaccine: A Study on Iranian People’s Opinions toward the COVID-19 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143028/
45945,"COVID-19 Vaccine Acceptability Among Healthcare Facility Workers in Sierra Leone, the Democratic Republic of Congo and Uganda: A Multi-Centre Cross-Sectional Survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537362/
45946,"Predictors of COVID-19 Vaccine Acceptance, Intention, and Hesitancy: A Scoping Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414566/
45947,"Methodology-Centered Review of Molecular Modeling,
Simulation, and Prediction of SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159519/
45948,"COVID-19 Epidemiology, Immunity, and Vaccine Development in Children: A Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781884/
45949,"The relevant information about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using the five-question approach (when, where, what, why, and how) and its impact on the environment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852932/
45950,Expert-Led Module Improves Non-STEM Undergraduate Perception of and Willingness to Receive COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157538/
45951,A modeling-based approach to optimize COVID-19 vaccine dosing schedules for improved protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371350/
45952,Evaluation of the systemic and mucosal immune response induced by COVID-19 and the BNT162b2 mRNA vaccine for SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578597/
45953,"SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188822/
45954,"Factors, enablers and challenges for COVID-19 vaccine development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255030/
45955,"Immunogenicity, effectiveness, and safety of COVID-19 vaccines among children and adolescents aged 2–18 years: an updated systematic review and meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890438/
45956,"Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109707/
45957,A statistical look at the COVID-19 vaccine development and vaccine policies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760853/
45958,Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927227/
45959,De-escalation of asymptomatic testing and potential of future COVID-19 outbreaks in US nursing homes amidst rising community vaccination coverage: A modeling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013672/
45960,"From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917907/
45961,Viral Load in COVID-19 Patients: Implications for Prognosis and Vaccine Efficacy in the Context of Emerging SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841511/
45962,Determinants of acceptance of Coronavirus disease-2019 (COVID-19) vaccine among Lebanese health care workers using health belief model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863223/
45963,COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709613/
45964,Does potential antibody-dependent enhancement occur during SARS-CoV-2 infection after natural infection or vaccination? A meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483537/
45965,Vaccination against COVID-19 and society’s return to normality in England: a modelling study of impacts of different types of naturally acquired and vaccine-induced immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595291/
45966,Managing the Impact of COVID-19 in Nursing Homes and Long-Term Care Facilities: An Update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250924/
45967,Therapeutic strategies for COVID-19: progress and lessons learned,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113999/
45968,Cross-protection and cross-neutralization capacity of ancestral and VOC-matched SARS-CoV-2 adenoviral vector-based vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550992/
45969,Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565686/
45970,Comparative Analysis of Antibody Titers against the Spike Protein of SARS-CoV-2 Variants in Infected Patient Cohorts and Diverse Vaccination Regimes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602709/
45971,COVID-19 vaccine behaviors and intentions among a national sample of United States adults ages 18–45,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988441/
45972,Correlates of Coronavirus Disease 2019 (COVID-19) Vaccine Hesitancy Among People Who Inject Drugs in the San Diego-Tijuana Border Region,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690110/
45973,Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130539/
45974,Understanding the immunological aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378842/
45975,Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095041/
45976,"Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832772/
45977,Biomarkers of COVID-19 and technologies to combat SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435336/
45978,T‐cell responses and therapies against SARS‐CoV‐2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730020/
45979,A Comprehensive Analysis of COVID-19 Vaccine Discourse by Vaccine Brand on Twitter in Korea: Topic and Sentiment Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891356/
45980,"A Survey of Awareness of COVID-19 Knowledge, Willingness and Influencing Factors of COVID-19 Vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027136/
45981,The Race for Global Equitable Access to COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412387/
45982,Neutralization assays for SARS-CoV-2: Implications for assessment of protective efficacy of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552365/
45983,Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288314/
45984,"Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258784/
45985,Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868365/
45986,SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938271/
45987,Nat Med. 2022; 28(3): 599. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815288/
45988,COVID-19 vaccines adverse events: potential molecular mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821369/
45989,A global survey in the developmental landscape of possible vaccination strategies for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865932/
45990,Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564421/
45991,Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151685/
45992,SARS-CoV-2: Targeted managements and vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706592/
45993,Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845038/
45994,Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016647/
45995,Nat Microbiol. 2022 Dec; 7(12): 1996–2010. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166187/
45996,Timing of last COVID-19 vaccine dose and SARS-CoV-2 breakthrough infections in fully (boosted) vaccinated healthcare personnel,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721165/
45997,"Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675435/
45998,"Molecular Mimicry of the Viral Spike in the SARS-CoV-2 Vaccine Possibly Triggers Transient Dysregulation of ACE2, Leading to Vascular and Coagulation Dysfunction Similar to SARS-CoV-2 Infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222462/
45999,Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248013/
46000,Transplacental Transfer of Maternal Antibody against SARS-CoV-2 and Its Influencing Factors: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318929/
46001,Microneedles: An Emerging Vaccine Delivery Tool and a Prospective Solution to the Challenges of SARS-CoV-2 Mass Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222661/
46002,"Factors associated with COVID-19 vaccination intent in Singapore, Australia and Hong Kong",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979826/
46003,Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515900/
46004,Drivers of the Intention to Receive a COVID-19 Booster Vaccine: Insights from the UK and Australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607201/
46005,COVID-19 in Latin America: A Snapshot in Time and the Road Ahead,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835740/
46006,"SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473168/
46007,Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973339/
46008,Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727711/
46009,Safety and Efficacy of the Common Vaccines against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027683/
46010,Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146933/
46011,Why Does the Severity of COVID-19 Differ With Age?: Understanding the Mechanisms Underlying the Age Gradient in Outcome Following SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740029/
46012,Spectrum of neurological complications following COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557950/
46013,“Any idea how fast ‘It’s just a mask!’ can turn into ‘It’s just a vaccine!’”: From mask mandates to vaccine mandates during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552554/
46014,Plant-derived immuno-adjuvants in vaccines formulation: a promising avenue for improving vaccines efficacy against SARS-CoV-2 virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487851/
46015,A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928010/
46016,"Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754925/
46017,Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885829/
46018,Insights into the evolutionary and prophylactic analysis of SARS-CoV-2: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610842/
46019,Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201272/
46020,Genomic communication via circulating extracellular vesicles and long-term health consequences of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563316/
46021,A Path Forward: COVID-19 Vaccine Equity Community Education and Outreach Initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079247/
46022,Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989890/
46023,COVID-19 Vaccine–Related Attitudes and Beliefs in Canada: National Cross-sectional Survey and Cluster Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709417/
46024,Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970234/
46025,Significant perspectives on various viral infections targeted antiviral drugs and vaccines including COVID-19 pandemicity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283561/
46026,Influence of the COVID-19 pandemic and social media on the behaviour of pregnant and lactating women towards vaccination: a scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922880/
46027,The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322591/
46028,A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356061/
46029,Awareness of and attitude toward COVID-19 vaccination among individuals with COPD and the strategies to overcome vaccine hesitation: A mini review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10732662/
46030,Multidimensional futuristic approaches to address the pandemics beyond COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257889/
46031,A COVID-19 primer for primary care clinicians,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919786/
46032,Controlled Human Infection Models To Accelerate Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491212/
46033,Pharmacological strategies to prevent SARS-CoV-2 infection and treat the early phases of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816887/
46034,"Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161727/
46035,Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449013/
46036,Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154542/
46037,Broad-spectrum pan-genus and pan-family virus vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265776/
46038,Safety surveillance and challenges in accelerated COVID-19 vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444812/
46039,"Exploring the attitudes, concerns, and knowledge regarding COVID-19 vaccine by the parents of children with rheumatic disease: Cross-sectional online survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813553/
46040,Antibody tests for identification of current and past infection with SARS‐CoV‐2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671206/
46041,Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10981760/
46042,NPJ Sci Food. 2024; 8: 26. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11074247/
46043,SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567292/
46044,When good messages go wrong: Perspectives on COVID-19 vaccines and vaccine communication from generally vaccine accepting individuals in Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762838/
46045,"The Prevalence, Features, Influencing Factors, and Solutions for COVID-19 Vaccine Misinformation: Systematic Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838721/
46046,Bulk IgG glycosylation predicts COVID-19 severity and vaccine antibody response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678812/
46047,Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646037/
46048,COVID-19 Vaccine Uptake among Healthcare Workers: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610263/
46049,"Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696466/
46050,Insight into SARS-CoV-2 Omicron variant immune escape possibility and variant independent potential therapeutic opportunities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886571/
46051,COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412973/
46052,Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390300/
46053,Profiling COVID-19 Vaccine Adverse Events by Statistical and Ontological Analysis of VAERS Case Reports,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263450/
46054,COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734167/
46055,A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981522/
46056,Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604724/
46057,Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746457/
46058,SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385766/
46059,"Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583051/
46060,Design and Cross-Cultural Invariance of the COVID-19 Vaccine Conspiracy Beliefs Scale (COVID-VCBS) in 13 Latin American Countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237359/
46061,SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110310/
46062,Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985404/
46063,Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497190/
46064,Emerging trends of research on mRNA vaccines: A co-citation analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746488/
46065,"Investigating Attitudes, Motivations and Key Influencers for COVID-19 Vaccination Uptake among Late Adopters in Urban Zimbabwe",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958877/
46066,"A Review on COVID-19: Primary Receptor, Endothelial Dysfunction, Related Comorbidities, and Therapeutics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843681/
46067,Iran J Sci. 2023; 47(1): 325. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894734/
46068,Predictors of COVID-19 Vaccine Acceptance among Healthcare Workers in Nigeria,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610788/
46069,"Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing antibodies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585342/
46070,Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441183/
46071,Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851657/
46072,Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487019/
46073,"Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718396/
46074,Endocrine system after 2 years of COVID-19 vaccines: A narrative review of the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685624/
46075,Determinants of COVID-19 Vaccine Acceptability among Healthcare Workers in Kenya—A Mixed Methods Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459762/
46076,Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009586/
46077,COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496428/
46078,The hindrances to perform the COVID-19 vaccination in Brazil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828154/
46079,Application of Nanotechnology in the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847377/
46080,Factors influencing refugees’ willingness to accept COVID‐19 vaccines in Greater Sydney: a qualitative study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347689/
46081,Nano-carriers of COVID-19 vaccines: the main pillars of efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544481/
46082,Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521454/
46083,"Anti-COVID-19 Nanomaterials: Directions to Improve Prevention, Diagnosis, and Treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912597/
46084,Adverse Events Following Immunization With mRNA and Viral Vector Vaccines in Individuals With Previous Severe Acute Respiratory Syndrome Coronavirus 2 Infection From the Canadian National Vaccine Safety Network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620384/
46085,The Rise of Vectored Vaccines: A Legacy of the COVID-19 Global Crisis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538930/
46086,Real-world uptake of COVID-19 vaccination among individuals expressing vaccine hesitancy: A registry-linkage study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889259/
46087,Salivary Antibody Responses to Two COVID-19 Vaccines following Different Vaccination Regimens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146373/
46088,COVID-19 mRNA vaccine effectiveness against hospitalisation and death in veterans according to frailty status during the SARS-CoV-2 delta (B.1.617.2) variant surge in the USA: a retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342932/
46089,Lancet Healthy Longev. 2022 Sep; 3(9): e588. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448302/
46090,COVID-19 Vaccine Reactogenicity and Vaccine Attitudes Among Children and Parents/Guardians After Multisystem Inflammatory Syndrome in Children or COVID-19 Hospitalization: September 2021—May 2022,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935230/
46091,A comprehensive review of the analysis and integration of omics data for SARS-CoV-2 and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574485/
46092,Low COVID-19 Vaccine Acceptance Is Correlated with Conspiracy Beliefs among University Students in Jordan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967761/
46093,The (apparent) antibody paradox in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935454/
46094,A novel vaccine based on SARS-CoV-2 CD4+ and CD8+ T cell conserved epitopes from variants Alpha to Omicron,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537284/
46095,COVID-19 vaccine and pregnancy: A safety weapon against pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828426/
46096,"Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247514/
46097,A Meta-Analysis on the Safety and Immunogenicity of Covid-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998390/
46098,Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646827/
46099,"Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962595/
46100,The Potential of Nanobodies for COVID-19 Diagnostics and Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850341/
46101,"An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346325/
46102,Are People Willing to Take Regular COVID-19 Vaccines? Prevalence and Determinants of Hesitancy for Regular COVID-19 Vaccination: A Random Population-Based Survey in Hong Kong,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459211/
46103,"RNA Viruses, Pregnancy and Vaccination: Emerging Lessons from COVID-19 and Ebola Virus Disease",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322689/
46104,Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376347/
46105,The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863906/
46106,"Effectiveness of mRNA-1273, BNT162b2, and JNJ-78436735 COVID-19 Vaccines Among US Military Personnel Before and During the Predominance of the Delta Variant",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021911/
46107,Singular insights into the immunology of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414121/
46108,Assessing the transition of COVID-19 burden towards the young population while vaccines are rolled out in China*,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045766/
46109,COVID-19 Pathogenesis: From Molecular Pathway to Vaccine Administration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389702/
46110,Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021130/
46111,“We need to protect each other”: COVID-19 vaccination intentions and concerns among Racialized minority and Indigenous Peoples in Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519366/
46112,Multisystem Inflammatory Syndrome in Adults After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Coronavirus Disease 2019 (COVID-19) Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690151/
46113,Nucleic Acids as Biotools at the Interface between Chemistry and Nanomedicine in the COVID-19 Era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031702/
46114,"Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831445/
46115,DNA vaccines against COVID-19: Perspectives and challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749647/
46116,From Bench to the Clinic: The Path to Translation of Nanotechnology-Enabled mRNA SARS-CoV-2 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722410/
46117,Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371587/
46118,COVID-19 Mechanisms in the Human Body—What We Know So Far,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592035/
46119,"COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950852/
46120,"Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778136/
46121,COVID-19 Vaccines for Optimizing Immunity in the Upper Respiratory Tract,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674974/
46122,“I don’t think there’s a point for me to discuss it with my patients”: exploring health care providers’ views and behaviours regarding COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621068/
46123,COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857087/
46124,mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947943/
46125,Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579698/
46126,Insights for COVID-19 in 2023,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066911/
46127,"Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885419/
46128,Transl Neurodegener. 2023; 12: 23. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175047/
46129,Identifying early adopters of COVID-19 vaccines in Latin America,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584855/
46130,The Impact of COVID-19 on People Living with HIV-1 and HIV-1-Associated Neurological Complications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223371/
46131,Healthcare Workers’ Attitudes towards Mandatory COVID-19 Vaccination: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142794/
46132,"Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross sectional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874281/
46133,A 21st Century Evil: Immunopathology and New Therapies of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652766/
46134,"Safety of Four COVID-19 Vaccines across Primary Doses 1, 2, 3 and Booster: A Prospective Cohort Study of Australian Community Pharmacy Vaccinations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786585/
46135,Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163958/
46136,A Promising Vaccination Strategy against COVID-19 on the Horizon: Heterologous Immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705928/
46137,The COVID‐19 vaccine intentions of Australian disability support workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111309/
46138,"The Interplay of Lung Cancer, COVID-19, and Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738445/
46139,COVID-19 and the human innate immune system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885626/
46140,Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910677/
46141,Strategies for the Management of Spike Protein-Related Pathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222799/
46142,Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV2 infection and severe outcomes in people living with multiple sclerosis: A population-based study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894758/
46143,"Factors impacting COVID-19 vaccine decision making in older adults and people with underlying conditions in Victoria, Australia: A cross-sectional survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891679/
46144,Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782520/
46145,Older adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for informing public health strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114588/
46146,Psychosocial Predictors of COVID-19 Vaccine Uptake among Pregnant Women: A Cross-Sectional Study in Greece,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967309/
46147,Priming with social benefit information of vaccination to increase acceptance of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769881/
46148,Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399140/
46149,Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991090/
46150,Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486761/
46151,Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182552/
46152,Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416135/
46153,Protection against Severe Illness versus Immunity—Redefining Vaccine Effectiveness in the Aftermath of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459411/
46154,Antibody Response of BNT162b2 and CoronaVac Platforms in Recovered Individuals Previously Infected by COVID-19 against SARS-CoV-2 Wild Type and Delta Variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705363/
46155,Early approval of COVID-19 vaccines: Pros and cons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437465/
46156,Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316821/
46157,"Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466451/
46158,"COVID-19 Disease, Women’s Predominant Non-Heparin Vaccine-Induced Thrombotic Thrombocytopenia and Kounis Syndrome: A Passepartout Cytokine Storm Interplay",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391920/
46159,"A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859620/
46160,What Happens to the Immune System after Vaccination or Recovery from COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619084/
46161,Attitudes Toward the Global Allocation of Chinese COVID-19 Vaccines: Cross-sectional Online Survey of Adults Living in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177168/
46162,Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054913/
46163,A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287509/
46164,Vaccines and vaccination: history and emerging issues,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903967/
46165,Psychological Determinants of COVID-19 Vaccine Acceptance among Healthcare Workers in Kuwait: A Cross-Sectional Study Using the 5C and Vaccine Conspiracy Beliefs Scales,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310287/
46166,The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350195/
46167,The development of DNA vaccines against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290423/
46168,Tapping the immunological imprints to design chimeric SARS-CoV-2 vaccine for elderly population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127164/
46169,"Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530779/
46170,Vaccines for Covid‐19: An insight on their effectiveness and adverse effects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088412/
46171,"Multiple Sclerosis, Disease-Modifying Therapies and COVID-19: A Systematic Review on Immune Response and Vaccination Recommendations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310076/
46172,The Immune Response to SARS-CoV-2 and Variants of Concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537260/
46173,"COVID-19 vaccination in people with multiple sclerosis, real-life experience",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293951/
46174,"Evaluation of BNT162b2 Vaccine Effectiveness in Galicia, Northwest Spain",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998680/
46175,SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427053/
46176,Social media and attitudes towards a COVID-19 vaccination: A systematic review of the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120591/
46177,"Knowledge about, attitude and acceptance towards, and
predictors of intention to receive the COVID-19 vaccine among cancer patients
in Eastern China: A cross-sectional survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559872/
46178,"COVID-19 vaccination in cancer patients: a narrative
review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943636/
46179,"COVID-19 vaccine coverage, safety, and perceptions among patients with diabetes mellitus in China: a cross-sectional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270113/
46180,Perceived risk and perceptions of COVID-19 vaccine: A survey among general public in Pakistan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947088/
46181, Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903336/
46182,COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003176/
46183,Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542617/
46184,"A longitudinal study of humoral immune responses induced by a 3-dose inactivated COVID-19 vaccine in an observational, prospective cohort",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666991/
46185,Recombinant vaccines for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711739/
46186,Novel corona virus (COVID-19); Global efforts and effective investigational medicines: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088038/
46187,The predictive role of parental attitudes toward COVID-19 vaccines and child vulnerability: A multi-country study on the relationship between parental vaccine hesitancy and financial well-being,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980903/
46188,Efforts at COVID-19 Vaccine Development: Challenges and Successes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762169/
46189,Attitude and Level of COVID-19 Vaccination among Women in Reproductive Age during the Fourth Pandemic Wave: A Cross-Sectional Study in Poland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180577/
46190,SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784649/
46191,The role of trust in the likelihood of receiving a COVID-19 vaccine: Results from a national survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284053/
46192,A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308489/
46193,Psychological determinants of COVID-19 vaccine acceptance among urban slum dwellers of Bangladesh,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523437/
46194,Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584854/
46195,The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473113/
46196,"Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167921/
46197,"Nanotechnology Interventions in the Management of COVID-19: Prevention, Diagnosis and Virus-Like Particle Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537718/
46198,One year update on the COVID-19 pandemic: Where are we now?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695590/
46199,Regional Differences in COVID-19 Vaccine Hesitancy in December 2020: A Natural Experiment in the French Working-Age Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622681/
46200,COVID-19 vaccination hesitancy and willingness among pregnant women in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575585/
46201,COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705445/
46202,Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297457/
46203,COVID-19 Vaccine Antibody Response in a Single-Center Urban Hemodialysis Unit,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384404/
46204,"SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167898/
46205,Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133385/
46206,"Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120813/
46207,"COVID-19 and SARS-CoV-2. Modeling the present, looking at the future",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386394/
46208,COVID-19 Vaccination: The Mainspring of Challenges and the Seed of Remonstrance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707780/
46209,Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457875/
46210,Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108189/
46211,Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406181/
46212,COVID-19 therapy: What weapons do we bring into battle?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481143/
46213,"Cross-sectional study of the knowledge, perception and attitude of first-year university students in Iraq towards SARS-CoV-2 Omicron variant and COVID-19 vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679870/
46214,Absence of antibody responses to SARS-CoV-2 N protein in COVID-19 vaccine breakthrough cases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679329/
46215,"SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077344/
46216,Humoral and cellular immunity of two‐dose inactivated COVID‐19 vaccination in Chinese children: A prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877748/
46217,Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10891120/
46218,"Role of Diet and Nutrients in SARS-CoV-2 Infection: Incidence on Oxidative Stress, Inflammatory Status and Viral Production",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182601/
46219,Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962967/
46220,Immune response scenario and vaccine development for SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846221/
46221,Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833205/
46222,Effectiveness of inactivated COVID-19 vaccines against SARS-CoV-2 infections among healthcare personnel in Pakistan: a test-negative case–control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410856/
46223,Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388371/
46224,COVID-19 mRNA vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959685/
46225,Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752368/
46226,Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881590/
46227,COVID-19 vaccine uptake and effectiveness in adults aged 50 years and older in Wales UK: a 1.2m population data-linkage cohort approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993055/
46228,Correlates of Vaccine-Induced Protection against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035658/
46229,Knowledge and Attitudes Toward Covid-19 and Vaccines Among a New York Haredi-Orthodox Jewish Community,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127857/
46230,COVID-19 Vaccine Misperceptions in a Community Sample of Adults Aged 18–49 Years in Australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180736/
46231,Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509779/
46232,COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249710/
46233,mRNA Vaccines against SARS-CoV-2: Advantages and Caveats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051235/
46234,Real-World Effectiveness of Primary Series and Booster Doses of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2 Variant Infection in China: A Retrospective Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420401/
46235,Asian-Origin Approved COVID-19 Vaccines and Current Status of COVID-19 Vaccination Program in Asia: A Critical Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226479/
46236,A Comprehensive Overview on COVID-19: Future Perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476999/
46237,Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610888/
46238,"Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962551/
46239,Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467281/
46240,Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249675/
46241,Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360993/
46242,"The Global Impact of COVID-19: Historical Development, Molecular Characterization, Drug Discovery and Future Directions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10748929/
46243,Coronavirus disease 2019 (Covid‐19) vaccination recommendations in special populations and patients with existing comorbidities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646697/
46244,"mRNA-based COVID-19 Vaccines Booster Dose: Benefits, Risks, and Coverage",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335425/
46245,Phase 4 clinical trials in the era of the Coronavirus Disease (COVID-19) pandemic and their importance to optimize the COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351445/
46246,Does natural and hybrid immunity obviate the need for frequent vaccine boosters against SARS‐CoV‐2 in the endemic phase?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878177/
46247,Knowledge of SARS-CoV-2 Epitopes and Population HLA Types Is Important in the Design of COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607178/
46248,Antibody response to different COVID-19 vaccines among the migrant workers of Bangladesh,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034009/
46249,Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270414/
46250,Long Term Immune Response Produced by the SputnikV Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537212/
46251,Management of COVID-19: current status and future prospects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052512/
46252,Antibody Response to SARS-CoV-2 Infection and Vaccination in COVID-19-naïve and Experienced Individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878640/
46253,Exploring the behavioral determinants of COVID-19 vaccine acceptance among an urban population in Bangladesh: Implications for behavior change interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382171/
46254,Students’ Attitudes toward COVID-19 Vaccination: An Inter-University Study from Bulgaria,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408712/
46255,COVID-19 and kidney disease: insights from epidemiology to inform clinical practice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006492/
46256,"Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977851/
46257,Vaccine. 2022 Nov 15; 40(48): 7009. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613972/
46258,"COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952219/
46259,Pharmacotherapeutics of SARS-CoV-2 Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785334/
46260,"“They have produced a vaccine, but we doubt if COVID-19 exists”: correlates of COVID-19 vaccine acceptability among adults in Kano, Nigeria",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828136/
46261,"COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711779/
46262,SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774290/
46263,Learning from the past: development of safe and effective COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566580/
46264,COVID-19 vaccination in patients with cancer: Opportunities and challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679654/
46265,Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848203/
46266,Patterns and influencing factors of COVID-19 vaccination willingness among college students in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995203/
46267,In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832442/
46268,"Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299744/
46269,"COVID-19 Vaccine Hesitancy among Pregnant Women Attending Antenatal Clinics in Pakistan: A Multicentric, Prospective, Survey-Based Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694328/
46270,Analyzing the Systems Biology Effects of COVID-19 mRNA Vaccines to Assess Their Safety and Putative Side Effects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320269/
46271,"Safety of Global SARS-CoV-2 Vaccines, a Meta-Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030038/
46272,Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495523/
46273,Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652789/
46274,Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273612/
46275,Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916834/
46276,Function Is More Reliable Than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538099/
46277,"Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893324/
46278,PLoS Med. 2022 Apr; 19(4): e1003982. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033280/
46279,COVID-19 in Southeast Asia: current status and perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974206/
46280,"COVID-19: Variants, Immunity, and Therapeutics for Non-Hospitalized Patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377623/
46281,Nanoparticles in clinical trials of COVID-19: An update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359769/
46282,Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849184/
46283,Adamalysins in COVID-19 – Potential mechanisms behind exacerbating the disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010236/
46284,Microbiota and COVID-19: Long-term and complex influencing factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417543/
46285,mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785933/
46286,Learning Through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831477/
46287,"Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863423/
46288,Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704374/
46289,SARS-CoV-2 in silico binding affinity to human leukocyte antigen (HLA) Class II molecules predicts vaccine effectiveness across variants of concern (VOC),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109665/
46290,Effect of Information about COVID-19 Vaccine Effectiveness and Side Effects on Behavioural Intentions: Two Online Experiments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070148/
46291,Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034329/
46292,American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878068/
46293,Thrombocytopenia in COVID-19 and vaccine-induced thrombotic thrombocytopenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815408/
46294,A Qualitative Study on Barriers to COVID-19 Vaccine Uptake among Community Members in Tanzania,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458528/
46295,Exposure to avian coronavirus vaccines is associated with increased levels of SARS‐CoV‐2‐cross‐reactive antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467642/
46296,"How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685122/
46297,COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145134/
46298,In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10805787/
46299,Broad protective RBD heterotrimer vaccines neutralize SARS-CoV-2 including Omicron sub-variants XBB/BQ.1.1/BF.7,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538664/
46300,COVID‐19 in cancer patients: The impact of vaccination on outcomes early in the pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10757141/
46301,Proteomic and Metabolomic Characterization of SARS-CoV-2-Infected Cynomolgus Macaque at Early Stage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315341/
46302,"Willingness toward COVID-19 vaccination, coadministration with other vaccines and receive a COVID-19 vaccine booster: a cross-sectional study on the guardians of children in China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196675/
46303,"Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106412/
46304,Assessment of COVID-19 vaccine hesitancy among Zimbabweans: A rapid national survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022878/
46305,An update on SARS-CoV-2 immunization and future directions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033701/
46306,The immune response to SARS-CoV-2 in people with HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10806256/
46307,Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482809/
46308,"Vaccine Innovation for Pandemic Preparedness: Patent Landscape, Global Sustainability, and Circular Bioeconomy in Post-COVID-19 era",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280571/
46309,Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380479/
46310,Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595975/
46311,Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157596/
46312,"Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863574/
46313,Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364194/
46314,The repeated setbacks of HIV vaccine development laid the groundwork for SARS-CoV-2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935961/
46315,Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585911/
46316,COVID-19 vaccine hesitancy: Considerations for reluctance and improving vaccine uptake,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897654/
46317,The Fear of SARS-CoV-2 Infection versus the Perception of COVID-19 Vaccination amongst Older Adults in Urban Areas (CoV-VAC-PL Study): A Polish Community-Based Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10974642/
46318,"COVID-19: The Disease, the Immunological Challenges, the Treatment with Pharmaceuticals and Low-Dose Ionizing Radiation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470324/
46319,American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082483/
46320,After the virus has cleared—Can preclinical models be employed for Long COVID research?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451097/
46321,"Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482959/
46322,Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020189/
46323,Effectiveness of two coronavirus disease 2019 (COVID-19) vaccines (viral vector and inactivated viral vaccine) against severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in a cohort of healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002147/
46324,Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584434/
46325,"COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988387/
46326,IgG level of the third booster dose for mRNA of SARS-CoV-2 vaccines among Iraqi healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553022/
46327,COVID-19 Vaccines and Autoimmune Hematologic Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231220/
46328,Assessment of attitude towards COVID-19 vaccine and associated factors among clinical practitioners in Ethiopia: A cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202929/
46329,DNA vaccines for SARS-CoV-2: toward third-generation vaccination era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567274/
46330,Viral Vector Vaccine Development and Application during the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317404/
46331,Coronavirus disease 2019 (COVID‐19) vaccines: A concise review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242875/
46332,"COVID-19: Discovery, diagnostics and drug development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543767/
46333,When the first vaccine arrived: An investigation of factors that influenced the intention of health care workers in the national health system of Greece to be vaccinated against the SARS COV‐2 virus during the first trimester of vaccine arrival,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538693/
46334,"Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145020/
46335,Global Predictors of COVID-19 Vaccine Hesitancy: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415631/
46336,Relationship of SARS-CoV-2–specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203446/
46337,What can neutralizing antibodies tell us about the quality of immunity in COVID-19 convalescents and vaccinees?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10760325/
46338,Parents' perceptions on COVID-19 vaccination as the new routine for their children ≤ 11 years old,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250244/
46339,Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596738/
46340,Systematic Review on Pathophysiological Complications in Severe COVID-19 among the Non-Vaccinated and Vaccinated Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318201/
46341,COVID-19 Vaccination in Pediatrics: Was It Valuable and Successful?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964251/
46342,The COVID-19 pandemic and ANCA-associated vasculitis – reports from the EUVAS meeting and EUVAS education forum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552556/
46343,Household and social characteristics associated with COVID-19 vaccine intent among Latino families in the San Francisco Bay Area,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171483/
46344,The immunology and immunotherapy for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723987/
46345,Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072399/
46346,Non-viral COVID-19 vaccine delivery systems,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744276/
46347,Can vitamin D status influence seroconversion to SARS-COV2 vaccines?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806423/
46348,Front Immunol. 2023; 14: 1210147. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189654/
46349,COVID-19 Vaccination Effectiveness Against Infection or Death in a National U.S. Health Care System: A Target Trial Emulation Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697485/
46350,Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614167/
46351,The development of COVID-19 treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909293/
46352,Where do T cell subsets stand in SARS-CoV-2 infection: an update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399648/
46353,"Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616567/
46354,"Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798788/
46355,COVID-19 and severity of liver diseases: Possible crosstalk and clinical implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247890/
46356,High–temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651857/
46357,SARS-CoV-2 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355592/
46358,Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113667/
46359,Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091641/
46360,Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746792/
46361,B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358275/
46362,Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156180/
46363,Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT): Protocol for a Multisite Longitudinal Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377426/
46364,Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504073/
46365,Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907831/
46366,Divergent SARS-CoV-2-specific T cell responses in intensive care unit workers following mRNA COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582956/
46367,"Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372504/
46368,Lancet HIV. 2022 Dec; 9(12): e822. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116898/
46369,Effect of Vaccination against SARS-CoV-2 on Long COVID-19: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785763/
46370,The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637175/
46371,Cardiovascular complications of COVID-19 vaccines: A review of case-report and case-series studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905103/
46372,Seroprevalence of anti-SARS-CoV-2 specific antibodies in vaccinated and vaccine naïve adult Nigerians,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870169/
46373,COVID-19: A review of therapeutic strategies and vaccine candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670907/
46374,Pathogenic Mechanism and Multi-omics Analysis of Oral Manifestations in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290522/
46375,Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678218/
46376,Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151325/
46377,Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538336/
46378,"A longitudinal seroepidemiology study to evaluate antibody response to SARS-CoV-2 virus infection and vaccination in children in Calgary, Canada from July 2020 to April 2022: Alberta COVID-19 Childhood Cohort (AB3C) Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079115/
46379,"Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India – a community based survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453251/
46380,"The influence of social network on COVID-19 vaccine hesitancy among healthcare workers: a cross-sectional survey in Chongqing, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903998/
46381,"Evaluation of immunoprotection against coronavirus disease 2019: Novel variants, vaccine inoculation, and complications",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605787/
46382,Side effects of COVID-19 vaccines in the middle eastern population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654979/
46383,A Global Map of COVID-19 Vaccine Acceptance Rates per Country: An Updated Concise Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760993/
46384,NIH funding for vaccine readiness before the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938738/
46385,A COVID-19 Vaccine: Big Strides Come with Big Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827578/
46386,Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639290/
46387,SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918810/
46388,Classical and Next-Generation Vaccine Platforms to SARS-CoV-2: Biotechnological Strategies and Genomic Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877900/
46389,Mucosal vaccines for SARS-CoV-2: triumph of hope over experience,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154910/
46390,Humoral immunity against SARS‐CoV‐2 variants including omicron in solid organ transplant recipients after three doses of a COVID‐19 mRNA vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052011/
46391,The COVID-19 experience in Africa and the Middle East,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288901/
46392,A qualitative study of COVID-19 vaccine intentions and mistrust in Black Americans: Recommendations for vaccine dissemination and uptake,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064113/
46393,"Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801873/
46394,Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129324/
46395,"Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Adolescents, Children, and Infants: A Systematic Review and Meta-Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046659/
46396,COVID-19 Vaccine Hesitancy Among Healthcare Personnel Who Generally Accept Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916908/
46397,"Assessment of early and post COVID-19 vaccination antibody response in healthcare workers: a multicentre cross-sectional study on inactivated, mRNA and vector-based vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874034/
46398,Effectiveness of Messenger RNA Coronavirus Disease 2019 Vaccines Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Delta Variant Epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047210/
46399,COVID‐19 vaccine effectiveness against hospitalization due to SARS‐CoV‐2: A test‐negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350393/
46400,"Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361752/
46401,"Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628277/
46402,Immunotherapeutic approaches to curtail COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441891/
46403,State-of-art high-performance Nano-systems for mutated coronavirus infection management: From Lab to Clinic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463543/
46404,Safety and immunogenicity of COVID-19 vaccination in immunocompromised patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945070/
46405,"Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598212/
46406,The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310117/
46407,COVID-19 and Dentistry in 72 Questions: An Overview of the Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919689/
46408,COVID-19 and liver disease: mechanistic and clinical perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945972/
46409,COVID-19 vaccination and thyroiditis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981269/
46410,"Estimating the number of symptomatic SARS-CoV-2 infections among vaccinated individuals in the United States—January–July, 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906607/
46411,Development trends of human organoid‐based COVID‐19 research based on bibliometric analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693193/
46412,Public health impact of covid-19 vaccines in the US: observational study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044401/
46413,"COVID-19 Vaccine Hesitancy Among Patients Recovered From COVID-19 Infection in Wuhan, China: Cross-Sectional Questionnaire Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337408/
46414,Circular RNAs as emerging regulators in COVID-19 pathogenesis and progression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681929/
46415,Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520885/
46416,COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920139/
46417,The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622307/
46418,Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047577/
46419,COVID-19: Insights into Potential Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001762/
46420,Receptor binding domain‐IgG levels correlate with protection in residents facing SARS‐CoV‐2 B.1.1.7 outbreaks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652754/
46421,Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034854/
46422,Acceptance of coronavirus disease 2019 (COVID-19) vaccines among healthcare workers: A meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525162/
46423,"COVID-19 Incidence and Vaccine Effectiveness in University Staff, 1 March 2020–2 April 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964987/
46424,mRNA vaccines in the prevention and treatment of diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409637/
46425,Effectiveness of COVID-19 Vaccine Booster Shot Compared with Non-Booster: A Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504142/
46426,First computational design using lambda-superstrings and in vivo validation of SARS-CoV-2 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016385/
46427,COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: A cross-sectional national survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472961/
46428,The changing health impact of vaccines in the COVID-19 pandemic: A modeling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015104/
46429,Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937514/
46430,The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684862/
46431,A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624722/
46432,mRNA vaccines in disease prevention and treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509165/
46433,COVID-19 Vaccine: A comprehensive status report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423510/
46434,"Intention to Receive a COVID-19 Vaccine by HIV Status Among a Population-Based Sample of Women and Gender Diverse Individuals in British Columbia, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753016/
46435,"COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infections, COVID-19 related hospitalizations and deaths, among individuals aged ≥65 years in Portugal: A cohort study based on data-linkage of national registries February-September 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469958/
46436,The Current Status of COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525400/
46437,"Repurposed Drugs, Molecular Vaccines, Immune‐Modulators, and Nanotherapeutics to Treat and Prevent COVID‐19 Associated with SARS‐CoV‐2, a Deadly Nanovector",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645867/
46438,Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824305/
46439,Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711057/
46440,"COVID-19 Vaccine Initiation and Dose Completion During the SARS-CoV-2 Delta Variant Surge in the United States, December 2020–October 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494161/
46441,Maximizing Completion of the Two-Dose COVID-19 Vaccine Series with Aid from Infographics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618920/
46442,"Clinical Evaluation of the Abbott Alinity SARS-CoV-2 Spike-Specific Quantitative IgG and IgM Assays among Infected, Recovered, and Vaccinated Groups",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218760/
46443,Severe Acute Respiratory Syndrome Coronavirus 2: Manifestations of Disease and Approaches to Treatment and Prevention in Humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594263/
46444,Effectiveness of BNT162b2 and mRNA-1273 Vaccines against COVID-19 Infection: A Meta-Analysis of Test-Negative Design Studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954872/
46445,Pseudoscience and fraudulent products for COVID-19 management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282830/
46446,Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543422/
46447,A Comprehensive Review of mRNA Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917162/
46448,COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208258/
46449,An Update on Protective Effectiveness of Immune Responses After Recovery From COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163347/
46450,Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894812/
46451,Public Health Surveillance for Adverse Events Following COVID-19 Vaccination in Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032114/
46452,Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530325/
46453,Vaccine-Acquired SARS-CoV-2 Immunity versus Infection-Acquired Immunity: A Comparison of Three COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782527/
46454,COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216497/
46455,Characterization of Two Heterogeneous Lethal Mouse-Adapted SARS-CoV-2 Variants Recapitulating Representative Aspects of Human COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858946/
46456,Immunogenicity of Intradermal Versus Intramuscular BNT162b2 COVID-19 Booster Vaccine in Patients with Immune-Mediated Dermatologic Diseases: A Non-Inferiority Randomized Controlled Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10819288/
46457,Applications of Social Media and Digital Technologies in COVID-19 Vaccination: Scoping Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924059/
46458,The role of perceived social norms in college student vaccine hesitancy: Implications for COVID-19 prevention strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789646/
46459,Pfizer-BioNTech mRNA Vaccine Protection among Children and Adolescents Aged 12–17 Years against COVID-19 Infection in Qatar,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610824/
46460,Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695449/
46461,"Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857265/
46462,Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093096/
46463,"Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676979/
46464,Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978324/
46465,Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381032/
46466,"Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978755/
46467,Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310533/
46468,Percentages of Vaccination Coverage Required to Establish Herd Immunity against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144560/
46469,COVID-19 Vaccine Hesitancy Associated With Vaccine Inequity Among Healthcare Workers in a Low-Income Fragile Nation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309570/
46470,Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9383521/
46471,Immune Responses against SARS-CoV-2—Questions and Experiences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533170/
46472,Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169434/
46473,Adv Ther. 2022; 39(1): 822–830. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600099/
46474,Factors Associated with COVID-19 Vaccine Hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004673/
46475,Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068669/
46476,Intention to receive a COVID-19 vaccine: results from a population-based survey in Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164402/
46477,Retrospective Cohort Study of the Effectiveness of the Sputnik V and EpiVacCorona Vaccines against the SARS-CoV-2 Delta Variant in Moscow (June–July 2021),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320764/
46478,COVID-19 vaccine hesitancy and its associated factors in Malaysia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436036/
46479,Molecular Determinants of the Early Life Immune Response to COVID-19 Infection and Immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052886/
46480,Acceptance of COVID-19 vaccine among sub-Saharan Africans (SSA): a comparative study of residents and diasporan dwellers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884132/
46481,Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756008/
46482,Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383267/
46483,Effects of COVID-19 vaccination on human fertility: a post-pandemic literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538453/
46484,"Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299183/
46485,"Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789245/
46486,Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340488/
46487,Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648802/
46488,Risk of Adverse Events and Delirium after COVID-19 Vaccination in Patients Living with Dementia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121138/
46489,Adverse Hematological Effects of COVID-19 Vaccination and Pathomechanisms of Low Acquired Immunity in Patients with Hematological Malignancies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058097/
46490,"COVID-19 vaccine design using reverse and structural vaccinology, ontology-based literature mining and machine learning",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294427/
46491,"COVID 19 pandemic challenges and their management: A review of medicines, vaccines, patents and clinical trials with emphasis on psychological health issues",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128298/
46492,The COVID-19 Vaccine in Clinical Trials: Where Are We Now?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057314/
46493,Circulating microRNAs as emerging regulators of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800721/
46494,Nano-based techniques: A revolutionary approach to prevent covid-19 and enhancing human awareness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183109/
46495,Mitigating co-circulation of seasonal influenza and COVID-19 pandemic in the presence of vaccination: A mathematical modeling approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845909/
46496,COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665770/
46497,Therapeutic Strategies in the Fight against COVID-19: From Bench to Bedside,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652495/
46498,Translation suppression underlies the restrained COVID-19 mRNA vaccine response in the high-risk immunocompromised group,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644109/
46499,COVID-19 Vaccination and Estimated Public Health Impact in California,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034409/
46500,"Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436448/
46501,"Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 – October 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001176/
46502,Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632224/
46503,Cutaneous and Allergic reactions due to COVID‐19 vaccinations: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661794/
46504,Humoral Response Following Triple Dose of mRNA Vaccines Against SARS-CoV-2 in Hemodialysis Patients: Results After 1 Year of Follow-Up,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314744/
46505,An integrative look at SARS-CoV-2 (Review),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797443/
46506,Faster than warp speed: early attention to COVD-19 by anti-vaccine groups on Facebook,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083299/
46507,Quantitative Synthesis of Factors Associated with COVID-19 Vaccine Acceptance and Vaccine Hesitancy in 185 Countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10818751/
46508,Single-epitope T cell–based vaccine protects against SARS-CoV-2 infection in a preclinical animal model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132166/
46509,Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233170/
46510,Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802458/
46511,Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604891/
46512,Vaccine development against tuberculosis before and after Covid-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684952/
46513,"SARS-CoV-2-Specific T Cell Responses in Immunocompromised Individuals with Cancer, HIV or Solid Organ Transplants",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966413/
46514,"Pandemic COVID-19 caused by SARS-CoV-2: genetic structure, vaccination, and therapeutic approaches",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365286/
46515,The Effect of Long COVID-19 Infection and Vaccination on Male Fertility; A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783106/
46516,"A new multiplex SARS-CoV-2 antigen microarray showed correlation of IgG, IgA, and IgM antibodies from patients with COVID-19 disease severity and maintenance of relative IgA and IgM antigen binding over time",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062637/
46517,Evaluation of the Acceptance Rate of Covid-19 Vaccine and its Associated Factors: A Systematic Review and Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186279/
46518,Current advances in the development of SARS-CoV-2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757035/
46519,"SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326314/
46520,Early warning and rapid public health response to prevent COVID-19 outbreaks in long-term care facilities (LTCF) by monitoring SARS-CoV-2 RNA in LTCF site-specific sewage samples and assessment of antibodies response in this population: prospective study protocol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382669/
46521,Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922846/
46522,"Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692185/
46523,Healthcare Staff Perceptions Following Inoculation with the BNT162b2 mRNA COVID-19 Vaccine at University Hospitals Coventry & Warwickshire NHS Trust,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430614/
46524,Immune response after COVID-19 vaccination among patients with chronic kidney disease and kidney transplant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515331/
46525,Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461092/
46526,Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336315/
46527,"Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536880/
46528,Gastrointestinal Involvement in SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228950/
46529,Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401623/
46530,SARS‐CoV‐2 and pediatric solid organ transplantation: Current knowns and unknowns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237081/
46531,Public attitudes and influencing factors toward COVID-19 vaccination for adolescents/children: a scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825307/
46532,Impaired VEGF-A-Mediated Neurovascular Crosstalk Induced by SARS-CoV-2 Spike Protein: A Potential Hypothesis Explaining Long COVID-19 Symptoms and COVID-19 Vaccine Side Effects?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784975/
46533,Comparison of AstraZeneca and sinopharm vaccines as boosters in protection against COVID-19 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008804/
46534,Biologicals. 2023 Nov; 84: 101719. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11042466/
46535,"Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255458/
46536,SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935673/
46537,"Gender, socioeconomic status, and COVID‐19 vaccine hesitancy in the US: An intersectionality approach",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348198/
46538,A bird's eye view on the role of dendritic cells in SARS‐CoV‐2 infection: Perspectives for immune‐based vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441836/
46539,SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846902/
46540,"Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485582/
46541,Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563351/
46542,Determinants of influenza and COVID-19 vaccine intent or uptake in Lebanon: a scoping review of the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404373/
46543,"SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723891/
46544,Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187423/
46545,Nat Med. 2023; 29(9): 2334–2346. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504073/
46546,"Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266301/
46547,Lancet. 2022 29 January-4 February; 399(10323): 436. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797026/
46548,"Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592561/
46549,Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358265/
46550,Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961186/
46551,"Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335243/
46552,Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care setting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763212/
46553,Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794738/
46554,Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143801/
46555,Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061467/
46556,"Views on COVID-19 vaccination of young children in Ireland, results from a cross-sectional survey of parents",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393176/
46557,Assessing COVID-19 Vaccine’s Acceptability Amongst Health Care Workers in Oman: A cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212921/
46558,Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465310/
46559,Recent advances of nanotechnology in COVID 19: A critical review and future perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749399/
46560,"Mutational Pattern, Impacts and Potential Preventive Strategies of Omicron SARS-CoV-2 Variant Infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017707/
46561,A Global Survey of COVID-19 Vaccine Acceptance Among Healthcare Workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860987/
46562,Platelet-neutrophil interaction in COVID-19 and vaccine-induced thrombotic thrombocytopenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237318/
46563,SARS-CoV-2 Omicron Variant: Exploring Healthcare Workers' Awareness and Perception of Vaccine Effectiveness: A National Survey During the First Week of WHO Variant Alert,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989964/
46564,Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338221/
46565,Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516444/
46566,Attitudes to Vaccine Mandates among Late Adopters of COVID-19 Vaccines in Zimbabwe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316741/
46567,The race to understand immunopathology in COVID-19: Perspectives on the impact of quantitative approaches to understand within-host interactions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826539/
46568,"Determinants of COVID-19 vaccine hesitancy among students and parents in Sentinel Schools Network of Catalonia, Spain",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997992/
46569,Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206116/
46570,COVID-19 Vaccination in Kidney Transplant Candidates and Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692413/
46571,A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836081/
46572,Optimizing testing regimes for the detection of COVID-19 in children and older adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425447/
46573,"Factors associated with COVID-19 vaccine confidence among primary care providers in Kazakhstan, March–April 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517263/
46574,Front Public Health. 2023; 11: 1308374. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660272/
46575,"Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133727/
46576,BMJ Open. 2022; 12(7): e059223corr1. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258483/
46577,Adolescent COVID-19 Vaccine Decision-Making among Parents in Southern California,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998887/
46578,Interventions to increase COVID‐19 vaccine uptake: a scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347311/
46579,COVID-19 Vaccination Strategy in China: A Case Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620874/
46580,The attitude and knowledge of pediatricians and family physicians toward COVID-19 vaccination in children: A cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332230/
46581,"Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359569/
46582,Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876335/
46583,"A retrospective evaluation of side‐effects associated with the booster dose of Pfizer-BioNTech/BNT162b2 COVID‐19 vaccine among females in Eastern Province, Saudi Arabia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574466/
46584,Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850379/
46585,SARS-CoV-2 Antibody Dynamics in Healthcare Workers after mRNA Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961091/
46586,Interactions between COVID-19 and Lung Cancer: Lessons Learned during the Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367272/
46587,Next-Generation Vaccines Against COVID-19 Variants: Beyond the Spike Protein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686570/
46588,"COVID-19 Testing, Vaccine Perceptions, and Trust among Hispanics Residing in an Underserved Community",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049437/
46589,Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10715640/
46590,Efficacy and Safety of COVID-19 Vaccines—An Update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777372/
46591,Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227274/
46592,Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651828/
46593,"COVID-19 vaccine coverage and factors associated with vaccine uptake among 23 247 adults with a recent history of homelessness in Ontario, Canada: a population-based cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906815/
46594,Review of COVID-19 testing and diagnostic methods,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970625/
46595,Safety and Effectiveness of Maternal COVID-19 Vaccines Among Pregnant People and Infants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941309/
46596,Stroke Associated with COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894799/
46597,A 30-day follow-up study on the prevalence of SARS-COV-2 genetic markers in wastewater from the residence of COVID-19 patient and comparison with clinical positivity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576909/
46598,One vaccine to counter many diseases? Modeling the economics of oral polio vaccine against child mortality and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580701/
46599,Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513326/
46600,"Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277081/
46601,Oral antiviral treatments for COVID-19: opportunities and challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309032/
46602,Pharmacol Rep. 2022; 74(6): 1326–1327. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510311/
46603,Next-generation treatments: Immunotherapy and advanced therapies for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10907543/
46604,Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375673/
46605,Immunity to SARS-CoV-2: Lessons Learned,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018176/
46606,COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532224/
46607,COVID-19 vaccines: Immune correlates and clinical outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962618/
46608,Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417850/
46609,Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in Nicotiana benthamiana Plant as a Vaccine Candidate against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621474/
46610,Immune Correlates Analysis of the ENSEMBLE Single Ad26.COV2.S Dose Vaccine Efficacy Clinical Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166187/
46611,COVID-19: The question of genetic diversity and therapeutic intervention approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075701/
46612,Time for action: towards an intersectional gender approach to COVID-19 vaccine development and deployment that leaves no one behind,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366282/
46613,Parental Attitudes and Hesitancy About COVID-19 vs. Routine Childhood Vaccinations: A National Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548678/
46614,Factors Associated with the COVID-19 Vaccination Status of Higher Education Students: Results of an Online Cross-Sectional Survey at Six Universities in Southwestern Germany,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505187/
46615,COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067136/
46616,Brain Behav Immun. 2024 Jan; 115: 758. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11021210/
46617,Challenges posed by COVID‐19 in cancer patients: A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855916/
46618,"Multiple Sclerosis, COVID-19 and Vaccines: Making the Point",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500471/
46619,Next-Generation Vaccines: Nanovaccines in the Fight against SARS-CoV-2 Virus and beyond SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175023/
46620,SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656179/
46621,SARS-CoV-2 reinfection and implications for vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641611/
46622,Advances in COVID-19 Vaccines and New Coronavirus Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305707/
46623,"COVID-19 Vaccine Perceptions among Ebola-Affected Communities in North Kivu, Democratic Republic of the Congo, 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223943/
46624,Omicron variant: Current insights and future directions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482093/
46625,Parents’ and guardians’ acceptability of COVID-19 vaccination for children in Ghana: An online survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423663/
46626,"Assessment of Anti-SARS-CoV-2 antibody levels among university students vaccinated with different COVID-19 primary and booster doses — fall 2021, Wisconsin",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240450/
46627,"Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904456/
46628,Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255436/
46629,Human mobility increased with vaccine coverage and attenuated the protection of COVID-19 vaccination: A longitudinal study of 107 countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078856/
46630,Antiviral Drug Discovery for the Treatment of COVID-19 Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143071/
46631,SARS‐CoV‐2 vaccination in patients with inflammatory bowel disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441891/
46632,"Analysis of Perception, Reasons, and Motivations for COVID-19 Vaccination in People with Diabetes across Sub-Saharan Africa: A Mixed-Method Approach",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266073/
46633,Evaluation of BNT162b2 vaccine effectiveness in Malaysia: test negative case-control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399819/
46634,Perceived public health threat a key factor for willingness to get the COVID-19 vaccine in Australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339499/
46635,"COVID-19 Immunobiology: Lessons Learned, New Questions Arise",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427766/
46636,"2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926109/
46637,"Vaccine conspiracy association with higher COVID-19 vaccination side effects and negative attitude towards booster COVID-19, influenza and monkeypox vaccines: A pilot study in Saudi Universities",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653693/
46638,Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377801/
46639,BMJ. 2021; 374: n2091. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419709/
46640,Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012137/
46641,"SARS-CoV-2 incidence, seroprevalence, and COVID-19 vaccination coverage in the homeless population: a systematic review and meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600393/
46642,Aptamers as promising nanotheranostic tools in the COVID‐19 pandemic era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111085/
46643,Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8+ T cell responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768424/
46644,"Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: A population-based cohort study from Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347443/
46645,COVID-19 and solid organ transplantation: Finding the right balance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251959/
46646,Drug-based therapeutic strategies for COVID-19-infected patients and their challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610072/
46647,Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117137/
46648,The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204314/
46649,"The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373339/
46650,Antibody responses to mRNA versus non-mRNA COVID vaccines among the Mongolian population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183229/
46651,Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC tool,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813551/
46652,Current and innovative methods for the diagnosis of COVID-19 infection (Review),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043662/
46653,COVID-19 vaccine uptake and hesitancy among HIV-infected men who have sex with men in mainland China: a cross-sectional survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903943/
46654,U.S. public support for COVID-19 vaccine donation to low- and middle-income countries during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942145/
46655,"Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361355/
46656,Potent immunogenicity and broad-spectrum protection potential of microneedle array patch-based COVID-19 DNA vaccine candidates encoding dimeric RBD chimera of SARS-CoV and SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155640/
46657,mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559634/
46658,The New Entity of Subacute Thyroiditis amid the COVID-19 Pandemic: From Infection to Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030970/
46659,Understanding “Hybrid Immunity”: Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213853/
46660,Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500552/
46661,Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757952/
46662,Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894131/
46663,Lancet. 2021 6-12 March; 397(10277): 880. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960635/
46664,Establishment of multicenter COVID-19 therapeutics preclinical test system in Republic of Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829441/
46665,Willingness to accept COVID-19 vaccine among the elderly and the chronic disease population in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903911/
46666,An update on COVID-19 and pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438995/
46667,Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115603/
46668,Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402626/
46669,A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871769/
46670,Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243212/
46671,A Review on Currently Available Potential Therapeutic Options for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387864/
46672,"An Overview of the Epidemiologic, Diagnostic and Treatment Approaches of COVID-19: What do We Know?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245675/
46673,A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721936/
46674,"Factors Associated With Willingness to Receive a COVID-19 Vaccine Among 23,819 Adults Aged 50 Years or Older: An Analysis of the Canadian Longitudinal Study on Aging",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903402/
46675,COVID-19 Vaccination in Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079439/
46676,The COVID-19 Humoral Immunological Status Induced by CoronaVac and AstraZeneca Vaccines Significantly Benefits from a Booster Shot with the Pfizer Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044956/
46677,COVID-19 Vaccine Acceptance among University Students and Lecturers in Different Provinces of Indonesia: A Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053557/
46678,"COVID‐19, obesity, and immune response 2 years after the pandemic: A timeline of scientific advances",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349458/
46679,Effect of a mobile app chatbot and an interactive small-group webinar on COVID-19 vaccine intention and confidence in Japan: a randomised controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230336/
46680,BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580836/
46681,Safety and potency of BIV1‐CovIran inactivated vaccine candidate for SARS‐CoV‐2: A preclinical study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646699/
46682,"Seroprevalence of SARS-CoV-2 anti-spike IgG antibody among COVID-19 vaccinated individuals residing in Surabaya, East Java, Indonesia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538276/
46683,"Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009845/
46684,"Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10900268/
46685,Factors Associated with Vaccine Breakthrough Incidence among Health Care Workers Vaccinated with Inactivated SARS-CoV-2 Vaccine (CoronaVac),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818040/
46686,"Cross-Protection Induced by Highly Conserved Human B, CD4+, and CD8+ T Cell Epitopes-Based Coronavirus Vaccine Against Severe Infection, Disease, and Death Caused by Multiple SARS-CoV-2 Variants of Concern",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245830/
46687,Front Immunol. 2024; 15: 1328905. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10839970/
46688,Natural history of COVID-19 and current knowledge on treatment therapeutic options,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332915/
46689,A mRNA Vaccine Encoding for a RBD 60-mer Nanoparticle Elicits Neutralizing Antibodies and Protective Immunity Against the SARS-CoV-2 Delta Variant in Transgenic K18-hACE2 Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299372/
46690,Behavioural and social drivers of COVID-19 vaccination in Vietnam: a scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10748879/
46691,Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784663/
46692,"OMICRON: Virology, immunopathogenesis, and laboratory diagnosis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350010/
46693,Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398604/
46694,Epidemiology and Clinical Presentation of COVID-19 in Older Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633621/
46695,"Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648333/
46696,Lancet. 2022 Feb 26; 399(10327): 802. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871410/
46697,"COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021 ",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650707/
46698,"COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760602/
46699,Impact of pandemics and disruptions to vaccination on infectious diseases epidemiology past and present,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332206/
46700,"Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254618/
46701,"Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741849/
46702,"COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734610/
46703,Psychometric validation of a chinese version of COVID-19 vaccine hesitancy scale: a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526461/
46704,Comparative Performance Evaluation of Personal Protective Measures and Antiviral Agents Against SARS-CoV-2 Variants: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014419/
46705,"mRNA vaccines for COVID-19: what, why and how",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071766/
46706,Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513558/
46707,"Narrative Review of the Evolution of COVID-19 Vaccination Recommendations in Countries in Latin America, Africa and the Middle East, and Asia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127189/
46708,Drugs for COVID-19: An Update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740261/
46709,"Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166516/
46710,COVID-19 vaccine hesitancy among healthcare workers in Arab Countries: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10760888/
46711,Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965150/
46712,A SARS-CoV-2 Vaccine Designed for Manufacturability Results in Unexpected Potency and Non-Waning Humoral Response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145385/
46713,SARS-CoV-2 spike-specific TFH cells exhibit unique responses in infected and vaccinated individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558553/
46714,"Effectiveness and safety of SARS‐CoV‐2 vaccine in Inflammatory Bowel Disease patients: a systematic review, meta‐analysis and meta‐regression",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111455/
46715,COVID-19 vaccine uptake among health care workers in Ghana: a case for targeted vaccine deployment campaigns in the global south,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571849/
46716,PARIS and SPARTA: Finding the Achilles’ Heel of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241545/
46717,SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423489/
46718,CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653804/
46719,How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249429/
46720,COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239481/
46721,Delayed Access to COVID-19 Vaccines: A Perspective on Low-income Countries in Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047600/
46722,A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517730/
46723,A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935276/
46724,The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870622/
46725,AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958481/
46726,"COVID-19 Vaccine Acceptance and Hesitancy among Healthcare Workers in Lusaka, Zambia; Findings and Implications for the Future",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459437/
46727,Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503550/
46728,"Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183216/
46729,Delivery Routes for COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158705/
46730,COVID-19 vaccine Mandates: An Australian attitudinal study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629747/
46731,Comparing hybrid and regular COVID-19 vaccine-induced immunity against the Omicron epidemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753877/
46732,"Association of vaccination, international travel, public health and social measures with lineage dynamics of SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434302/
46733,A Scoping Review to Find Out Worldwide COVID-19 Vaccine Hesitancy and Its Underlying Determinants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624792/
46734,"Scope of SARS-CoV-2 variants, mutations, and vaccine technologies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962228/
46735,Immune features of COVID-19 convalescent individuals revealed by a single-cell RNA sequencing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013654/
46736,Recent advances in antibody‐based immunotherapy strategies for COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427040/
46737,Measuring the Effectiveness of COVID-19 Vaccines Used during a Surge of the Delta Variant of SARS-CoV-2 in Bangladesh: A Test-Negative Design Evaluation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780914/
46738,Imperfect messengers? An analysis of vaccine confidence among primary care physicians,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931689/
46739,Characterizing intentions to receive the COVID-19 vaccine among the general population in British Columbia based on their future intentions towards the seasonal influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387116/
46740,Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414589/
46741,Insights into COVID-19 vaccines development: Translation from benchside to bedside,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271228/
46742,Egypt's COVID-19 Recent Happenings and Perspectives: A Mini-Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415352/
46743,Introduction of the BNT162b2 vaccine during a COVID-19 nursing home outbreak,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339455/
46744,Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282241/
46745,COVID-19 Vaccine Hesitancy Among Health Care Workers in Thailand: The Comparative Results of Two Cross-Sectional Online Surveys Before and After Vaccine Availability,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376379/
46746,"Age and Comorbidities as Risk Factors for Severe COVID-19 in Mexico, before, during and after Massive Vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674414/
46747,"Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination—United States, December 2020 to August 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787833/
46748,Assessing the Self-reported After Events Following Immunization of COVID-19 Vaccines in Turkey and Bangladesh,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898704/
46749,Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381941/
46750,SARS-CoV-2 infection and COVID-19 vaccination in pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931577/
46751,Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID‐19 vaccines: A systematic review and meta‐analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878056/
46752,Do we need to vaccinate every child against COVID-19: What evidence suggests—A systematic review of opinions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679503/
46753,Role of aging in Blood–Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386676/
46754,The COVID-19 pandemic in the African continent,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059455/
46755,Investigation of factors affecting COVID-19 vaccine acceptance among communities of universities in the United Arab Emirates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302497/
46756,COVID-19 vaccine and booster hesitation around the world: A literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878297/
46757,Immune responses in mildly versus critically ill COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923185/
46758,Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830698/
46759,"SARS-CoV-2 Vaccine Development: An Overview
and Perspectives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526333/
46760,Comparing the longer-term effectiveness of a single dose of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines across the age spectrum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918854/
46761,Regulatory concepts to guide and promote the accelerated but safe clinical development and licensure of COVID‐19 vaccines in Europe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251031/
46762,Cellular and Humoral Immunity to SARS‐CoV‐2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease‐Modifying Therapies: A Multi‐Ethnic Observational Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082484/
46763,Impact of COVID-19 in individuals with and without pre-existent digestive disorders with a particular focus on elderly patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354572/
46764,Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years: A Systematic Review and Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871947/
46765,Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699636/
46766,Myocarditis With COVID-19 mRNA Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340726/
46767,Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865546/
46768,Management of patients with lymphoma and COVID‐19: Narrative review and evidence‐based practical recommendations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874581/
46769,Considering a COVID-19 vaccine mandate for pediatric kidney transplant candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949834/
46770,A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560864/
46771,Dynamics of temporal immune responses in nonhuman primates and humans immunized with COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586671/
46772,Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463331/
46773,SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of Oncogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10792266/
46774,Integrating health behavior theories to predict American’s intention to receive a COVID-19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889032/
46775,COVID-19 vaccine hesitancy among the adult population in Bangladesh: A nationwide cross-sectional survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659424/
46776,"Animal models for studying COVID-19, prevention, and therapy: Pathology and disease phenotypes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208071/
46777,Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156175/
46778,COVID-19 vaccine uptake among people who inject drugs in Tijuana Mexico,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485825/
46779,"Effectiveness of public health measures
in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19
mortality: systematic review and meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423125/
46780,BMJ. 2021; 375: n2997. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640736/
46781,"COVID-19 vaccine-related adverse events following immunization in the WHO Western Pacific Region, 2021–2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363417/
46782,Challenges and developments in universal vaccine design against SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761649/
46783,Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: The CONsort‐19 study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441741/
46784,Facing the Omicron variant—how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449804/
46785,Programmed cell death: the pathways to severe COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022977/
46786,"A multi-component, community-based strategy to facilitate COVID-19 vaccine uptake among Latinx populations: From theory to practice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452046/
46787,Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727357/
46788,Assessment of acceptability of the COVID-19 vaccine based on the health belief model among Malaysians-A qualitative approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197030/
46789,Correlation of SARS-CoV-2 to cancer: Carcinogenic or anticancer? (Review),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923649/
46790,Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317544/
46791,Evolution of Public Attitudes and Opinions Regarding COVID-19 Vaccination During the Vaccine Campaign in China: Year-Long Infodemiology Study of Weibo Posts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937109/
46792,Changes in Parents’ COVID-19 Vaccine Hesitancy for Children Aged 3–17 Years before and after the Rollout of the National Childhood COVID-19 Vaccination Program in China: Repeated Cross-Sectional Surveys,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502861/
46793,Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076570/
46794,Scaling up the discovery of hesitancy profiles by identifying the framing of beliefs towards vaccine confidence in Twitter discourse,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148945/
46795,Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174323/
46796,"SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge – Denver, Colorado, and San Diego, California, January–April 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250903/
46797,The immune response as a double‐edged sword: The lesson learnt during the COVID‐19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538066/
46798,Perspectives on the COVID-19 vaccine uptake: a qualitative study of community members and health workers in Zambia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684276/
46799,SARS-CoV-2—The Role of Natural Immunity: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655392/
46800,A comparative study of the COVID-19 vaccine efficacy among cancer patients: mRNA versus non-mRNA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977046/
46801,Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375293/
46802,Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510595/
46803,Humoral Immune Responses following COVID-19 Vaccinations among Adults in Tanzania,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10819524/
46804,Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437500/
46805,COVID-19 Vaccine Booster Dose Acceptance: Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611447/
46806,"COVID‐19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446947/
46807,Durable CD8 T Cell Memory against SARS-CoV-2 by Prime/Boost and Multi-Dose Vaccination: Considerations on Inter-Dose Time Intervals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698736/
46808,"Children’s rates of COVID-19 vaccination as reported by parents, vaccine hesitancy, and determinants of COVID-19 vaccine uptake among children: a multi-country study from the Eastern Mediterranean Region",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294741/
46809,"HIV and COVID-19 Co-Infection: Epidemiology, Clinical Characteristics, and Treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962407/
46810,"Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276767/
46811,SARS-CoV-2 Infection and Lung Regeneration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809385/
46812,COVID‐19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652673/
46813,SARS-CoV-2 immunity and vaccine strategies in people with HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452103/
46814,COVID-19 Vaccine for Children: Determinants and Beliefs Contributing to Vaccination Decision of Parents in Germany 2021/2022,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10820980/
46815,"Active Surveillance With Seroprevalence-based Infection Rates Indicates Racial Disparities With Pediatric SARS-CoV-2 Requiring Hospitalization in Mississippi, March 2020–February 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359681/
46816,Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064595/
46817,"Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20–22 April 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441545/
46818,"The Epidemiological, Clinical Features and Outcomes of Imported Chinese COVID-19 Patients Following Inactivated Vaccines Injection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042076/
46819,"Early and Longitudinal Humoral Response to the SARS-CoV-2 mRNA BNT162b2 Vaccine in Healthcare Workers: Significance of BMI, Adipose Tissue and Muscle Mass on Long-Lasting Post-Vaccinal Immunity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143881/
46820,"Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224379/
46821,Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560774/
46822,Strategies for fighting pandemic virus infections: Integration of virology and drug delivery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810279/
46823,Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111046/
46824,"COVID-19: An Update on Epidemiology, Prevention and Treatment, September-2023",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10986731/
46825,SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900244/
46826,"COVID-19 Bivalent Booster in Pregnancy: Maternal and Neonatal Antibody Response to Omicron BA.5, BQ.1, BF.7 and XBB.1.5 SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537670/
46827,SARS-CoV-2 vaccines: a triumph of science and collaboration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262277/
46828,American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426685/
46829,Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626274/
46830,"Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064825/
46831,COVID-19 vaccine development from the perspective of cancer patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437497/
46832,COVID-19 vaccination in Nigeria: A rapid review of vaccine acceptance rate and the associated factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094528/
46833,"“When,” “Where,” and “How” of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10767774/
46834,"SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: Concerns, challenges, management and mitigation strategies–a narrative review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062420/
46835,"Aging in COVID-19: Vulnerability, immunity and intervention",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604159/
46836,Race with virus evolution: The development and application of mRNA vaccines against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837160/
46837,Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552625/
46838,Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249443/
46839,Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018421/
46840,Association of BNT162b2 mRNA and mRNA-1273 Vaccines With COVID-19 Infection and Hospitalization Among Patients With Cirrhosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278308/
46841,Evidence and speculations: vaccines and therapeutic options for COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018497/
46842,Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163167/
46843,"Perceived threat of COVID‐19, attitudes towards vaccination, and vaccine hesitancy: A prospective longitudinal study in the UK",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347957/
46844,Immunogenicity of COVID-19 vaccines and their effect on the HIV reservoir in older people with HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370192/
46845,iScience. 2023 Oct 20; 26(10): 107915. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542941/
46846,"Pre-Vaccination Stress, Post-Vaccination Adverse Reactions, and Attitudes towards Vaccination after Receiving the COVID-19 Vaccine among Health Care Workers",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952304/
46847,Mouse models in COVID-19 research: analyzing the adaptive immune response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166226/
46848,COVID-19 in Children: Clinical Manifestations and Pharmacologic Interventions Including Vaccine Trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130516/
46849,SARS-CoV-2 Vaccination and the Bridge between First and Fourth Dose: Where Are We?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953092/
46850,Adaptive Immune Responses and Immunity to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114812/
46851,Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352588/
46852,Immunological Findings in a Group of Individuals Who Were Poor or Non-Responders to Standard Two-Dose SARS-CoV-2 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963224/
46853,COVID-19 vaccine uptake and associated factors among pregnant women attending antenatal care in Debre Tabor public health institutions: A cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343782/
46854,Comprehensive analysis of COVID-19 during pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759124/
46855,"Covid-19, an unfinished story",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395148/
46856,SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454552/
46857,"Willingness to vaccinate among adults, and factors associated with vaccine acceptance of COVID-19 vaccines in a nationwide study in Poland between March 2021 and April 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10726053/
46858,SARS-CoV-2 and COVID-19: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486701/
46859,An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622245/
46860,Acute ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia post COVID-19 vaccination; a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212261/
46861,Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case–control real-world study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425710/
46862,An overview of vaccine development for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923686/
46863,Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328570/
46864,Should COVID-19 vaccines be mandated in schools? - an international caregiver perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339978/
46865,COVID‐19 and inflammatory bowel disease crosstalk: From emerging association to clinical proposal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538900/
46866,Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470727/
46867,Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971065/
46868,SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765460/
46869,PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281226/
46870,Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921182/
46871,Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445433/
46872,PLoS Pathog. 2022 Jan; 18(1): e1010220. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730411/
46873,"Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349635/
46874,One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074502/
46875,"SARS-CoV-2 placentitis, stillbirth, and maternal COVID-19 vaccination: clinical–pathologic correlations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554221/
46876,COVID-19 vaccine platforms: Delivering on a promise?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381795/
46877,"Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: A cross-sectional analysis of the HELIUS study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922586/
46878,SARS-CoV-2 accessory proteins reveal distinct serological signatures in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135746/
46879,Thrombotic events and COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412105/
46880,Application of omics technology to combat the COVID‐19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554664/
46881,"Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260535/
46882,Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472384/
46883,"Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174470/
46884,"Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898979/
46885,A Review of Virus-Like Particle-Based SARS-CoV-2 Vaccines in Clinical Trial Phases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293385/
46886,Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095020/
46887,Clinical features and mechanistic insights into drug repurposing for combating COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570392/
46888,COVID-19 and Immune-Mediated RBC Destruction: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755306/
46889,Nanoparticles and Antiviral Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10819235/
46890,Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294060/
46891,"The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522676/
46892,SARS‐CoV‐2 variants and vulnerability at the global level,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088647/
46893,"The COVID-19 pandemic in children and young people during 2020-2021: Learning about clinical presentation, patterns of spread, viral load, diagnosis and treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763336/
46894,A bivalent SARS-CoV-2 monoclonal antibody combination does not impact the immunogenicity of a vector-based COVID-19 vaccine in macaques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348747/
46895,Remdesivir for the treatment of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875553/
46896,"SARS‐CoV‐2 in animals: susceptibility of animal species, risk for animal and public health, monitoring, prevention and control",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968901/
46897,COVID-19 vaccine hesitancy and vaccine passports: a cross-sectional conjoint experiment in Japan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207577/
46898,Nucleocapsid protein of SARS‐CoV‐2 is a potential target for developing new generation of vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169192/
46899,Acceptance of COVID-19 vaccines in Palestine: a cross-sectional online study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507407/
46900,COVID-DSNet: A novel deep convolutional neural network for detection of coronavirus (SARS-CoV-2) cases from CT and Chest X-Ray images,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574866/
46901,Peculiarities of the T Cell Immune Response in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877307/
46902,Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536331/
46903,"COVID‐19 vaccine breakthrough infection among fully vaccinated healthcare workers in Duhok governorate, Iraqi Kurdistan: A retrospective cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350230/
46904,Immune response to COVID-19 vaccination in a population with a history of elevated exposure to per- and polyfluoroalkyl substances (PFAS) through drinking water,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541329/
46905,Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910835/
46906,"Do Side Effects to the Primary COVID-19 Vaccine Reduce Intentions for a
COVID-19 Vaccine Booster?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275396/
46907,Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980225/
46908,Return to School and COVID-19 Vaccination for Pediatric Solid Organ Transplant Recipients in the United States: Expert Opinion for 2021-2022,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689907/
46909,Effects of Confounding Bias in Coronavirus Disease 2019 (COVID-19) and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129127/
46910,SARS‐COV‐2 (COVID‐19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537523/
46911,"Knowledge, Attitudes and Practices towards SARS-CoV-2 vaccination among morbid obese individuals: a pilot study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335429/
46912,"Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000357/
46913,Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102365/
46914,Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice Models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954996/
46915,The new normal: Covid-19 risk perceptions and support for continuing restrictions past vaccinations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993013/
46916,Evaluating COVID-19 Vaccine Willingness and Hesitancy among Parents of Children Aged 5–11 Years with Chronic Conditions in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953590/
46917,"Vaccines for Children Provider Practices in the COVID-19 Vaccination Program: Barriers to Participation, Intentions to Offer COVID-19 Vaccination to Children Aged <5 Years, and Vaccination Promotion, United States, March 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018114/
46918,"BNT162b2, mRNA-1273, and Sputnik V Vaccines Induce Comparable Immune Responses on a Par With Severe Course of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044856/
46919,"Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422376/
46920,"Comparing COVID-19 Vaccination Outcomes with Parental Values, Beliefs, Attitudes, and Hesitancy Status, 2021–2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611997/
46921,Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901181/
46922,From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272596/
46923,Cutaneous and hypersensitivity reactions associated with COVID-19 vaccination—a narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381144/
46924,An overview of viral mutagenesis and the impact on pathogenesis of SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742215/
46925,"COVID-19 Vaccine Intentions and Perceptions Among Public School Staff of the Greater Vancouver Metropolitan Area, British Columbia, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092339/
46926,Impaired function and delayed regeneration of dendritic cells in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523079/
46927,Effectiveness of Booster Vaccinations on the Control of COVID-19 during the Spread of Omicron Variant in Malaysia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861773/
46928,mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284784/
46929,COVID‐19 Vaccine Response in People with Multiple Sclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652739/
46930,"Genome-Wide B-Cell, CD4+ and CD8+ T-Cell Epitopes, that are Highly Conserved Between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Pre-Emptive Pan-Coronavirus Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722450/
46931,Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270963/
46932,"Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574180/
46933,Hesitancy towards COVID-19 vaccines on social media in Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921001/
46934,Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073085/
46935,"Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252508/
46936,"Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726493/
46937,Vax attacks: How conspiracy theory belief undermines vaccine support,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713072/
46938,"COVID-19 vaccine acceptance among cold-chain workers in Shenzhen, China: A cross-sectional survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620985/
46939,Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624071/
46940,"EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867401/
46941,COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592693/
46942,Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014240/
46943,Vaccines alone will not prevent COVID-19 outbreaks among migrant workers—the example of meat processing plants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856748/
46944,SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021850/
46945,A qualitative study exploring the relationship between mothers’ vaccine hesitancy and health beliefs with COVID-19 vaccination intention and prevention during the early pandemic months,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437482/
46946,"Myocarditis following COVID-19 vaccination: incidence, mechanisms, and clinical considerations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115793/
46947,Immunogenicity Characterization of COVID-19 Vaccines: A Systematic Review and Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870285/
46948,Patterns and mediators of racial and ethnic disparities in COVID-19 vaccine hesitancy among young adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072749/
46949,A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791831/
46950,Neutralizing antibodies and T-cell responses to inactivated SARS-CoV-2 vaccine in COVID-19 convalescents one and a half years after infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595495/
46951,Do We Really Need Omicron Spike-Based Updated COVID-19 Vaccines? Evidence and Pipeline,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692555/
46952,Overview of SARS-CoV-2 infection in adults living with HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075775/
46953,Mechanisms of COVID-19 pathogenesis in diabetes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359655/
46954,COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369212/
46955,Attitudes towards coronavirus (COVID-19) vaccine and sources of information across diverse ethnic groups in the UK: a qualitative study from June to October 2020,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437733/
46956,Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299225/
46957,Characteristics of patients with SARS-COV-2 PCR re-positivity after recovering from COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019929/
46958,A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562195/
46959,COVID-19 vaccine acceptance among adults in four major US metropolitan areas and nationwide,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569192/
46960,The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283842/
46961,Eight Good Reasons for Careful Monitoring and Evaluation of the Vaccine Campaign against COVID-19: Lessons Learned through the Lombardy Experience for Dealing with Next Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834613/
46962,Impact of maternal SARS-CoV-2 booster vaccination on blood and breastmilk antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263312/
46963,"Evaluation of safety and immunogenicity of receptor-binding domain-based COVID-19 vaccine (Corbevax) to select the optimum formulation in open-label, multicentre, and randomised phase-1/2 and phase-2 clinical trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372721/
46964,The 2019–2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384689/
46965,Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11040945/
46966,Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903393/
46967,"Parental health beliefs, intention, and strategies about covid-19 vaccine for their children: A cross-sectional analysis from five Arab countries in the Middle East",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500095/
46968,"Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116636/
46969,Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489881/
46970,COVID‐19 breakthroughs: separating fact from fiction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300672/
46971,Immune Response 5–7 Months after Vaccination against SARS-CoV-2 in Elderly Nursing Home Residents in the Czech Republic: Comparison of Three Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147580/
46972,The role of B cells in COVID-19 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468879/
46973,"COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806148/
46974,Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983822/
46975,Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626513/
46976,Antibody response to inactivated COVID‐19 vaccine in patients with type 2 diabetes mellitus after the booster immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667667/
46977,"Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187065/
46978,Assessment of COVID-19 Anxiety Levels and Attitudes to COVID-19 Vaccine among Older Adults in Poland: A Pilot Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697294/
46979,Direct and Indirect Associations of Media Use With COVID-19 Vaccine Hesitancy in South Korea: Cross-sectional Web-Based Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734608/
46980,"Association between COVID-19 vaccination status, time elapsed since the last vaccine dose, morbidity, and absenteeism among healthcare personnel: A prospective, multicenter study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597548/
46981,Perspectives on the use and risk of adverse events associated with cytokine-storm targeting antibodies and challenges associated with development of novel monoclonal antibodies for the treatment of COVID-19 clinical cases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127167/
46982,Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077482/
46983,"The COVID-19 Vaccine: Trust, doubt, and hope for a future beyond the pandemic in Germany",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989326/
46984,New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434078/
46985,"Test negative case–control study of COVID-19 vaccine effectiveness for symptomatic SARS-CoV-2 infection among healthcare workers: Zambia, 2021–2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10729193/
46986,Risk of COVID-19 after natural infection or vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518569/
46987,Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935365/
46988,Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120446/
46989,Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519847/
46990,SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570522/
46991,COVID-19 Vaccination Intention and Vaccine Hesitancy among Patients with Autoimmune and Autoinflammatory Rheumatological Diseases: A Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159235/
46992,"Understanding COVID-19 vaccine uptake during pregnancy: ‘Hesitance’, knowledge, and evidence-based decision-making",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947956/
46993,"Cross-Sectional Study of University Students’ Attitudes to ‘On Campus’ Delivery of COVID-19, MenACWY and MMR Vaccines and Future-Proofing Vaccine Roll-Out Strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415485/
46994,"An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366108/
46995,Protection of the third-dose and fourth-dose mRNA vaccines against SARS-CoV-2 Omicron subvariant: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10748972/
46996,"A Retrospective Cross-Sectional Study on the Risk of Getting Sick with COVID-19, the Course of the Disease, and the Impact of the National Vaccination Program against SARS-CoV-2 on Vaccination among Health Professionals in Poland",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223641/
46997,Risks and Preventions for Pregnant Women and Their Preterm Infants in a World with COVID-19: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056995/
46998,"Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148186/
46999,A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793938/
47000,"Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978432/
47001,Reduced antibody response to COVID-19 vaccine composed of inactivated SARS-CoV-2 in diabetic individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773130/
47002,Tolerance for three commonly administered COVID-19 vaccines by healthcare professionals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553122/
47003,The Long-COVID Experience Changed People’s Vaccine Hesitancy but Not Their Vaccination Fear,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654193/
47004,Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547971/
47005,Healthcare Workers and Nonhealthcare Workers Pro-Vaccination Attitude and Its Associated Factors towards COVID-19 Vaccine Globally: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576430/
47006,"Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: A systematic review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110321/
47007,"Risk of SARS-CoV-2 infection and hospitalization in individuals with natural, vaccine-induced and hybrid immunity: a retrospective population-based cohort study from Estonia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663482/
47008,"Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971277/
47009,Review Article: vaccination for patients with inflammatory bowel disease during the COVID‐19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653045/
47010,"Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825982/
47011,Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989492/
47012,Transition to endemic: acceptance of additional COVID-19 vaccine doses among Canadian adults in a national cross-sectional survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473459/
47013,"An updated review on potential therapeutic drug candidates, vaccines and an insight on patents filed for COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498785/
47014,The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678390/
47015,"Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city, Iran",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577998/
47016,Effectiveness of Booster Doses of the SARS-CoV-2 Inactivated Vaccine KCONVAC against the Mutant Strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503905/
47017,BCG and SARS-CoV-2—What Have We Learned?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610589/
47018,Characteristics of headaches attributed to SARS-CoV-2 vaccination and factors associated with its frequency and prolongation: a cross-sectional cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433229/
47019,Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148145/
47020,COVID-19 in Adult Patients with Hematological Malignancies—Lessons Learned after Three Years of Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136203/
47021,"SARS-CoV-2, COVID-19 and the Ageing Immune System",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570568/
47022,The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799268/
47023,"Effectiveness of COVID-19 vaccines in older adults in Colombia: a retrospective, population-based study of the ESPERANZA cohort",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8937302/
47024,Lancet Healthy Longev. 2022 Aug; 3(8): e518. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296099/
47025,SARS-CoV-2: An Updated Review Highlighting Its Evolution and Treatments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780920/
47026,Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001674/
47027,The Role of Serology Testing in the Context of Immunization Policies for COVID-19 in Latin American Countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706237/
47028,Immunomodulation and immunotherapeutics of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393504/
47029,Protective Effect of Inactivated COVID-19 Vaccines against Omicron BA.2 Infection in Guangzhou: A Test-Negative Case-Control Real-World Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053421/
47030,Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245316/
47031,Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702495/
47032,Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087393/
47033,"COVID-19 vaccine acceptance, hesitancy, and determinants among physicians in a university-based teaching hospital in Thailand",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607407/
47034,Global incidence pattern and factors associated with common cutaneous reactions related to COVID-19 vaccination of 2.55 million participants in real-world settings: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910561/
47035,American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427105/
47036,The correlates and dynamics of COVID-19 vaccine-specific hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850099/
47037,COVID-19 vaccine hesitancy among different population groups in China: a national multicenter online survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845236/
47038,A scoping review of global vaccine certificate solutions for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920155/
47039,Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955763/
47040,SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10844289/
47041,"Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905385/
47042,COVID-19 Infection in Children and Infants: Current Status on Therapies and Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870718/
47043,Sex-related susceptibility in coronavirus disease 2019 (COVID-19): Proposed mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486578/
47044,Accelerated waning of the humoral response to COVID-19 vaccines in obesity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202802/
47045,Do we need nasal vaccines against COVID 19 to suppress the transmission of infections?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803331/
47046,Global COVID-19 vaccine acceptance rate: Systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773145/
47047,Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355618/
47048,Diagnostics for COVID-19: moving from pandemic response to control,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687671/
47049,"Impacts of exposure to air pollution, radon and climate drivers on the COVID-19 pandemic in Bucharest, Romania: A time series study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113773/
47050,Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727532/
47051,Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045126/
47052,Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387562/
47053,Strategies and safety considerations of booster vaccination in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162749/
47054,Predictors of COVID-19 vaccine acceptability among health professions students in Vietnam,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047623/
47055,Cross-protective immunity following coronavirus vaccination and coronavirus infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670840/
47056,The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056986/
47057,COVID-19 Vaccine Hesitancy in the United States: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650625/
47058,Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290371/
47059,"Is the BNT162b2 COVID-19 vaccine effective in elderly populations? Results from population data from Bavaria, Germany",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570490/
47060,Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560800/
47061,Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11058186/
47062,COVID-19 Lung Pathogenesis in SARS-CoV-2 Autopsy Cases ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521087/
47063,"COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933006/
47064,Racial/ethnic and nativity disparities in U.S. Covid-19 vaccination hesitancy during vaccine rollout and factors that explain them,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242888/
47065,Global Prevalence and Drivers of Dental Students’ COVID-19 Vaccine Hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226539/
47066,Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183156/
47067,"Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970446/
47068,A replicon RNA vaccine can induce durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150980/
47069,Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination Programs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879800/
47070,Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An In Silico Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678744/
47071,Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478577/
47072,COVID-19 Vaccine Fact-Checking Posts on Facebook: Observational Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217154/
47073,COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305262/
47074,"Trends in COVID-19 vaccination intent and factors associated with deliberation and reluctance among adult homeless shelter residents and staff, 1 November 2020 to 28 February 2021 – King County, Washington",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590934/
47075,Kinetics of adaptive immune responses after administering mRNA-Based COVID-19 vaccination in individuals with and without prior SARS-CoV-2 infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604405/
47076,A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 delta infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995033/
47077,mRNA-based therapeutics: powerful and versatile tools to combat diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123296/
47078,"Impact of prior SARS-CoV-2 infection on college students’ hesitancy to receive additional COVID-19 vaccine booster doses: A study from Taizhou, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10992892/
47079,Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619587/
47080,The immune response to COVID‐19: Does sex matter?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111683/
47081,Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10797606/
47082,"Pilot Study on Evaluating the Impact of Tetanus, Diphtheria, and Pertussis (Tdap), Influenza, and COVID-19 Vaccinations on Antibody Responses in Pregnant Women",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10974830/
47083,"Analysis of IgG, IgA and IgM antibodies against SARS‐CoV‐2 spike protein S1 in convalescent and vaccinated patients with the Pfizer‐BioNTech and CanSinoBio vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662108/
47084,"SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649989/
47085,"Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671836/
47086,Differences in Global Scientific Production Between New mRNA and Conventional Vaccines Against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213638/
47087,Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570475/
47088,Association between Adult Vaccine Hesitancy and Parental Acceptance of Childhood COVID-19 Vaccines: A Web-Based Survey in a Northwestern Region in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539638/
47089,Ultrasensitive detection of salivary SARS-CoV-2 IgG antibodies in individuals with natural and COVID-19 vaccine-induced immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132168/
47090,Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880999/
47091,Lancet Respir Med. 2022 Jun; 10(6): e60. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005117/
47092,Transplacental transmission of SARS‐CoV‐2 immunoglobulin G antibody to infants from maternal COVID‐19 vaccine immunization before pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877834/
47093,"COVID-19 Infections in Gonads: Consequences on
Fertility?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363149/
47094,Comparison of the Effectiveness and Safety of Heterologous Booster Doses with Homologous Booster Doses for SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517782/
47095,Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542448/
47096,Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582773/
47097,Self-Reported Adverse Events of COVID-19 Vaccines in Polish Healthcare Workers and Medical Students. Cross-Sectional Study and Pooled Analysis of CoVaST Project Results in Central Europe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623766/
47098,How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082137/
47099,Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge one year later,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765459/
47100,Harnessing immunological targets for COVID-19 immunotherapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375415/
47101,Review on Up-to-Date Status of Candidate Vaccines for COVID-19 Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826065/
47102,Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719161/
47103,Recent advances on smart glycoconjugate vaccines in infections and cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542079/
47104,Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052735/
47105,Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837559/
47106,Vacuna frente al COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638770/
47107,"COVID-19 in City Council Civil Servants, 1 March 2020–31 January 2023: Risk of Infection, Reinfection, Vaccine Effectiveness and the Impact of Heterologous Triple Vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10974058/
47108,Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211875/
47109,"Ofeleein i mi Vlaptin—Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874934/
47110,Summary of Safety and Efficacy of COVID Vaccination in Patients with Multiple Sclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614228/
47111,Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972750/
47112,Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342436/
47113,The landscape of antibody binding in SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245122/
47114,COVID-19 vaccine hesitancy: A Systematic review of cognitive determinants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257562/
47115,Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142524/
47116,Nat Commun. 2022; 13: 4732. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372969/
47117,Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243822/
47118,"COVID-19, the firestone in 21st century: a review on coronavirus disease and its clinical perspectives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486628/
47119,mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545397/
47120,Effectiveness and Durability of COVID-19 Vaccination in 9447 Patients With IBD: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856753/
47121,Determinants of the Hesitancy toward COVID-19 Vaccination in Eastern European Countries and the Relationship with Health and Vaccine Literacy: A Literature Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146656/
47122,DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158926/
47123,PLoS Negl Trop Dis. 2023 Jan; 17(1): e0011045. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821517/
47124,Can the Nasal Cavity Help Tackle COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537957/
47125,"Emerging roles of extracellular vesicles in COVID‐19, a double‐edged sword?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251486/
47126,Comparative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Against the Delta Variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047165/
47127,Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrate the Functional Importance of the Receptor Binding Domain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482837/
47128,Superior possibilities and upcoming horizons for nanoscience in COVID-19: noteworthy approach for effective diagnostics and management of SARS-CoV-2 outbreak,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072050/
47129,Burden of SARS-CoV-2 infection in healthcare workers during second wave in England and impact of vaccines: prospective multicentre cohort study (SIREN) and mathematical model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295077/
47130,Hamster models of COVID-19 pneumonia reviewed: How human can they be?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207993/
47131,"SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363382/
47132,A Comprehensive Review on Various Aspects of SARS-CoV-2 (COVID-19) Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999094/
47133,COVID‐19 as a trigger of Guillain‐Barré syndrome: A review of the molecular mechanism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187022/
47134,"Association between COVID‐19 and consistent mask wearing during contact with others outside the household—A nested case–control analysis, November 2020–October 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835433/
47135,"Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: A randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343811/
47136,COVID-19 Vaccination Prioritization Strategies in Malaysia: A Retrospective Analysis of Early Evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861551/
47137,Effectiveness of the BNT162b2 vaccine in preventing morbidity and mortality associated with COVID-19 in children aged 5 to 11 years: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695397/
47138,Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233959/
47139,Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873345/
47140,Clinical and Molecular Relationships between COVID-19 and Feline Infectious Peritonitis (FIP),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954060/
47141,Pregnancy Status at the Time of Coronavirus Disease 2019 Vaccination and Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494391/
47142,Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995697/
47143,The Omic Insights on Unfolding Saga of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564481/
47144,Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528426/
47145,SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833750/
47146,Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWE™,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028357/
47147,Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014664/
47148,Hesitancy to receive the novel coronavirus vaccine and potential influences on vaccination among a cohort of healthcare workers in the Democratic Republic of the Congo,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247270/
47149,The impact of immuno-aging on SARS-CoV-2 vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875765/
47150,Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652989/
47151,Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439633/
47152,Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203263/
47153,A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939767/
47154,Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465349/
47155,Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049574/
47156,Bibliometric analysis of the highly cited publications in COVID-19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413004/
47157,Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269986/
47158,Effectiveness and Safety of SARS-CoV-2 Vaccines among Children and Adolescents: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953823/
47159,A low dose of RBD and TLR7/8 agonist displayed on influenza virosome particles protects rhesus macaque against SARS-CoV-2 challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044094/
47160,"Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346248/
47161,COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887620/
47162,Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583882/
47163,The Epidemiology of COVID-19 Vaccine-Induced Myocarditis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11045291/
47164,COVID-19 Vaccine Acceptance Among US Parents: A Nationally Representative Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278238/
47165,Global COVID-19 vaccine acceptance level and its determinants: an umbrella review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10759439/
47166,COVID-19 spike polypeptide vaccine reduces the pathogenesis and viral infection in a mouse model of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020603/
47167,"Innate immunity, cytokine storm, and inflammatory cell death in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682745/
47168,COVID-19 vaccine hesitancy and acceptance: a comprehensive scoping review of global literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278223/
47169,International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625196/
47170,Dietary intervention with functional foods modulating gut microbiota for improving the efficacy of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121067/
47171,Opinion Polls and Antibody Response Dynamics of Vaccination with COVID-19 Booster Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143648/
47172,Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009612/
47173,SARS-CoV-2 seropositivity and COVID-19 among 5 years-old Amazonian children and their association with poverty and food insecurity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292121/
47174,Advances and gaps in SARS-CoV-2 infection models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757994/
47175,"COVID-19, cytokines, inflammation, and spices: How are they related?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884924/
47176,COVID-19 vaccine hesitancy: a survey in a population highly compliant to common vaccinations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437535/
47177,What Should We Do after the COVID-19 Vaccination? Vaccine-Associated Diseases and Precautionary Measures against Adverse Reactions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228524/
47178,Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866568/
47179,Therapeutic vaccine for chronic diseases after the COVID-19 Era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184354/
47180,Racial/Ethnic Differences in COVID-19 Vaccine Hesitancy Among Health Care Workers in 2 Large Academic Hospitals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406078/
47181,Exploring the magic bullets to identify Achilles’ heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694479/
47182,Experiences and perceptions of COVID-19 infection and vaccination among Palestinian refugees in Jerash camp and Jordanian citizens: a comparative cross-sectional study by face-to-face interviews,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744667/
47183,Recent biotechnological advances as potential intervention strategies against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796695/
47184,Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123480/
47185,Human coronaviruses: The emergence of SARS-CoV-2 and management of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351210/
47186,The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti–Cancer Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020811/
47187,The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429934/
47188,Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491181/
47189,Clin Microbiol Rev. 2023 Jun; 36(2): e00052-23. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283480/
47190,"Immunopathological changes, complications, sequelae and immunological memory in COVID-19 patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040416/
47191,Rheumatologists’ knowledge and perception of COVID-19 and related vaccines: the vaXurvey2 online survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012992/
47192,Cancer Patients and the COVID-19 Vaccines: Considerations and Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688380/
47193,An Overview of COVID-19 and Its Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762443/
47194,"Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8030738/
47195,"COVID-19 vaccine hesitancy between teachers and students in a college, a cross-sectional study in China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621023/
47196,Understanding perception and acceptance of Sinopharm vaccine and vaccination against COVID–19 in the UAE,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404750/
47197,COVID-19 Vaccine Safety First Year Findings in Adolescents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262343/
47198,COVID-19 and Inborn Errors of Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550578/
47199,Human Coronaviruses: Counteracting the Damage by Storm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402835/
47200,Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687760/
47201,Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553965/
47202,COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007420/
47203,J Korean Med Sci. 2021 Oct 4; 36(38): e270. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490788/
47204,SARS-CoV-2 immunity in animal models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10806257/
47205,Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619452/
47206,SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433040/
47207,Will Africans take COVID-19 vaccination?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635331/
47208,Efficacy of Vaccine Protection Against COVID-19 Virus Infection in Patients with Chronic Liver Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037513/
47209,Is SARS-CoV-2 vaccination safe and effective for elderly individuals with neurodegenerative diseases?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054494/
47210,"Barriers to COVID-19 vaccination among medical students in Kazakhstan: development, validation, and use of a new COVID-19 Vaccine Hesitancy Scale",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903916/
47211,Race-ethnicity and COVID-19 Vaccination Beliefs and Intentions: A Cross-Sectional Study among the General Population in the San Francisco Bay Area,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705240/
47212,"Effectiveness of four vaccines in preventing SARS-CoV-2 infection in Almaty, Kazakhstan in 2021: retrospective population-based cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282771/
47213,Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796696/
47214,Stakeholders’ hopes and concerns about the COVID-19 vaccines in Southeastern Nigeria: a qualitative study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848682/
47215,"Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824525/
47216,Lancet Microbe. 2022 May; 3(5): e333. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005118/
47217,Achievements of the COVID-19 Turkey Platform in vaccine and drug development with an approach of “co-creation and succeeding together”,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790050/
47218,Factors associated with receipt of COVID-19 vaccination and SARS-CoV-2 seropositivity among healthcare workers in Albania (February 2021–June 2022): secondary analysis of a prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969343/
47219,Antibody response in elderly vaccinated four times with an mRNA anti-COVID-19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465611/
47220,"Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960152/
47221,COVID-19 associated thyroid dysfunction and other comorbidities and its management using phytochemical-based therapeutics: a natural way,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372472/
47222,Disposable face masks and reusable face coverings as non-pharmaceutical interventions (NPIs) to prevent transmission of SARS-CoV-2 variants that cause coronavirus disease (COVID-19): Role of new sustainable NPI design innovations and predictive mathematical modelling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848491/
47223,Comparison of COVID-19 Vaccine-Associated Myocarditis and Viral Myocarditis Pathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967770/
47224,Effectiveness of first and second boost COVID-19 vaccination in healthy adults during BA.5.2/BF.7 surge in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486280/
47225,Bidirectionality between Cardiometabolic Diseases and COVID-19: Role of Humoral Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256583/
47226,"EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013422/
47227,Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671759/
47228,Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443330/
47229,Multi-site observational maternal and infant COVID-19 vaccine study (MOMI-vax): a study protocol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096328/
47230,Going Forward: Potential Impact of Protein-Based COVID-19 Vaccination Coverage on Population Outcomes and Costs in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10819070/
47231,Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651957/
47232,The misunderstanding of vaccine efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314794/
47233,"COVID-19 Knowledge, Attitudes, and Vaccine Hesitancy in Ethiopia: A Community-Based Cross-Sectional Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140841/
47234,Contrasting Association Between COVID-19 Vaccine Hesitancy and Mental Health Status in India and Saudi Arabia—A Preliminary Evidence Collected During the Second Wave of COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116149/
47235,Emerging Therapeutic Modalities against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465781/
47236,Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149948/
47237,"Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418359/
47238,Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10879490/
47239,Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556310/
47240,T cell immune memory after covid-19 and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668147/
47241,Pediatricians’ COVID-19 experiences and views on the willingness to receive COVID-19 vaccines: a cross-sectional survey in Turkey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475573/
47242,Evaluation of the T cell and B cell response following the administration of COVID-19 vaccines in Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516877/
47243,Preclinical study of a DNA vaccine targeting SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020527/
47244,Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530467/
47245,Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472620/
47246,Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845949/
47247,Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441872/
47248,Vaccines for COVID-19: Where do we stand in 2021?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274273/
47249,How to Deal With Vaccine Breakthrough Infection With SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965021/
47250,Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662368/
47251,Divergent COVID-19 Disease Trajectories Predicted by a DAMP-Centered Immune Network Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582279/
47252,Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251854/
47253,Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9383463/
47254,"Assessing the impact of air pollution and climate seasonality on COVID-19 multiwaves in Madrid, Spain",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343379/
47255,Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054487/
47256,Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194875/
47257,IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102086/
47258,Proinflammatory Innate Cytokines and Distinct Metabolomic Signatures Shape the T Cell Response in Active COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609972/
47259,The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698608/
47260,Pre-clinical models to define correlates of protection for SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097995/
47261,SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330865/
47262,The Challenge of Reaching Undocumented Migrants with COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408401/
47263,Assessing the Impact of Vaccination on the Dynamics of COVID-19 in Africa: A Mathematical Modeling Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144609/
47264,Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771167/
47265,In-depth analysis of SARS-CoV-2–specific T cells reveals diverse differentiation hierarchies in vaccinated individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057595/
47266,Efficacy and safety of four COVID-19 vaccines in preventing SARS-CoV-2 infection: A rapid review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714523/
47267,"Retrospective, Observational Studies for Estimating Vaccine Effects on the Secondary Attack Rate of SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505422/
47268,"Comparison of Biological, Pharmacological Characteristics, Indications, Contraindications, Efficacy, and Adverse Effects of Inactivated Whole-Virus COVID-19 Vaccines Sinopharm, CoronaVac, and Covaxin: An Observational Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146574/
47269,Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822773/
47270,The Main Molecular and Serological Methods for Diagnosing COVID-19: An Overview Based on the Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823618/
47271,"Understanding the influence of political orientation, social network, and economic recovery on COVID-19 vaccine uptake among Americans",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860708/
47272,Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110947/
47273,BNT162b2 COVID-19 Vaccine Hesitancy among Parents of 4023 Young Adolescents (12–15 Years) in Qatar,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473301/
47274,‘Corona is coming’: COVID‐19 vaccination perspectives and experiences amongst Culturally and Linguistically Diverse West Australians,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700143/
47275,"Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10865805/
47276,Whole blood‐based measurement of SARS‐CoV‐2‐specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid‐organ cancers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653009/
47277,"A Revisit to the Research Updates of Drugs, Vaccines, and Bioinformatics Approaches in Combating COVID-19 Pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868442/
47278,"Safety, immunogenicity and efficacy of an mRNA-based COVID-19 vaccine, GLB-COV2-043, in preclinical animal models",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692331/
47279,"Could Nanotechnology Help to End the Fight Against COVID-19? Review of Current Findings, Challenges and Future Perspectives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402990/
47280,Immune damage mechanisms of COVID-19 and novel strategies in prevention and control of epidemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028144/
47281,ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282004/
47282,Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910434/
47283,"The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405220/
47284,Effectiveness and safety of COVID-19 vaccines on maternal and perinatal outcomes: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11002410/
47285,Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023494/
47286,"Post COVID-19 vaccination side effects and associated factors among vaccinated health care providers in Oromia region, Ethiopia in 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731451/
47287,"COVID-19 vaccine hesitancy: assessing the prevalence, predictors, and effectiveness of a community pharmacy based counseling intervention",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10771691/
47288,"COVID‐19 coagulopathies: Human blood proteins mimic SARS‐CoV‐2 virus, vaccine proteins and bacterial co‐infections inducing autoimmunity: Combinations of bacteria and SARS‐CoV‐2 synergize to induce autoantibodies targeting cardiolipin, cardiolipin‐binding proteins, platelet factor 4, prothrombin, and coagulation factors.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646673/
47289,Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12–18 Years in Saudi Arabia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621258/
47290,From the COVID-19 pandemic to corrupt practices: a tale of two evils,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742567/
47291,Adaptive immunity to SARS-CoV-2 infection: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589156/
47292,Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2–inactivated vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349640/
47293,Death after the Administration of COVID-19 Vaccines Approved by EMA: Has a Causal Relationship Been Demonstrated?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875435/
47294,Effects of COVID-19 Infection and Vaccination on the Female Reproductive System: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175880/
47295,"CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746539/
47296,Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989774/
47297,"Safety, Efficacy, and Immunogenicity of Varying Types of COVID-19 Vaccines in Children Younger Than 18 Years: An Update of Systematic Review and Meta-Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864967/
47298,COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802612/
47299,"Applications of laboratory findings in the prevention, diagnosis, treatment, and monitoring of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386162/
47300,T-Cell Immunity in COVID-19-Recovered Individuals and Individuals Vaccinated with the Combined Vector Vaccine Gam-COVID-Vac,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916700/
47301,"Population (Antibody) Testing for COVID-19—Technical Challenges, Application and Relevance, an English Perspective",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225097/
47302,The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040543/
47303,"COVID‐19 infection, progression, and vaccination: Focus on obesity and related metabolic disturbances",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420274/
47304,A prospective cohort study of SARS-CoV-2 infection-induced seroconversion and disease incidence in German healthcare workers before and during the rollout of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10826949/
47305,BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250979/
47306,COVID-19: The Immune Responses and Clinical Therapy Candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432271/
47307,Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013662/
47308,Humoral and Cellular Immunity following Five Doses of COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384009/
47309,Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331543/
47310,A longitudinal study of vaccine hesitancy attitudes and social influence as predictors of COVID-19 vaccine uptake in the US,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196649/
47311,"Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439218/
47312,"Determinants of healthcare workers perceptions, acceptance and choice of COVID-19 vaccines: a cross-sectional study from the United Arab Emirates",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928822/
47313,Understanding COVID-19 vaccine hesitancy in vasculitis patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10726054/
47314,Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484576/
47315,Uptake of COVID-19 Booster Dose among Saudi Arabian Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323634/
47316,Efficacy and Short-Term Safety of COVID-19 Vaccines: A Cross-Sectional Study on Vaccinated People in the UAE,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786180/
47317,Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655106/
47318,Models of determinants of COVID-19 vaccine hesitancy in non-pregnant and pregnant population: Review of current literature”,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746492/
47319,Outcomes of single dose COVID-19 vaccines: Eight month follow-up of a large cohort in Saudi Arabia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986276/
47320,"Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277121/
47321,Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172228/
47322,A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000430/
47323,Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473448/
47324,Developing-country vaccine manufacturers’ technical capabilities can make a difference in global immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330991/
47325,HLA‐dependent variation in SARS‐CoV‐2 CD8 + T cell cross‐reactivity with human coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111820/
47326,First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130647/
47327,A DNA Vaccine Encoding the Full-Length Spike Protein of Beta Variant (B.1.351) Elicited Broader Cross-Reactive Immune Responses against Other SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054764/
47328,"Knowledge, attitude, and acceptance regarding COVID-19 vaccines in Sudan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589339/
47329,The Evolution and Disparities of Online Attitudes Toward COVID-19 Vaccines: Year-long Longitudinal and Cross-sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786033/
47330,Dental students’ attitudes and hesitancy toward COVID‐19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242421/
47331,Protecting Nursing Homes and Long-Term Care Facilities From COVID-19: A Rapid Review of International Evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328566/
47332,Various vaccine platforms in the field of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899459/
47333,COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370876/
47334,T cell perturbations persist for at least 6 months following hospitalization for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393525/
47335,COVID-19 and cellular senescence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533263/
47336,Impact of computational approaches in the fight against COVID-19: an AI guided review of 17 000 studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689952/
47337,Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051933/
47338,Lancet Reg Health Eur. 2022 Oct; 21: 100468. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364716/
47339,Hesitancy and reactogenicity to mRNA-based COVID-19 vaccines–Early experience with vaccine rollout in a multi-site healthcare system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355214/
47340,Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641406/
47341,COVID-19—Lessons Learned and Questions Remaining,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797746/
47342,The Willingness to Receive COVID-19 Vaccine and Its Associated Factors: “Vaccination Refusal Could Prolong the War of This Pandemic” – A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232962/
47343,Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561726/
47344,SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920339/
47345,Efficacy and Safety of a Protein-Based SARS-CoV-2 Vaccine: A Randomized Clinical Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157429/
47346,Development and Efficacy of Lateral Flow Point-of-Care Testing Devices for Rapid and Mass COVID-19 Diagnosis by the Detections of SARS-CoV-2 Antigen and Anti-SARS-CoV-2 Antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534532/
47347,What Contributes to COVID-19 Vaccine Hesitancy? A Systematic Review of the Psychological Factors Associated with COVID-19 Vaccine Hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698528/
47348,Information and vaccine hesitancy: Evidence from the early stage of the vaccine roll-out in 28 European countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491558/
47349,Understanding the Relationship of the Human Bacteriome with COVID-19 Severity and Recovery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177376/
47350,Influenza vaccination and single cell multiomics reveal sex dimorphic immune imprints of prior mild COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887138/
47351,Nature. 2023 Feb; 614(7949): 752–761. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481789/
47352,"Guardians of the oral and nasopharyngeal galaxy: IgA and protection against SARS‐CoV‐2 infection
",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349649/
47353,Long COVID: a review and proposed visualization of the complexity of long COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157068/
47354,Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020736/
47355,"COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276532/
47356,Therapeutic approaches for SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096528/
47357,"An update on the interaction between COVID-19, vaccines, and diabetic kidney disease",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630353/
47358,Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204679/
47359,Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318028/
47360,A Bibliometric Visualization Analysis on Vaccine Development of Coronavirus Disease 2019 (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959778/
47361,COVID-19 vaccine acceptance and associated factors in 13 African countries: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903367/
47362,"Virology, pathogenesis, diagnosis and in-line treatment of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366121/
47363,Association between bisphosphonate use and COVID-19 related outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691801/
47364,A pathogen-like antigen-based vaccine confers immune protection against SARS-CoV-2 in non-human primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536523/
47365,Evaluation of PastoCovac plus vaccine as a booster dose on vaccinated individuals with inactivated COVID-19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551543/
47366,Risk Factors Associated with the Clinical Outcomes of COVID-19 and Its Variants in the Context of Cytokine Storm and Therapeutics/Vaccine Development Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402745/
47367,"Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353375/
47368,Lower SARS-CoV-2–specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675463/
47369,"Healthcare Workers’ Perspectives on the Upcoming COVID-19 Vaccine in Terms of Their Exposure to the Influenza Vaccine in Riyadh, Saudi Arabia: A Cross-Sectional Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148208/
47370,Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694471/
47371,Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911984/
47372,SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073272/
47373,"Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348030/
47374,Addressing the Challenges of Vaccine Hesitancy Broadly and Related to COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862750/
47375,The effects of the COVID-19 pandemic on community respiratory virus activity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574826/
47376,Should the world collaborate imminently to develop neglected live‐attenuated vaccines for COVID‐19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662152/
47377,Vaccine development and therapeutic design for 2019‐nCoV/SARS‐CoV‐2: Challenges and chances,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323389/
47378,Is the Immunization of Pregnant Women against COVID-19 Justified?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473171/
47379,COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920465/
47380,"Independent control of COVID-19 vaccines by EU Official Control Authority Batch Release: challenges, strengths and successes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950138/
47381,Global Cross-Sectional Study Evaluating the Attitudes towards a COVID-19 Vaccine in Pregnant and Postpartum Women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961540/
47382,ChatGPT Output Regarding Compulsory Vaccination and COVID-19 Vaccine Conspiracy: A Descriptive Study at the Outset of a Paradigm Shift in Online Search for Information,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931398/
47383,Characterization of Immune Response Diversity in Rodents Vaccinated with a Vesicular Stomatitis Virus Vectored COVID-19 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227808/
47384,Malaysian Parents’ Willingness to Vaccinate Their Children against COVID-19 Infection and Their Perception of mRNA COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693578/
47385,Barriers and facilitators of childhood COVID-19 vaccination among parents: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731120/
47386,Associations between COVID-19 Vaccination Status and Self-Reported SARS-CoV-2 Infection among 8538 Children Aged 3–17 Years during a Massive COVID-19 Outbreak after China Changed Its Zero-COVID-19 Policy: A Cross-Sectional Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535453/
47387,Exploring COVID-19 Vaccine Hesitancy Amongst Black Americans: Contributing Factors and Motivators,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618913/
47388,"Importance, Applications and Features of Assays Measuring SARS-CoV-2 Neutralizing Antibodies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048970/
47389,Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383528/
47390,Immunogenicity and safety of SARS-CoV-2 vaccine in hemodialysis patients: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539993/
47391,The demand for a COVID-19 vaccine in Kenya,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437500/
47392,Knowledge about COVID-19 vaccine and vaccination in Vietnam: A population survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767973/
47393,Canadian parents’ perceptions of COVID-19 vaccination and intention to vaccinate their children: Results from a cross-sectional national survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500474/
47394,"Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373613/
47395,COVID-19 Vaccine Uptake and Associated Factors in Sub-Saharan Africa: Evidence from a Community-Based Survey in Tanzania,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961769/
47396,"Immunogenicity of BNT162b2, BBIBP-CorV, Gam-COVID-Vac and ChAdOx1 nCoV-19 Vaccines Six Months after the Second Dose: A Longitudinal Prospective Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865554/
47397,"T cell responses to COVID-19 infection and vaccination in patients with
multiple sclerosis receiving disease-modifying therapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708532/
47398,Willingness to Receive SARS-CoV-2 Vaccination and Associated Factors among Chinese Adults: A Cross Sectional Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922368/
47399,New onset or relapsing neuromyelitis optica temporally associated with SARS-CoV-2 infection and COVID-19 vaccination: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323143/
47400,ACTIVating Resources for the COVID-19 Pandemic: In Vivo Models for Vaccines and Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528903/
47401,The UPTAKE study: a cross-sectional survey examining the insights and beliefs of the UK population on COVID-19 vaccine uptake and hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210694/
47402,Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465644/
47403,A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835890/
47404,"Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640495/
47405,Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563977/
47406,"Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088091/
47407,The role of mild and asymptomatic infections on COVID-19 vaccines performance: A modeling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592646/
47408,"Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815329/
47409,Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276969/
47410,Humoral and cellular response in convalescent COVID-19 lupus patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374301/
47411,"COVID-19 Vaccination of Individuals with Down Syndrome—Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be Vaccinated",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030605/
47412,The prevention and treatment of COVID-19 in patients treated with hemodialysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563282/
47413,COVID-19 Vaccine Acceptance of Pregnant and Lactating Women (PLW) in Czechia: An Analytical Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708407/
47414,Solid Organ Rejection following SARS-CoV-2 Vaccination or COVID-19 Infection: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412452/
47415,COVID-19 vaccine intention among young adults: Comparative results from a cross-sectional study in Canada and France,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890971/
47416,Insight into the Advances in Clinical Trials of SARS-CoV-2 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850041/
47417,Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161123/
47418,A comparison of seasonal influenza and novel Covid-19 vaccine intentions: A cross-sectional survey of vaccine hesitant adults in England during the 2020 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621000/
47419,Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990563/
47420,Nat Commun. 2023; 14: 2031. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088574/
47421,Nucleic Acid Vaccines against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695141/
47422,"Investigating the uptake, effectiveness and safety of COVID-19 vaccines: protocol for an observational study using linked UK national data",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844955/
47423,Factors Affecting Hesitancy to mRNA and Viral Vector COVID-19 Vaccines among College Students in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402724/
47424,What is the extent of COVID-19 vaccine hesitancy in Bangladesh? A cross-sectional rapid national survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387740/
47425,Waning effectiveness of SARS-CoV-2 mRNA vaccines in older adults: a rapid review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196671/
47426,"Update of the recommendations of the Sociedade Portuguesa de
Cuidados Intensivos and the Infection and Sepsis Group for the
approach to COVID-19 in Intensive Care Medicine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889599/
47427,Current State of the First COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826947/
47428,"SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940980/
47429,Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246416/
47430,The effect of health literacy on COVID-19 vaccine hesitancy among community population in China: The moderating role of stress,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174466/
47431,COVID-19 vaccines: their effectiveness against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991668/
47432,Adenovirus and RNA-based COVID-19 vaccines’ perceptions and acceptance among healthcare workers in Saudi Arabia: a national survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219485/
47433,A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481243/
47434,Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022055/
47435,"Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115794/
47436,Immunogenicity of two doses of BNT162b2 and mRNA‐1273 vaccines for solid cancer patients on treatment with or without a previous SARS‐CoV‐2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538813/
47437,Multiomics integration-based molecular characterizations of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769889/
47438,The top 100 most cited articles on COVID-19 vaccine: a bibliometric analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026222/
47439,Vaccine effectiveness for prevention of covid-19 related hospital admission during pregnancy in England during the alpha and delta variant dominant periods of the SARS-CoV-2 pandemic: population based cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410807/
47440,Vaccination of multiple sclerosis patients during the COVID-19 era: Novel insights into vaccine safety and immunogenicity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462931/
47441,Immune Response in Regard to Hypersensitivity Reactions after COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312871/
47442,"Acceptance of and Preference for COVID-19 Vaccination in India, the United Kingdom, Germany, Italy, and Spain: An International Cross-Sectional Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230582/
47443,Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384625/
47444,"Exploring the beliefs and experiences with regard to COVID-19 vaccine hesitancy and acceptance in a slum of Karachi, Pakistan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620344/
47445,Coronavirus disease 2019 (COVID-19): Biophysical and biochemical aspects of SARS-CoV-2 and general characteristics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142027/
47446,"Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469568/
47447,Therapeutics for COVID-19 and post COVID-19 complications: An update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813675/
47448,COVID-19 vaccine confidence and hesitancy among health care workers: A cross-sectional survey from a MERS-CoV experienced nation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629228/
47449,"Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457761/
47450,Effectiveness of Three Doses of mRNA COVID-19 Vaccines in the Hemodialysis Population during the Omicron Period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103340/
47451,The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310467/
47452,Monoclonal antibody therapies in the management of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862171/
47453,Lessons from SARS-CoV-2 and its variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260876/
47454,"The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326733/
47455,Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358634/
47456,mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948517/
47457,Trends in COVID-19 Vaccine Administration and Effectiveness Through October 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972031/
47458,"Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January–April, 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246475/
47459,An update on emerging therapeutics to combat COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239852/
47460,"Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896606/
47461,The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714775/
47462,"mRNA vaccines: Past, present, future",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459002/
47463,Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977452/
47464,Sociodemographic and psychological correlates of COVID-19 vaccine hesitancy and resistance in the young adult population in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920409/
47465,The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069794/
47466,COVID-19 vaccine acceptance and hesitancy among dental and medical students,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997309/
47467,A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392193/
47468,Host factors: Implications in immunopathogenesis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505027/
47469,Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978955/
47470,Oral Lesions Associated with COVID-19 and the Participation of the Buccal Cavity as a Key Player for Establishment of Immunity against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517300/
47471,Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652288/
47472,Immune Response after 2 Doses of BNT162b2 mRNA COVID-19 Vaccinations in Children and Adolescents with Cancer and Hematologic Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587837/
47473,Exploring the Role of Immune System and Inflammatory Cytokines in SARS-CoV-2 Induced Lung Disease: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953200/
47474,Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646950/
47475,"Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779615/
47476,Beyond the new normal: Assessing the feasibility of vaccine-based suppression of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284637/
47477,"Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513220/
47478,Ascertainment of vaccination status by self‐report versus source documentation: Impact on measuring COVID‐19 vaccine effectiveness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350035/
47479,Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA–mRNA or Vector–mRNA COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780959/
47480,"Future developments in the prevention, diagnosis and treatment of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003455/
47481,COVID-19 vaccine delay: An examination of United States residents’ intention to delay vaccine uptake,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381811/
47482,Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334944/
47483,A scoping review of the pathophysiology of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477699/
47484,Prevention of host-to-host transmission by SARS-CoV-2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439617/
47485,Lancet Infect Dis. 2021 Dec; 21(12): e363. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525916/
47486,SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793671/
47487,Role of miR-2392 in driving SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481092/
47488,Efficacy of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436781/
47489,COVID-19 disease and autoimmune disorders: A mutual pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350728/
47490,Acceptance of a COVID-19 vaccine and associated factors among pregnant women in China: a multi-center cross-sectional study based on health belief model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475603/
47491,β-Glucans Could Be Adjuvants for SARS-CoV-2 Virus Vaccines (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656611/
47492,Sex-Related Factors in Cardiovascular Complications Associated to COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773922/
47493,"The Barriers, Challenges, and Strategies of COVID-19 (SARS-CoV-2) Vaccine Acceptance: A Concurrent Mixed-Method Study in Tehran City, Iran",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620861/
47494,Assessing the influence of French vaccine critics during the two first years of the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352068/
47495,What has vaccination against COVID-19 in CKD patients taught us?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157569/
47496,Multilevel Determinants of COVID-19 Vaccine Uptake Among South Asian Ethnic Minorities in Hong Kong: Cross-sectional Web-Based Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582756/
47497,Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022880/
47498,SARS-CoV-2 vaccines: Lights and shadows,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084611/
47499,Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614600/
47500,"Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252509/
47501,Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic Strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554795/
47502,COVID-19: impact on Public Health and hypothesis-driven investigations on genetic susceptibility and severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961091/
47503,COVID-19 Vaccination in Pregnancy and Lactation: Current Research and Gaps in Understanding,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481914/
47504,Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case–control analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714718/
47505,Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962369/
47506,SARS-CoV-2-Specific Adaptive Immunity in COVID-19 Survivors With Asthma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339657/
47507,COVID-19 immunopathology: From acute diseases to chronic sequelae,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537925/
47508,Humoral and Cellular Immunogenicity of Six Different Vaccines against SARS-CoV-2 in Adults: A Comparative Study in Tunisia (North Africa),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332781/
47509,Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people living with HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696686/
47510,The path towards herd immunity: Predicting COVID-19 vaccination uptake through results from a stated choice study across six continents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848547/
47511,Extra-Pulmonary Complications in SARS-CoV-2 Infection: A Comprehensive Multi Organ-System Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781813/
47512,Emerging Concepts and Technologies in Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554600/
47513,A Review of Recent Studies on the Effects of SARS-CoV-2 Infection and SARS-CoV-2 Vaccines on Male Reproductive Health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951594/
47514,COVID-19 illness and autoimmune diseases: recent insights,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914392/
47515,Mechanisms of Lung Injury Induced by SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873036/
47516,Monitoring the safety of COVID-19 vaccines in pregnancy in the US,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903939/
47517,Socio-demographic Heterogeneity in Prevalence of SARS-COV-2 Infection and Death Rate: Relevance to Black College Student Knowledge of COVID-19 and SARS-COV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815385/
47518,"Hospitalisations and Deaths Averted by COVID-19 Vaccination in Navarre, Spain, 2021–2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10818920/
47519,Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4+ T-cell response with pre-primed responses directed against common cold coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196118/
47520,Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689804/
47521,Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470049/
47522,"Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317171/
47523,Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382605/
47524,The Matrix-M™ adjuvant: A critical component of vaccines for the 21st century,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158541/
47525,Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350892/
47526,The community acceptance of COVID-19 vaccines in Rakhine State: A cross-sectional study in Myanmar,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399871/
47527,COVID‐19 vaccination hesitancy among people with chronic neurological disorders: A position paper,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111566/
47528,"Effectiveness of COVID-19 Vaccines Over Time Prior to Omicron Emergence in Ontario, Canada: Test-Negative Design Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487707/
47529,Effectiveness estimates of three COVID-19 vaccines based on observational data from Puerto Rico,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867062/
47530,Quantitative multiorgan proteomics of fatal COVID‐19 uncovers tissue‐specific effects beyond inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493576/
47531,Combined assessment of S‐ and N‐specific IL‐2 and IL‐13 secretion and CD69 neo‐expression for discrimination of post–infection and post‐vaccination cellular SARS‐CoV‐2‐specific immune response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348018/
47532,The COVID‐19 pandemic and its consequences for chronic pain: a narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350079/
47533,Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602852/
47534,Ethical Challenges Involved in COVID-19 Vaccine Mandates for Children: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052847/
47535,A comprehensive analysis of the efficacy and safety of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342868/
47536,"Inactivated vaccine effectiveness against symptomatic COVID-19 in Fujian, China during the Omicron BA.2 outbreak",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10757624/
47537,Prevalence and factors related to COVID‐19 vaccine hesitancy and unwillingness in Canada: A systematic review and meta‐analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538578/
47538,Severity of infection with the SARS-CoV-2 B.1.1.7 lineage among hospitalized COVID-19 patients in Belgium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165825/
47539,"Association of SARS-CoV-2 Vaccinations with SARS-CoV-2 Infections, ICU Admissions and Deaths in Greece",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876225/
47540,Recent SARS-CoV-2 Outlook and Implications in a COVID-19 Vaccination Era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454280/
47541,Two Years of Genomic Surveillance in Belgium during the SARS-CoV-2 Pandemic to Attain Country-Wide Coverage and Monitor the Introduction and Spread of Emerging Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612291/
47542,Cross-variant protection against SARS-CoV-2 infection in hamsters immunized with monovalent and bivalent inactivated vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305277/
47543,"How to Best Protect People With Diabetes From the Impact of
SARS-CoV-2: Report of the International COVID-19 and Diabetes
Summit",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925443/
47544,Determinants of COVID-19 Vaccine Uptake in Adolescents 12–17 Years Old: Examining Pediatric Vaccine Hesitancy Among Racially Diverse Parents in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980347/
47545,"Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556577/
47546,Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610764/
47547,Immunogenic SARS-CoV-2 S and N Protein Peptide and Cytokine Combinations as Biomarkers for Early Prediction of Fatal COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979210/
47548,COVID-19 vaccine hesitancy among Nigerians living with non-communicable diseases: a qualitative study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895914/
47549,Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941626/
47550,Cell Rep Med. 2021 Jul 20; 2(7): 100355. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249675/
47551,COVID-19 vaccine effectiveness among healthcare workers in Albania (COVE-AL): protocol for a prospective cohort study and cohort baseline data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943479/
47552,New insights into human immune memory from SARS‐CoV‐2 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538469/
47553,Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637126/
47554,Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979721/
47555,Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759301/
47556,Immunological memory to SARS-CoV-2 assessed for up to eight months after infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805444/
47557,Science. 2021 Jan 6 : eabf4063. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919858/
47558,Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell®,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141225/
47559,Landscape and progress of global COVID-19 vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290367/
47560,"Vaccination status, acceptance, and knowledge toward a COVID-19 vaccine among healthcare workers: a cross-sectional survey in China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828068/
47561,Human genetic basis of coronavirus disease 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450706/
47562,COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864787/
47563,Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753942/
47564,"SARS-CoV-2 variants-associated outbreaks of COVID-19 in a tertiary institution, North-Central Nigeria: Implications for epidemic control",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876355/
47565,"Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610426/
47566,Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798886/
47567,Vaccine Hesitancy in the Time of COVID-19: Attitudes and Intentions of Teens and Parents Regarding the COVID-19 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777704/
47568,"Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867771/
47569,Reasons and consequences of COVID‐19 vaccine failure in patients with chronic lymphocytic leukemia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652891/
47570,"Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036128/
47571,"Knowledge, Attitudes, and Acceptance of COVID-19 Vaccines among Secondary School Pupils in Zambia: Implications for Future Educational and Sensitisation Programmes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784903/
47572,A systematic review of communication interventions for countering vaccine misinformation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829031/
47573,Understanding national trends in COVID-19 vaccine hesitancy in Canada: results from five sequential cross-sectional representative surveys spanning April 2020–March 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983402/
47574,"COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639866/
47575,“I Would Rather Take the Vaccine Than Undergo Weekly Testing”: Correlates of Health Workers’ Support for COVID-19 Vaccine Mandates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658226/
47576,Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550199/
47577,Experimental Models of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791197/
47578,Understanding COVID-19 Vaccines Today: Are T-cells Key Players?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227180/
47579,Coronavirus pandemic: treatment and future prevention,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675013/
47580,Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249371/
47581,COVID-19 and Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802611/
47582,Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519143/
47583,Animal models for COVID-19 and tuberculosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451089/
47584,Association between influenza vaccination and SARS-CoV-2 infection and its outcomes: systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771237/
47585,Understanding the policy dynamics of COVID-19 vaccination in Ghana through the lens of a policy analytical framework,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434511/
47586,Association between COVID-19 Vaccination and SARS-CoV-2 Infection among Household Contacts of Infected Individuals: A Prospective Household Study in England,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10892628/
47587,Short-term side effects of COVID-19 vaccines: A cross-sectional study in Jordan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621041/
47588,Looking ahead: Caregivers’ COVID-19 vaccination intention for children 5 years old and younger using the health belief model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806122/
47589,A Live Attenuated COVID-19 Candidate Vaccine for Children: Protection against SARS-CoV-2 Challenge in Hamsters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965573/
47590,Severe acute respiratory syndrome coronavirus 2 variants–Possibility of universal vaccine design: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221512/
47591,"COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213040/
47592,COVID-19 Vaccine Hesitancy and Implications for Economic Recovery: Evidence from Nelson Mandela Bay Municipality in South Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458140/
47593,"Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871594/
47594,Lancet. 2022 Apr 16; 399(10334): 1468. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009837/
47595,Characteristics of SARS-CoV-2 and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537588/
47596,Nat Rev Microbiol. 2022; 20(5): 315. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864972/
47597,Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330385/
47598,COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568271/
47599,Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062180/
47600,Infection with SARS-CoV-2 can cause pancreatic impairment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11014980/
47601,COVID-19: Imbalanced Immune Responses and Potential Immunotherapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878382/
47602,Heterologous prime-boost immunisation with mRNA- and AdC68-based 2019-nCoV variant vaccines induces broad-spectrum immune responses in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050358/
47603,SARS-CoV-2 Antibody Response against Mild-to-Moderate Breakthrough COVID-19 in Home Isolation Setting in Thailand,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318962/
47604,COVID-19 2022 update: transition of the pandemic to the endemic phase,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156835/
47605,The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499991/
47606,A guide to COVID‐19 antiviral therapeutics: a summary and perspective of the antiviral weapons against SARS‐CoV‐2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874604/
47607,Development of an Inactivated Vaccine against SARS CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624180/
47608,Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688056/
47609,Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368295/
47610,"COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623745/
47611,COVID-19 vaccination among pregnant people in the United States: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908633/
47612,Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009914/
47613,COVID-19 vaccine hesitancy and acceptance among the public in the Gulf Cooperation Council countries: A review of the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746509/
47614,Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009960/
47615,Association of Receipt of the Fourth BNT162b2 Dose With Omicron Infection and COVID-19 Hospitalizations Among Residents of Long-term Care Facilities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227688/
47616,"Recent updates on liposomal formulations for detection, prevention and treatment of coronavirus disease (COVID-19)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674400/
47617,The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836975/
47618,"Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958317/
47619,SARS-CoV-2 spreads through cell-to-cell transmission,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740724/
47620,Year‐long wastewater monitoring for SARS‐CoV‐2 signals in combined and separate sanitary sewers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350404/
47621,Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592446/
47622,U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118666/
47623,COVID-19: Insights into long-term manifestations and lockdown impacts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977467/
47624,Development of an in-house quantitative ELISA for the evaluation of different Covid-19 vaccines in humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252535/
47625,Disparities in COVID-19 vaccine uptake among health care workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947975/
47626,"Immunoglobulins response of COVID-19 patients, COVID-19 vaccine recipients, and random individuals",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928079/
47627,Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597631/
47628,Microbiol Spectr. 2022 Jul-Aug; 10(4): e00553-22. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431419/
47629,"A Single Dose of the Deactivated Rabies-Virus Vectored COVID-19 Vaccine, CORAVAX, Is Highly Efficacious and Alleviates Lung Inflammation in the Hamster Model",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229041/
47630,Impaired antibody response to inactivated COVID-19 vaccines in hospitalized patients with type 2 diabetes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026888/
47631,The effectiveness of mRNA vaccines to prevent SARS-CoV-2 infection and hospitalisation for COVID-19 according to the time elapsed since their administration in health professionals in the Valencian Autonomous Community (Spain),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433063/
47632,Optimization of Single-Dose VSV-Based COVID-19 Vaccination in Hamsters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770858/
47633,Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389568/
47634,Parental concerns about COVID-19 vaccine safety and hesitancy in Korea: implications for vaccine communication,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266931/
47635,Immunogenicity and safety of COVID-19 vaccines among people living with HIV: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600909/
47636,Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728886/
47637,Neurological complications associated with Covid‐19; molecular mechanisms and therapeutic approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111040/
47638,Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489983/
47639,Determining the Time of Booster Dose Based on the Half-Life and Neutralization Titers against SARS-CoV-2 Variants of Concern in Fully Vaccinated Individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434144/
47640,Cross-reactive antibodies after SARS-CoV-2 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610423/
47641,Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313047/
47642,Will vaccine-derived protective immunity curtail COVID-19 variants in the US?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426325/
47643,Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241906/
47644,Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860853/
47645,"Attitudes towards COVID-19 vaccination among incarcerated persons in the Federal Bureau of Prisons, June-July 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151452/
47646,SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG Response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769934/
47647,"Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127435/
47648,COVID-19 and Respiratory Virus Co-Infections: A Systematic Review of the Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142898/
47649,Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972327/
47650,Impaired humoral and cellular response to primary COVID‐19 vaccination in patients less than 2 years after allogeneic bone marrow transplant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348196/
47651,Animal Models of COVID-19 II. Comparative Immunology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135340/
47652,Robust immune responses after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885942/
47653,Sci Transl Med. 2021 Dec 7 : eabi8961. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248013/
47654,The Effect of Combining the COVID-19 Vaccine with the Seasonal Influenza Vaccine on Reducing COVID-19 Vaccine Rejection Among Libyans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176301/
47655,Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in France,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148144/
47656,"Assessing COVID-19 Vaccine Booster Hesitancy Using the Modified 5C Scale in Zhejiang Province, China: A Cross-Sectional Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056561/
47657,"Factors Influencing COVID-19 Vaccine Acceptance in the Workplace: Results From a Rapid Survey at 2 Corporations in Los Angeles County, California, 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548445/
47658,SARS-CoV-2: vaccines in the pandemic era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785400/
47659,"An Analysis of the COVID-19 Situation in India in Terms of Testing, Treatment, Vaccine Acceptance and National Economic Performance",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667391/
47660,Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003049/
47661,"A comprehensive account of SARS-CoV-2 genome structure, incurred mutations, lineages and COVID-19 vaccination program",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203033/
47662,Politicization and COVID-19 vaccine resistance in the U.S.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577882/
47663,Mapping the Prevalence of COVID-19 Vaccine Acceptance at the Global and Regional Level: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506365/
47664,Vaccine hesitancy: Beliefs and barriers associated with COVID‐19 vaccination among Egyptian medical students,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013865/
47665,Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852454/
47666,Lancet. 2021 20-26 February; 397(10275): 670. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906627/
47667,Allogeneic hematopoietic stem cell transplantation in the COVID-19 era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993088/
47668,"Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614574/
47669,Anticipation of COVID-19 vaccines reduces willingness to socially distance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442531/
47670,A two-adjuvant multiantigen candidate vaccine induces superior protective immune responses against SARS-CoV-2 challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610932/
47671,"The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505773/
47672,Therapeutic approaches and vaccination in fighting COVID-19 infections: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066810/
47673,A Review on Current COVID-19 Vaccines and Evaluation of Particulate Vaccine Delivery Systems,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540464/
47674,"Barriers Influencing Vaccine Development Timelines, Identification, Causal Analysis, and Prioritization of Key Barriers by KOLs in General and Covid-19 Vaccine R&D",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096063/
47675,Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941049/
47676,Nat Med. 2024; 30(1): 305. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10803247/
47677,How the Italian Twitter Conversation on Vaccines Changed During the First Phase of the Pandemic: A Mixed-Method Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157769/
47678,"COVID-19, SARS-CoV-2 Vaccination, and Human Herpesviruses Infections",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963083/
47679,A Longitudinal Study in Tunisia to Assess the Anti-RBD IgG and IgA Responses Induced by Three Different COVID-19 Vaccine Platforms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10975151/
47680,Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699630/
47681,Advances in the possible treatment of COVID-19: A review.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366101/
47682,From program suspension to the pandemic: A qualitative examination of Australia’s vaccine pharmacovigilance system over 10 years,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445694/
47683,Waning and boosting of functional humoral immunity to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347272/
47684,Nat Commun. 2023; 14: 4174. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345146/
47685,Infection‐induced inflammation from specific inborn errors of immunity to COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236961/
47686,Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224680/
47687,Pressing Questions and Challenges in the HIV-1 and SARS-CoV-2 Syndemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312028/
47688,"T Cell Receptor Sequences Amplified during Severe COVID-19 and Multisystem Inflammatory Syndrome in Children Mimic SARS-CoV-2, Its Bacterial Co-Infections and Host Autoantigens",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861234/
47689,Understanding the Impact of General Vaccine Attitudes on the Intent for Early COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966616/
47690,Changes in Parental Attitudes Toward COVID-19 Vaccination and Routine Childhood Vaccination During the COVID-19 Pandemic: Repeated Cross-sectional Survey Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109779/
47691,Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147674/
47692,"Attitudes toward COVID-19 and Other Vaccines: Comparing Parents to Other Adults, September 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10748314/
47693,New-Onset and Relapsed Membranous Nephropathy post SARS-CoV-2 and COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611660/
47694,"Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584828/
47695,Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10760386/
47696,Attitudes and perceptions of Nigerians regarding receiving COVID-19 vaccines: an online cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188000/
47697,Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129202/
47698,Determinants of humoral and cellular immune responses to three doses of mRNA SARS-CoV-2 vaccines in older adults: a longitudinal cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156136/
47699,Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332924/
47700,Safety and Efficacy of Coronavirus Disease 2019 (COVID-19) mRNA Vaccines During Lactation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975040/
47701,Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262352/
47702,Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613808/
47703,Model-Based Planning and Delivery of Mass Vaccination Campaigns against Infectious Disease: Application to the COVID-19 Pandemic in the UK,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706890/
47704,"ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690006/
47705,Eur Heart J. 2022 May 7; 43(18): 1776. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194802/
47706,Highly Networked SARS-CoV-2 Peptides Elicit T Cell Responses with Enhanced Specificity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580120/
47707,ZnO-Based Electrochemical Immunosensor to Assess Vaccine-Induced Antibody-Mediated Immunity against Wild-Type and Gamma SARS-CoV-2 Strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046366/
47708,Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129308/
47709,Victorian Specialist Immunisation Services (VicSIS) – bolstering adult clinics for COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225531/
47710,Prospective Evaluation of Side-Effects Following the First Dose of Oxford/AstraZeneca COVID-19 Vaccine among Healthcare Workers in Saudi Arabia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875598/
47711,"Knowledge, attitude and acceptability of COVID-19 vaccine among residents in rural communities in Ghana: a multi-regional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887558/
47712,Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775119/
47713,Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239905/
47714,Cellular Immunity of SARS-CoV-2 in the Borriana COVID-19 Cohort: A Nested Case–Control Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11036210/
47715,The public’s attitude to and acceptance of periodic doses of the COVID-19 vaccine: A survey from Jordan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299352/
47716,Molecular Mechanisms Responsible for Diabetogenic Effects of COVID-19 Infection—Induction of Autoimmune Dysregulation and Metabolic Disturbances,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380525/
47717,Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131060/
47718,Robust neutralizing antibody response to SARS-CoV-2 mRNA vaccination in adolescents and young adults with childhood-onset rheumatic diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903460/
47719,Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571409/
47720,An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816618/
47721,Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788624/
47722,Artificial intelligence and clinical data suggest the T cell-mediated SARS-CoV-2 nonstructural protein intranasal vaccines for global COVID-19 immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226295/
47723,mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047160/
47724,Immunological Approaches to the Treatment of New Coronavirus Infection (Review),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482822/
47725,Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789382/
47726,COVID-19 vaccine rumors and conspiracy theories: The need for cognitive inoculation against misinformation to improve vaccine adherence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115834/
47727,Examination of Preferences for COVID-19 Vaccines in Hungary Based on Their Properties—Examining the Impact of Pandemic Awareness with a Hybrid Choice Approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858986/
47728,Immunisation against COVID-19 in Pregnancy and of Women Planning Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059008/
47729,SCARF Genes in COVID-19 and Kidney Disease: A Path to Comorbidity-Specific Therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671056/
47730,"Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045746/
47731,Vitamin D Supplementation and Prior Oral Poliovirus Vaccination Decrease Odds of COVID-19 Outcomes among Adults Recently Inoculated with Inactivated Poliovirus Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10892023/
47732,Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196109/
47733,COVID-19 and thyroid function: What do we know so far?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806267/
47734,"Social norms and vaccine uptake: College students’ COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7965606/
47735,Fiction and Facts about BCG Imparting Trained Immunity against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316941/
47736,Attitudes and personal beliefs about the COVID-19 vaccine among people with COVID-19: a mixed-methods analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579584/
47737,Clinical and Genetic Characteristics of Coronaviruses with Particular Emphasis on SARS-CoV-2 Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252140/
47738,Effect of SARS-CoV-2 Mutations on the Efficacy of Antibody Therapy and Response to Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402590/
47739,Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646713/
47740,Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346010/
47741,Uptake of COVID-19 vaccines and associated factors among adults in Uganda: a cross-sectional survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030279/
47742,"Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190452/
47743,Homologous and Heterologous Covid-19 Booster Vaccinations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820244/
47744,"Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687670/
47745,"Willingness to receive future COVID-19 vaccines following the COVID-19 epidemic in Shanghai, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188944/
47746,SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288264/
47747,Worldwide beliefs among pregnant women on SARS-CoV-2 vaccine: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648617/
47748,"Assessing the long-stand antibody response induced by COVID-19 vaccines: A study in an educational cohort in San Luis, Argentina",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676178/
47749,Vaccine versus Variants (3Vs): Are the COVID-19 Vaccines Effective against the Variants? A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622454/
47750,Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861143/
47751,The relationship between knowledge about the pandemic and willingness to get vaccinated against SARS-CoV-2 in medical students in Poland: A cross-sectional survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453487/
47752,"Early Effectiveness of Four SARS-CoV-2 Vaccines in Preventing COVID-19 among Adults Aged ≥60 Years in Vojvodina, Serbia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954033/
47753,"Ultra-Rapid and Ultra-Sensitive Detection of SARS-CoV-2 Antibodies in
COVID-19 Patients via A 3D-Printed Nanomaterial-Based Biosensing
Platform",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538259/
47754,The long-term effectiveness of coronavirus disease 2019 (COVID-19) vaccines: A systematic literature review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614898/
47755,COVID-19 Anti-Vaccine Sentiments in Malaysia: Narratives of Comments from Facebook Post,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146169/
47756,Multilevel determinants of COVID-19 vaccination hesitancy in the United States: A rapid systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675390/
47757,Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832760/
47758,Diagnostic assay and technology advancement for detecting SARS-CoV-2 infections causing the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872642/
47759,Post-COVID Syndrome in Adults—An Overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056158/
47760,"A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis in Indonesia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461222/
47761,"Wastewater, waste, and water-based epidemiology (WWW-BE): A novel hypothesis and decision-support tool to unravel COVID-19 in low-income settings?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481624/
47762,"Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255947/
47763,Lancet Infect Dis. 2022 Sep; 22(9): e239. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286701/
47764,A Qualitative Study Exploring Motivators and Barriers to COVID-19 Vaccine Uptake among Adults in South Africa and Zimbabwe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145404/
47765,"Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924704/
47766,Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331206/
47767,mRNA vaccination boosts S-specific T cell memory and promotes expansion of CD45RAint TEMRA-like CD8+ T cells in COVID-19 recovered individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439252/
47768,Supporting Tourism by Assessing the Predictors of COVID-19 Vaccination for Travel Reasons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775532/
47769,The Impact of COVID-19 and Vaccine on the Human Nervous System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148879/
47770,"COVID-19 and the eye: alternative facts The 2022 Bowman Club, David L. Easty lecture",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114314/
47771,Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844421/
47772,mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402682/
47773,The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102044/
47774,Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654598/
47775,"Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294770/
47776,Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539757/
47777,Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629105/
47778,Nat Med. 2021; 27(12): 2249. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628279/
47779,COVID-19 Infection and Circulating Microparticles—Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235918/
47780,Therapeutic and Vaccine Options for COVID-19: Status after Six Months of the Disease Outbreak,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940856/
47781,Communications to Promote Interest and Confidence in COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008475/
47782,FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071495/
47783,A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009945/
47784,"A Multi-Center Study Investigating Long COVID-19 in Healthcare Workers from North-Eastern Italy: Prevalence, Risk Factors and the Impact of Pre-Existing Humoral Immunity—ORCHESTRA Project",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10747427/
47785,A Pictorial Essay Describing the CT Imaging Features of COVID-19 Cases throughout the Pandemic with a Special Focus on Lung Manifestations and Extrapulmonary Vascular Abdominal Complications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452395/
47786,COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206176/
47787,"Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses to omicron and historical variants",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774211/
47788,mBio. 2024 Feb; 15(2): e02928-23. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10865805/
47789,COVID-19 vaccine hesitancy among young adults in Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542468/
47790,Exploring the experience of developing COVID-19 vaccines in Iran,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950226/
47791,Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310237/
47792,The biological and clinical significance of emerging SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447121/
47793,An Immunoinformatics Approach for SARS-CoV-2 in Latam Populations and Multi-Epitope Vaccine Candidate Directed towards the World’s Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228945/
47794,mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201026/
47795,Scientific research progress of COVID‐19/SARS‐CoV‐2 in the first five months,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264656/
47796,"Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755034/
47797,"Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem
Cells in COVID-19 Treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328058/
47798,Longitudinal and proteome-wide analyses of antibodies in COVID-19 patients reveal features of the humoral immune response to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313818/
47799,Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245055/
47800,Association of Influenza Vaccination With SARS-CoV-2 Infection and Associated Hospitalization and Mortality Among Patients Aged 66 Years or Older,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520345/
47801,Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400054/
47802,"Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803382/
47803,A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165147/
47804,Plasma cell-free RNA characteristics in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805721/
47805,Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597982/
47806,Epidemiological assessment of SARS-CoV-2 reinfection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345650/
47807,"Hesitancy, reactogenicity and immunogenicity of the mRNA and whole-virus inactivated Covid-19 vaccines in pediatric neuromuscular diseases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294767/
47808,"The Virological, Immunological, and Imaging Approaches for COVID-19 Diagnosis and Research",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435207/
47809,Race to arsenal COVID-19 therapeutics: Current alarming status and future directions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588316/
47810,SARS-CoV-2 epitopes inform future vaccination strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732895/
47811,"Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population: A global survey of 20 countries",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797205/
47812,"Rapid, robust, and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564891/
47813,Understanding the content of COVID-19 vaccination and pregnancy videos on YouTube: An analysis of videos published at the start of the vaccine rollout,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302522/
47814,"Sociodemographic Determinants of COVID-19 Vaccine Hesitancy, Fear of Infection, and Protection Self-Efficacy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388227/
47815,"Effectiveness of Heterologous Coronavirus Disease 2019 (COVID-19) Vaccine Booster Dosing in Brazilian Healthcare Workers, 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213833/
47816,A narrative review of vaccine pharmacovigilance during mass vaccination campaigns: Focus on myocarditis and pericarditis after COVID‐19 mRNA vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878271/
47817,SARS-CoV-2 infection and liver involvement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243815/
47818,"Neutralizing Activity against BQ.1.1, BN.1, and XBB.1 in Bivalent COVID-19 Vaccine Recipients: Comparison by the Types of Prior Infection and Vaccine Formulations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458764/
47819,A Literature Review on SARS-CoV-2 and Other Viruses in Thyroid Disorders: Environmental Triggers or No-Guilty Bystanders?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916247/
47820,Optimizing COVID-19 vaccination programs during vaccine shortages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872681/
47821,Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10927586/
47822,CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049468/
47823,COVID-19 vaccine acceptance and hesitancy among patients with cancer: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452406/
47824,Immune Cells Profiles In The Peripheral Blood Of Patients With Moderate To Severe COVID-19 And Healthy Subjects With and Without Vaccination With The Pfizer-BioNTech mRNA Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309529/
47825,Meharry Medical College Mobile Vaccination Program: Implications for Increasing COVID-19 Vaccine Uptake among Minority Communities in Middle Tennessee,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878662/
47826,"COVID-19 and its impact on cancer, HIV, and mentally ill patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347297/
47827,"COVID-19 Vaccination Intention in a Community Cohort in Ponce, Puerto Rico",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393461/
47828,"Antibody Response against SARS-CoV-2 Infection: Implications for Diagnosis, Treatment and Vaccine Development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442988/
47829,Clinically available/under trial drugs and vaccines for treatment of SARS-COV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300481/
47830,"Perception and Acceptance of Using Different Generic Types of COVID-19 Vaccine, the “Mix-and-Match” Strategy, in Saudi Arabia: Cross-Sectional Web-Based Survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657038/
47831,Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149241/
47832,"Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19–associated hospitalizations among immunocompromised adults—Nine States, January–September 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805402/
47833,Overview of Breastfeeding Under COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192965/
47834,Effectiveness of the Inactivated SARS-CoV-2 (Vero Cell) Vaccine in Peruvian Health Workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503886/
47835,Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708818/
47836,Vaccines (Basel). 2023 Jan; 11(1): 172. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864205/
47837,Prevalence and Determinants of COVID-19 Vaccine Hesitancy Among the Ethiopian Population: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346414/
47838,Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107573/
47839,A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033969/
47840,Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110804/
47841,Functional studies of HLA and its role in SARS-CoV-2: Stimulating T cell response and vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815883/
47842,Anatomy of the first six months of COVID-19 vaccination campaign in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173644/
47843,SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139428/
47844,"Viral RNA Load and Infectivity of SARS-CoV-2 in Paired Respiratory and Oral Specimens from Symptomatic, Asymptomatic, or Postsymptomatic Individuals",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241670/
47845,Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235902/
47846,Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492383/
47847,Blood. 2023 Jun 15; 141(24): 3007. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268901/
47848,Investigating the Potential for Ultraviolet Light to Modulate Morbidity and Mortality From COVID-19: A Narrative Review and Update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786057/
47849,Examining Pregnant Veterans’ Acceptance and Beliefs Regarding the COVID-19 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427157/
47850,"Longitudinal Postvaccine SARS-CoV-2 Immunoglobulin G Titers, Memory B-Cell Responses, and Risk of COVID-19 in Multiple Sclerosis Over 1 Year",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747147/
47851,Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389516/
47852,Effectiveness of Comirnaty® Vaccine and Correlates of Immunogenicity and Adverse Reactions: A Single-Center Prospective Case Series Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330441/
47853,Advances in clinical outcomes: What we have learned during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704728/
47854,"Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428569/
47855,Small molecules in the treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719906/
47856,SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931091/
47857,Self-Reported adverse events among Chinese healthcare workers immunized with COVID-19 vaccines composed of inactivated SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897645/
47858,SARS-CoV-2 vaccination in children and adolescents with and without type 1 diabetes mellitus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543146/
47859,"Assessment of COVID-19 vaccine take-up and its predictors among healthcare professionals in public hospitals, Addis Ababa, Ethiopia: Facility-based cross-sectional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012945/
47860,Drivers of and Barriers to COVID-19 Vaccine Booster Dose Acceptance in Indonesia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783536/
47861,A qualitative study of pregnant women's opinions on COVID-19 vaccines in Turkey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385582/
47862,Communicating about COVID-19 vaccine development and safety,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355181/
47863,Exploring perception and hesitancy toward COVID-19 vaccine: A study from Jordan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475591/
47864,"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639161/
47865,Lancet. 2021 Dec 18; 398(10318): 2246. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8676693/
47866,COVID-19 Vaccine in Pregnant and Lactating Women: A Review of Existing Evidence and Practice Guidelines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395843/
47867,The role of machine learning in health policies during the COVID-19 pandemic and in long COVID management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126380/
47868,"Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580569/
47869,Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428395/
47870,Beneficial non-specific effects of live vaccines against COVID-19 and other unrelated infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417283/
47871,Change in willingness to COVID‐19 vaccination in China: Two online surveys during the pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349959/
47872,Understanding determinants of COVID-19 vaccine hesitancy; an emphasis on the role of religious affiliation and individual’s reliance on traditional remedy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172606/
47873,RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691975/
47874,COVID‐19 vaccines and risks of hematological abnormalities: Nested case–control and self‐controlled case series study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011752/
47875,"Levels of handwashing and vaccine uptake in Kenya, Uganda, and Tanzania to prevent and control COVID-19: a systematic review and meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666047/
47876,"Musculoskeletal Manifestations of COVID-19: Currently Described
Clinical Symptoms and Multimodality Imaging Findings",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341171/
47877,Landscape and selection of vaccine epitopes in SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201469/
47878,A Study on the Key Elements of Bangladesh’s Vaccine Diplomacy During COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261944/
47879,"Evaluation of long-term antibody kinetics in healthcare workers vaccinated with inactivated COVID-19 Vero cell vaccine (CoronaVac), a propensity score-matched observational study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093161/
47880,Clinical and Virological Features of Patients Hospitalized with Different Types of COVID-19 Vaccination in Mexico City,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330015/
47881,"Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359381/
47882,COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363502/
47883,Parental Perspectives on Immunizations: Impact of the COVID-19 Pandemic on Childhood Vaccine Hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299444/
47884,Immune correlates of protection by vaccine against SARS‐CoV‐2 in patients with chronic lymphocytic leukaemia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878216/
47885,Against COVID‐19 vaccination of healthy children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111802/
47886,An intranasal vaccine targeting the receptor binding domain of SARS-CoV-2 elicits a protective immune response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708728/
47887,Immunologically relevant aspects of the new COVID-19 vaccines—an ÖGAI (Austrian Society for Allergology and Immunology) and AeDA (German Society for Applied Allergology) position paper,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212077/
47888,The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588549/
47889,Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465958/
47890,"Association of
COVID-19 with Comorbidities: An Update",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000013/
47891,"Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 Influenza Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407757/
47892,Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922251/
47893,Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006106/
47894,Factors associated with neutralizing antibody levels induced by two inactivated COVID-19 vaccines for 12 months after primary series vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501884/
47895,COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060025/
47896,COVID-19 Vaccine Hesitancy—A Scoping Review of Literature in High-Income Countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402587/
47897,"The Dynamics of Changes in the Concentration of IgG against the S1 Subunit in Polish Healthcare Workers in the Period from 1 to 12 Months after Injection, Including Four COVID-19 Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024925/
47898,Third trimester messenger RNA COVID-19 booster vaccination upsurge maternal and neonatal SARS-CoV-2 immunoglobulin G antibody levels at birth,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148860/
47899,The Nervous System During COVID-19: Caught in the Crossfire,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350403/
47900,COVID-19 vaccine hesitancy and its determinants among sub-Saharan African adolescents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022111/
47901,"“On the last day of the last month, I will go”: A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831134/
47902,The systemic inflammatory landscape of COVID-19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in utero SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549189/
47903,"An update comprehensive review on the status of COVID-19: vaccines, drugs, variants and neurological symptoms",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573837/
47904,Presence of symptoms 6 weeks after COVID-19 among vaccinated and unvaccinated US healthcare personnel: a prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895915/
47905,The Willingness of Parents to Vaccinate Their Children Aged from Five to under Twelve Years with COVID-19 Vaccines between February and March 2022 in Vietnam,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695614/
47906,mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160618/
47907,Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808735/
47908,"Qualitative exploration of intentions, concerns and information needs of vaccine‐hesitant adults initially prioritised to receive COVID‐19 vaccines in Australia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968588/
47909,COVID‐19 vaccination intention in the first year of the pandemic: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447353/
47910,Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588772/
47911,"Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757655/
47912,"Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124924/
47913,The Potential of Probiotics as Ingestible Adjuvants and Immune Modulators for Antiviral Immunity and Management of SARS-CoV-2 Infection and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384479/
47914,Phenotypes and Functions of SARS-CoV-2-Reactive T Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245315/
47915,Application of a life table approach to assess duration of BNT162b2 vaccine-derived immunity by age using COVID-19 case surveillance data during the Omicron variant period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511074/
47916,Decreased memory B cell frequencies in COVID‐19 delta variant vaccine breakthrough infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899913/
47917,Pregnant women’s perceptions of the COVID-19 vaccine: A French survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820613/
47918,Hospitalization and Mortality by Vaccination Status among COVID-19 Patients Aged ≥ 25 Years in Bangladesh: Results from a Multicenter Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786706/
47919,Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105989/
47920,"Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863504/
47921,"Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990482/
47922,Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579272/
47923,"Immunogenicity, effectiveness, and safety of SARS-CoV-2 vaccination in people with HIV",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328433/
47924,MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10817990/
47925,Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026850/
47926,In vitro generated antibodies guide thermostable ADDomer nanoparticle design for nasal vaccination and passive immunization against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10702856/
47927,Current vaccine strategies against SARS-CoV-2: Promises and challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126615/
47928,SARS-CoV-2-Specific and Functional Cytotoxic CD8 Cells in Primary Antibody Deficiency: Natural Infection and Response to Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976534/
47929,Unraveling attributes of COVID-19 vaccine acceptance and uptake in the U.S.: a large nationwide study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209066/
47930,"Identity resilience, science mistrust, COVID-19 risk and fear predictors of vaccine positivity and vaccination likelihood: A survey of UK and Portuguese samples",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043349/
47931,Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214158/
47932,"COVID-19 in the homeless population: a scoping review and meta-analysis examining differences in prevalence, presentation, vaccine hesitancy and government response in the first year of the pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012317/
47933,"Dynamic observation of SARS‐CoV‐2 IgM, IgG, and neutralizing antibodies in the development of population immunity through COVID‐19 vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993648/
47934,Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080532/
47935,The Current Evidence Regarding COVID-19 and Pregnancy: Where Are We Now and Where Should We Head to Next?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541470/
47936,Whither COVID-19 vaccines?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520880/
47937,"Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: A web-based survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362951/
47938,Relative vaccine effectiveness against Delta and Omicron COVID-19 after homologous inactivated vaccine boosting: a retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659710/
47939,"A Potential Association between Abdominal Obesity and the Efficacy of Humoral Immunity Induced by COVID-19 and by the AZD1222, Convidecia, BNT162b2, Sputnik V, and CoronaVac Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10819553/
47940,"Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291337/
47941,"Mandate or Not Mandate: Knowledge, Attitudes, and Practices of Italian Occupational Physicians towards SARS-CoV-2 Immunization at the Beginning of Vaccination Campaign",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402502/
47942,COVID-19 Vaccine Hesitancy among the Public in Kuwait: A Cross-Sectional Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394561/
47943,COVID-19 Vaccine Acceptance among Health Care Workers in the Kingdom of Saudi Arabia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260488/
47944,Exploring COVID-19 vaccine uptake among healthcare workers in Zimbabwe: A mixed methods study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371179/
47945,PLOS Glob Public Health. 2023; 3(12): e0002256. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10734954/
47946,Vaccination‐hesitancy and vaccination‐inequality as challenges in Pakistan's COVID‐19 response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426931/
47947,Criteria for judging the immune markers of COVID‐19 disease vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719528/
47948,"Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150955/
47949,"Estimating the size of “anti-vax” and vaccine hesitant populations in the US, UK, and Canada: comparative latent class modeling of vaccine attitudes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009899/
47950,CDC’s COVID-19 International Vaccine Implementation and Evaluation Program and Lessons from Earlier Vaccine Introductions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745216/
47951,"Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367469/
47952,COVID-19 vaccine use in immunocompromised patients: A commentary on evidence and recommendations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499782/
47953,COVID-19 Vaccination Status as Well as Factors Associated with COVID-19 Vaccine Acceptance and Hesitancy among Prisoners and the Implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301173/
47954,"Vaccine anxieties, vaccine preparedness: Perspectives from Africa in a Covid-19 era",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848721/
47955,The rapid and efficient strategy for SARS-CoV-2 Omicron transmission control: analysis of outbreaks at the city level,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694873/
47956,Peptides for Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384901/
47957,Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974155/
47958,Approach to COVID-19 in older adults and indications for improving the outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578089/
47959,The Spike of SARS-CoV-2: Uniqueness and Applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297464/
47960,"A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003899/
47961,Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619119/
47962,Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836319/
47963,Immunogenicity of COVID-19 Vaccination in People Living with HIV: Progress and Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143399/
47964,"Thrombosis, cancer, and COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106567/
47965,"Knowledge about COVID-19 and vaccine acceptability among priority groups defined for vaccination: A cross-sectional study in Araba/Alava, Spain, before the vaccination against SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170284/
47966,DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984610/
47967,COVID-19 Vaccinating Russian Medical Students—Challenges and Solutions: A Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517622/
47968,"Trends in COVID-19 Vaccine Development: Vaccine Platform, Developer, and Nationality",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10974130/
47969,Optimal planning of the COVID-19 vaccine supply chain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313510/
47970,Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588584/
47971,CHARM: COVID-19 Health Action Response for Marines–Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989306/
47972,"COVID-19 Vaccination Among Individuals With Inflammatory Bowel Disease: Perception, Efficacy, and Safety",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666812/
47973,Vaccine-induced seroconversion in participants in the North Carolina COVID-19 community Research Partnership,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464595/
47974,Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894098/
47975,Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814155/
47976,Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330583/
47977,"Covid-19 and Artificial Intelligence: Genome sequencing, drug development and vaccine discovery",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767913/
47978,mRNA-1273 Protects against SARS-CoV-2 Beta Infection in Nonhuman Primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488000/
47979,"Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393178/
47980,Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10871123/
47981,Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106328/
47982,The role of antigen-presenting cells in the pathogenesis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941975/
47983,"COVID-19 Vaccine Perceptions and Differences by Sex, Age, and Education in 1,367 Community Adults in Ontario",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494003/
47984,Concerns about COVID-19 Vaccine Hesitancy among Law Enforcement Officers: Prevalence and Risk Factor Data from a Nationally Representative Sample in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144532/
47985,COVID-19 challenges: From SARS-CoV-2 infection to effective point-of-care diagnosis by electrochemical biosensing platforms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428033/
47986,Cutaneous adverse effects of the available COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076732/
47987,Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504152/
47988,"Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967513/
47989,Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199392/
47990,Ivermectin for preventing and treating COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215332/
47991,COVID-19 Testing and Vaccine Acceptability Among Homeless-Experienced Adults: Qualitative Data from Two Samples,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547296/
47992,Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375972/
47993,Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID‐19 and response to treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929328/
47994,Interactions between Humans and Dogs during the COVID-19 Pandemic: Recent Updates and Future Perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913536/
47995,Narrative review on century of respiratory pandemics from Spanish flu to COVID-19 and impact of nanotechnology on COVID-19 diagnosis and immune system boosting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589879/
47996,"Unraveling the association between vaccine attitude, vaccine conspiracies and self-reported side effects following COVID-19 vaccination among nurses and physicians in Jordan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10755110/
47997,Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510518/
47998,The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744686/
47999,COVID-19 vaccine booster dose hesitancy among key groups: A cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072063/
48000,"Experimental pre-tests of public health communications on the COVID-19 vaccine: A null finding for medical endorsement, risk and altruism",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108026/
48001,"COVID-19 Vaccine Attitude and Its Predictors Among People Living With Chronic Health Conditions in Ibadan, Nigeria",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613940/
48002,Unfolding the Determinants of COVID-19 Vaccine Acceptance in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813210/
48003,Development of Bivalent mRNA Vaccines against SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693459/
48004,COVID-19 Outbreak Management and Vaccination Strategy in The United States of America,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620927/
48005,Therapeutics and Vaccines: Strengthening Our Fight Against the Global Pandemic COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779084/
48006,Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367759/
48007,"High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular immune responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289822/
48008,Ketogenic Diet and Ketone Bodies as Clinical Support for the Treatment of SARS-CoV-2—Review of the Evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326824/
48009,A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763207/
48010,Vaccine Attitudes and COVID-19 Vaccine Intention Among Parents of Children With Kidney Disease or Primary Hypertension,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212850/
48011,"Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18–55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597768/
48012,Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285122/
48013,"Incidence of SARS‐CoV‐2 infection among COVID‐19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January–September 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983896/
48014,"Efficacy, Safety and Immunogenicity of Anti-SARS-CoV-2 Vaccines in Patients with Cirrhosis: A Narrative Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966438/
48015,COVID-19 vaccine acceptance rate and its predictors in Ethiopia: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746388/
48016,VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708688/
48017,Oxidative stress and COVID-19-associated neuronal dysfunction: mechanisms and therapeutic implications: SARS-CoV-2 (COVID-19)-mediated oxidative stress in neurons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465323/
48018,COVID-19: Myths and Reality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265000/
48019,Hesitancy towards COVID-19 Vaccines: An Analytical Cross–Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151245/
48020,Acceptance towards COVID-19 vaccine among Qassim populations: A cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114579/
48021,Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142516/
48022,Clin Microbiol Rev. 2021 Oct; 34(4): e00163-21. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404690/
48023,"Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008123/
48024,"Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233449/
48025,Parental Acceptance of COVID-19 Vaccination for Children and Its Association With Information Sufficiency and Credibility in South Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856328/
48026,Impact of vaccination and non-pharmacological interventions on COVID-19: a review of simulation modeling studies in Asia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560858/
48027,Lack of clear national policy guidance on COVID-19 vaccines influences behaviors in pregnant and lactating women in Kenya,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746464/
48028,Factors associated with COVID-19 vaccine receipt at two integrated healthcare systems in New York City: a cross-sectional study of healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739539/
48029,SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411904/
48030,Effectiveness of COVID-19 Vaccines in the General Population of an Italian Region before and during the Omicron Wave,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146679/
48031,Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939238/
48032,Children’s SARS-CoV-2 Infection and Their Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962844/
48033,Neurological effects of COVID‐19 in infants and children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111795/
48034,Unmasking the Enigma: An In-Depth Analysis of COVID-19 Impact on the Pediatric Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299956/
48035,Effectiveness and durability of a second COVID-19 booster against severe outcomes among older people in Norway: a population-based cohort study comparing mono- and bivalent booster doses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10749769/
48036,"Parental Willingness for COVID-19 Vaccination among Children Aged 5 to 11 Years in Riyadh City, Saudi Arabia: A Cross-Sectional Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781819/
48037,Enhanced Vaccine Effectiveness during the Delta Phase of the COVID-19 Pandemic in the Medicare Population Supports a Multilayered Prevention Approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774613/
48038,The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689956/
48039,Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823859/
48040,Surveillance of Side Effects after Two Doses of COVID-19 Vaccines among Patients with Comorbid Conditions: A Sub-Cohort Analysis from Saudi Arabia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783784/
48041,Factors Influencing Australian Healthcare Workers’ COVID-19 Vaccine Intentions across Settings: A Cross-Sectional Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781521/
48042,"Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878800/
48043,Applications of nanoengineered therapeutics and vaccines: special emphasis on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212255/
48044,The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767530/
48045,Vaccine Liability in the Light of Covid-19: A Defence of Risk–Benefit,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807205/
48046,Understanding hesitancy with revealed preferences across COVID-19 vaccine types,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345393/
48047,COVID-19: Mechanistic Model of the African Paradox Supports the Central Role of the NF-κB Pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473087/
48048,Anti-SARS-CoV-2 antibody levels and kinetics of vaccine response: potential role for unresolved inflammation following recovery from SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749002/
48049,Role of the humoral immune response during COVID-19: guilty or not guilty?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530436/
48050,Vaccine‐induced immune thrombotic thrombocytopenia after vaccination against Covid‐19: A clinical dilemma for clinicians and patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420499/
48051,Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749477/
48052,Reported COVID-19 vaccines side effects among Jordanian population: a cross sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920252/
48053,Inhibitor screening using microarray identifies the high capacity of neutralizing antibodies to Spike variants in SARS-CoV-2 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965487/
48054,Attitudes toward COVID-19 Vaccines among Patients with Complex Non-Communicable Disease and Their Caregivers in Rural Malawi,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145400/
48055,"Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565933/
48056,SARS-CoV-2 vaccines — the biggest medical research project of the 21st century,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096205/
48057,Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405506/
48058,"Perception and willingness to accept COVID-19 Vaccines: A cross-sectional survey of the general population of Sokoto State, Nigeria",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714919/
48059,"Reduction in COVID-19 Vaccine Effectiveness against SARS-CoV-2 Variants in Seoul according to Age, Sex, and Symptoms: A Test-Negative Case-Control Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779328/
48060,"A systemic review on liquid crystals, nanoformulations and its application for detection and treatment of SARS – CoV- 2 (COVID – 19)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265145/
48061,"Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283343/
48062,Cardiovascular Tropism and Sequelae of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228192/
48063,COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920402/
48064,Role of genetic variants and host polymorphisms on COVID‐19: From viral entrance mechanisms to immunological reactions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015257/
48065,A modeling-based approach to optimize COVID-19 vaccine dosing schedules for improved protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681049/
48066,JCI Insight. 2023 Jul 10; 8(13): e169860. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371350/
48067,Recipients of COVID-19 vaccines face challenges of SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305267/
48068,COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480963/
48069,Autoinflammatory and autoimmune conditions at the crossroad of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296326/
48070,Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251722/
48071,Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832503/
48072,Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106882/
48073,Immunity. 2022 Feb 8; 55(2): 366–375. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822770/
48074,Intention to get vaccinated against COVID-19 among the general population in France: Associated factors and gender disparities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437523/
48075,Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017959/
48076,Emerging role of artificial intelligence in therapeutics for COVID-19: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738208/
48077,"COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10868124/
48078,Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939771/
48079,A Peek into Pandora’s Box: COVID-19 and Neurodegeneration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870638/
48080,SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282065/
48081,Factors influencing hesitancy towards adult and child COVID-19 vaccines in rural and urban West Africa: a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013792/
48082,"Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689871/
48083,Self-Reported COVID-19 Vaccine Hesitancy and Willingness to Pay: A Cross-Sectional Survey in Thailand,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031534/
48084,Understanding the determinants of COVID-19 vaccination intention and willingness to pay: findings from a population-based survey in Bangladesh,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406014/
48085,Complement dysregulation is associated with severe COVID-19 illness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052917/
48086,Targets and strategies for vaccine development against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843096/
48087,Which older Brazilians will accept a COVID-19 vaccine? Cross-sectional evidence from the Brazilian Longitudinal Study of Aging (ELSI-Brazil),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572357/
48088,SARS-CoV-2/COVID-19: a primer for cardiologists,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360901/
48089,The Role of General Attitudes and Perceptions Towards Vaccination on the Newly-Developed Vaccine: Results From a Survey on COVID-19 Vaccine Acceptance in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194573/
48090,COVID-19 vaccine literacy and vaccine hesitancy among pregnant women and mothers of young children in Japan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574944/
48091,Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143166/
48092,Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689350/
48093,The Potential Role of SARS-CoV-2 Infection and Vaccines in Multiple Sclerosis Onset and Reactivation: A Case Series and Literature Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385211/
48094,RNA Vaccines against Infectious Diseases: Vital Progress with Room for Improvement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622374/
48095,COVID-19 and gut immunomodulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678818/
48096,"A Prospective Cohort Study of COVID-19 Vaccination, SARS-CoV-2 Infection, and Fertility",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807200/
48097,Co-infection associated with SARS-CoV-2 and their management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912272/
48098,COVID-19 vaccination hesitancy and associated factors among solid organ transplant recipients in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903951/
48099,Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900119/
48100,"The role of immune activation and antigen persistence in acute and long
COVID",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996119/
48101,SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925644/
48102,Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078907/
48103,Willingness to receive COVID-19 vaccine and associated factors among adult chronic patients. A cross-sectional study in Northwest Ethiopia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275707/
48104,Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036966/
48105,Vaccine allergy: evidence to consider for COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270228/
48106,Humoral Immune Response Diversity to Different COVID-19 Vaccines: Implications for the “Green Pass” Policy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130843/
48107,"Christian nationalism and COVID-19 vaccine hesitancy and
uptake",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489517/
48108,Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368053/
48109,COVID-19 Vaccinations: A Comprehensive Review of Their Safety and Efficacy in Special Populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539110/
48110,Dynamics of Different Classes and Subclasses of Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants after Coronavirus Disease 2019 and CoronaVac Vaccination in Thailand,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942573/
48111,"A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477646/
48112,Clinical and experimental bacteriophage studies: Recommendations for possible approaches for standing against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830156/
48113,Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in non-human primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451060/
48114,Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278117/
48115,COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108345/
48116,Understanding the dynamic relation between wastewater SARS-CoV-2 signal and clinical metrics throughout the pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444583/
48117,Limited Impact of Delta Variant’s Mutations on the Effectiveness of Neutralization Conferred by Natural Infection or COVID-19 Vaccines in a Latino Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707683/
48118,Immunogenicity and Safety of COVID-19 Vaccines among People Living with HIV: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503586/
48119,Nanotechnology and COVID-19: quo vadis?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901091/
48120,The germinal centre B cell response to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647067/
48121,Association between history of HBV vaccine response and anti-SARS-CoV-2 spike antibody response to the BioNTech/Pfizer’s BNT162b2 mRNA SARS-CoV-2 vaccine among healthcare workers in Japan: A prospective observational study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109930/
48122,Determinants of COVID-19 vaccine hesitancy and uptake in sub-Saharan Africa: a scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676416/
48123,A systematic review of effectiveness of BNT162b2 mRNA and ChAdOx1 adenoviral vector COVID-19 vaccines in the general population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383253/
48124,The COVID-19 pandemic and Alzheimer’s disease: mutual risks and mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464468/
48125,"Promising natural products against SARS‐CoV‐2: Structure, function, and clinical trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538226/
48126,Epidemiological and clinical characteristics of pregnant women and neonates with COVID‐19 in Northwest Mexico,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348056/
48127,"The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969831/
48128,COVID-19-related health outcomes in people with primary immunodeficiency: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375253/
48129,COVID-19 and interstitial lung diseases: a multifaceted look at the relationship between the two diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281233/
48130,"Immunogenicity, efficacy, and safety of CoronaVac and Pfizer/BioNTech mRNA vaccines in patients with psoriasis receiving systemic therapies: A prospective cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239265/
48131,The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678181/
48132,"COVID-19: The Course, Vaccination and Immune Response in People with Multiple Sclerosis: Systematic Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253145/
48133,Insight into the biological impact of COVID-19 and its vaccines on human health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837491/
48134,Fall 2021 Update: Navigating COVID Vaccination in Tumultuous Times,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647522/
48135,An Immune Response to Heterologous ChAdOx1/BNT162b2 Vaccination against COVID-19: Evaluation of the anti-RBD Specific IgG Antibodies Titers and Interferon Gamma Release Assay (IGRA) Test Results,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506411/
48136,Omicron related COVID-19 prevention and treatment measures for patients with hematological malignancy and strategies for modifying hematologic treatment regimes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622671/
48137,Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252532/
48138,Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165493/
48139,A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130996/
48140,Longitudinal Changes in IgG-Type SARS-CoV-2 Antibody Titers after COVID-19 Vaccination and a Prominent Increase in Antibody Titers When Infected after Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145145/
48141,Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080055/
48142,Primed for global coronavirus pandemic: Emerging research and clinical outcome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501876/
48143,Alum/CpG Adjuvanted Inactivated COVID-19 Vaccine with Protective Efficacy against SARS-CoV-2 and Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413105/
48144,Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966717/
48145,"SARS-CoV-2 Antibody Prevalence among Industrial Livestock Operation Workers and Nearby Community Residents, North Carolina, 2021 to 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942583/
48146,Vaccines and the social amplification of risk,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347756/
48147,DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907653/
48148,The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802596/
48149,"COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662254/
48150,COVID-19 Vaccine-Induced Lichenoid Eruptions—Clinical and Histopathologic Spectrum in a Case Series of Fifteen Patients with Review of the Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967301/
48151,"Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817129/
48152,"COVID-19 Vaccine Early Skepticism, Misinformation and Informational Needs among Essential Workers in the USA",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707450/
48153,Signaling COVID-19 Vaccine Adverse Events,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219360/
48154,Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480269/
48155,SARS-CoV-2 and Its Bacterial Co- or Super-Infections Synergize to Trigger COVID-19 Autoimmune Cardiopathies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418384/
48156,"Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971107/
48157,"Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529090/
48158,"COVID-19 vaccination in the Federal Bureau of Prisons, December 2020—April 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363472/
48159,Multifaceted roles of Fcγ receptors in COVID-19 and vaccine responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250970/
48160,Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546713/
48161,JAMA Netw Open. 2023 May; 6(5): e2317317. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203894/
48162,"Unveiling Associations of COVID-19 Vaccine Acceptance, Hesitancy, and Resistance: A Cross-Sectional Community-Based Adult Survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656487/
48163,"A cross sectional study to examine factors influencing COVID-19 vaccine acceptance, hesitancy and refusal in urban and rural settings in Tamil Nadu, India",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182563/
48164,COVID-19 mRNA BNT162b2 vaccine immunogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103624/
48165,Antibody Responses to COVID-19 Vaccination in Cancer: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599356/
48166,"Effectiveness of COVID-19 mRNA Vaccines in Preventing COVID-19-Associated
Outpatient Visits and Hospitalizations Among American Indian and Alaska Native Persons,
January–November 2021: A Test-Negative Case-Control Analysis Using Surveillance
Data",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114530/
48167,Open Forum Infect Dis. 2023 May; 10(5): ofad261. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209007/
48168,"Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784533/
48169,Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212999/
48170,Impact of COVID-19 on Immunization Services for Maternal and Infant Vaccines: Results of a Survey Conducted by Imprint—The Immunising Pregnant Women and Infants Network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563512/
48171,A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364787/
48172,Immunogenicity and safety of the BBIBP‐CorV vaccine in patients with autoimmune inflammatory rheumatic diseases undergoing immunosuppressive therapy in a monocentric cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186999/
48173,Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553964/
48174,Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606168/
48175,"Satisfaction with COVID-19 Vaccines in Health Care Workers and the General Population: A Cross-Sectional Study in Urban Bangkok, Thailand",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413823/
48176,Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908850/
48177,First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203460/
48178,Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612125/
48179,Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407655/
48180,"Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959277/
48181,"Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137272/
48182,"A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919065/
48183,Misconceptions Drive COVID-19 Vaccine Hesistancy in Individuals with Inflammatory Bowel Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482530/
48184,COVID-19 Vaccine Hesitancy and Vaccination Coverage in India: An Exploratory Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143697/
48185,"Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212595/
48186,"Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812084/
48187,Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720049/
48188,Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323250/
48189,Understanding the epigenetic mechanisms in SARS CoV-2 infection and potential therapeutic approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236910/
48190,"Clinical characteristics, radiological features and prognostic factors of transverse myelitis following COVID-19 vaccination: A systematic review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258415/
48191,Policies on children and schools during the SARS-CoV-2 pandemic in Western Europe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411527/
48192,Parental Perceptions Related to Co-Administration of Adolescent COVID-19 and Routine Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722677/
48193,Perceived health literacy and COVID-19 vaccine acceptance among Chinese college students: A mediation analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439250/
48194,"Review of epidemic, containment strategies, clinical management, and economic evaluation of COVID-19 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156902/
48195,Clinical Efficacy of SARS-CoV-2 Vaccination in Hemodialysis Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287586/
48196,"Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906655/
48197,Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Vaccination for Negative Conversion Time of Nucleic Acid in Nonsevere COVID-19 Patients Infected by SARS-CoV-2 Omicron Variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545465/
48198,Changes of the Public Attitudes of China to Domestic COVID-19 Vaccination After the Vaccines Were Approved: A Semantic Network and Sentiment Analysis Based on Sina Weibo Texts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632040/
48199,Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868520/
48200,"Stamping the vaccine passport? Public support for lifting COVID-19 related restrictions for vaccinated citizens in France, Germany, and Sweden",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385771/
48201,"Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924650/
48202,"COVID‐19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281639/
48203,Comparative analysis of the effectiveness difference of SARS-COV-2 mRNA vaccine in different populations in the real world: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470718/
48204,Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169129/
48205,COVID-19 Vaccination in Inflammatory Bowel Disease (IBD),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104993/
48206,"COVID-19 Vaccination and Intent Among Pregnant Women, United States,
April 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357823/
48207,"Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941865/
48208,"Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414359/
48209,"Knowledge, attitude and practice survey towards COVID‐19 vaccination: A mediation analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087425/
48210,Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241654/
48211,"The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913045/
48212,Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040355/
48213,Analysis of Key Factors of a SARS-CoV-2 Vaccination Program: A Mathematical Modeling Approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824484/
48214,Immunosenescence and inflamm-ageing in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741765/
48215,Biomedical Science to Tackle the COVID-19 Pandemic: Current Status and Future Perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587204/
48216,Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938429/
48217,"Knowledge, Attitudes, and Perception towards COVID-19 Vaccination among the Adult Population: A Cross-Sectional Study in Turkey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877322/
48218,"Factors associated with willingness to take COVID-19 vaccine among pregnant women at Gondar town, Northwest Ethiopia: A multicenter institution-based cross-sectional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632816/
48219,Stopping the COVID-19 pandemic in dental offices: A review of SARS-CoV-2 transmission and cross-infection prevention,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606959/
48220,What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870421/
48221,Evaluating the Impact of SARS-CoV-2 Variants on the COVID-19 Epidemic and Social Restoration in the United States: A Mathematical Modelling Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786080/
48222,Biological and Psychological Factors Determining Neuropsychiatric Outcomes in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485771/
48223,Some common deleterious mutations are shared in SARS-CoV-2 genomes from deceased COVID-19 patients across continents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616235/
48224,COVID-19 vaccine policy development in a sample of 44 countries – Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671626/
48225,Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866189/
48226,Determinants of Acceptance of COVID-19 Vaccination in Healthcare and Public Health Professionals: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961323/
48227,Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053079/
48228,Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439918/
48229,Next-Generation Bioinformatics Approaches and Resources for Coronavirus Vaccine Discovery and Development—A Perspective Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402397/
48230,Effective Vaccination and Education Strategies for Emerging Infectious Diseases Such as COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643251/
48231,Challenges of vaccination and herd immunity in COVID‐19 and management strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539035/
48232,Using the COM-B framework to elucidate facilitators and barriers to COVID-19 vaccine uptake in pregnant women: a qualitative study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481472/
48233,Dynamics of Anti-S IgG Antibodies Titers after the Second Dose of COVID-19 Vaccines in the Manual and Craft Worker Population of Qatar,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058349/
48234,Review on Drug Regulatory Science Promoting COVID-19 Vaccine Development in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779850/
48235,"Path analysis of perceived disease vulnerability, COVID-19 fear, and lower vaccine hesitancy within the context of protection motivation theory",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10881856/
48236,"Public Discourse, User Reactions, and Conspiracy Theories on the X Platform About HIV Vaccines: Data Mining and Content Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11024739/
48237,COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666422/
48238,"The role of blood groups, vaccine type and gender in predicting the severity of side effects among university students receiving COVID-19 vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242595/
48239,Clinical manifestations and disease severity of SARS-CoV-2 infection among infants in Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401116/
48240,Kidney transplant recipients’ attitudes toward COVID‐19 vaccination and barriers and enablers to vaccine acceptance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646313/
48241,An empirical assessment of the factors influencing acceptance of COVID-19 vaccine uptake between Kenyan and Hungarian residing populations: A cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786518/
48242,Efficacy of COVID-19 vaccines: a systematic review and network meta-analysis of phase 3 randomized controlled trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640819/
48243,What attributes influence rural household’s willingness to get vaccinated for COVID-19? Perspectives from six Chinese townships,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705199/
48244,COVID-19 vaccination during pregnancy: coverage and safety,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352848/
48245,Immune response variables and viral mutations impact on COVID-19 reinfection and relapse,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423905/
48246,Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535809/
48247,"Oxford COVID-19 Vaccine Hesitancy in School Principals: Impacts of Gender, Well-Being, and Coronavirus-Related Health Literacy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471420/
48248,"Vaccination practices, knowledge and attitudes regarding COVID-19 vaccines among Chinese university students: a cross-sectional study from a comprehensive university in Wuhan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670092/
48249,Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913025/
48250,Cerebral Vein Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378439/
48251,Boosting with an aerosolized Ad5-nCoV elicited robust immune responses in inactivated COVID-19 vaccines recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585368/
48252,Vaccine innovation model: A technology transfer perspective in pandemic contexts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236274/
48253,"Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059134/
48254,Global trends in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895648/
48255,Estimated Effectiveness of a Primary Cycle of Protein Recombinant Vaccine NVX-CoV2373 Against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551773/
48256,Determinants of COVID-19 Vaccine Acceptance among the Adult Population of Bangladesh Using the Health Belief Model and the Theory of Planned Behavior Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707510/
48257,An assessment of the strategy and status of COVID-19 vaccination in India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089693/
48258,Potential COVID‐19 Therapeutic Agents and Vaccines: An Evidence‐Based Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014753/
48259,Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482810/
48260,Cellular therapies for the treatment and prevention of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896869/
48261,Exploring COVID-19 vaccine uptake among healthcare workers in Zimbabwe: A mixed methods study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10734954/
48262,Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419561/
48263,Metallic nanoplatforms for COVID-19 diagnostics: versatile applications in the pandemic and post-pandemic era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403867/
48264,"Timing of BNT162b2 vaccine prior to COVID‐19 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660398/
48265,Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224263/
48266,"New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981536/
48267,Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013627/
48268,COVID-19 Vaccination and Alcohol Consumption: Justification of Risks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967163/
48269,COVID-19 vaccines: progress and understanding on quality control and evaluation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129697/
48270,COVID-19: Relationship and Impact on Breastfeeding—A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470649/
48271,Viral Vectors for COVID-19 Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922679/
48272,Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996067/
48273,Bibliometric Analysis of Global Scientific Production on COVID-19 and Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049169/
48274,COVID-19 Blind Spots: A Consensus Statement on the Importance of Competent Political Leadership and the Need for Public Health Cognizance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045535/
48275,Vaccines and more: The response of Dark Web marketplaces to the ongoing COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648775/
48276,Neurological consequences of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524739/
48277,Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881000/
48278,"Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263255/
48279,Precision therapeutic targets for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006140/
48280,Effectiveness of mRNA COVID-19 Vaccination on SARS-CoV-2 Infection and COVID-19 in Sicily over an Eight-Month Period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949048/
48281,Investigating the Links Between Vaccination Against COVID-19 and Public Attitudes Toward Protective Countermeasures: Implications for Public Health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333618/
48282,Molecular Characterization and Selection of Indigenous SARS-CoV-2 Delta Variant for the Development of the First Inactivated SARS-CoV-2 Vaccine of Pakistan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051781/
48283,High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228150/
48284,Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869965/
48285,IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108089/
48286,Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106700/
48287,CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884904/
48288,Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960081/
48289,Safety and effectiveness of vaccines against COVID-19 in children aged 5–11 years: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112865/
48290,Lancet Child Adolesc Health. 2024 Apr; 8(4): e6. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11074000/
48291,T cells in SARS-CoV-2 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425900/
48292,"Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513709/
48293,The Longitudinal Analysis on the Anti-SARS-CoV-2 Antibodies among Healthcare Workers in Poland—Before and after BNT126b2 mRNA COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607217/
48294,SARS‐CoV‐2 spike trimer vaccine expressed in Nicotiana benthamiana adjuvanted with Alum elicits protective immune responses in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538723/
48295,High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608966/
48296,Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324317/
48297,Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394010/
48298,Evolving perceptions of COVID-19 vaccines among remote Alaskan communities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786257/
48299,"Engineering Materials and Devices for the Prevention, Diagnosis, and Treatment of COVID-19 and Infectious Diseases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10490511/
48300,"Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876839/
48301,Immune targets to stop future SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714790/
48302,Efficacy of antibody response following the vaccination of SARS‐CoV‐2 infected and noninfected healthcare workers by two‐dose inactive vaccine against COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088406/
48303,The emerging role of miRNAs in the pathogenesis of COVID-19: Protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346380/
48304,Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553653/
48305,Cutaneous findings following COVID‐19 vaccination: review of world literature and own experience,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656409/
48306,Covid-19 vaccination intensions among literate Ghanaians: Still the need to dissipate fear and build trust on vaccine efficacy?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242507/
48307,"Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399076/
48308,Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646283/
48309,Is vaccine confidence an unexpected victim of the COVID-19 pandemic?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618445/
48310,"An opinion on Wastewater-Based Epidemiological Monitoring
(WBEM) with Clinical Diagnostic Test (CDT) for detecting high-prevalence areas
of community COVID-19 Infections",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612100/
48311,Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545089/
48312,Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029629/
48313,"Scientific Evidence Supporting Coronavirus Disease 2019 (COVID-19)
Vaccine Efficacy and Safety in People Planning to Conceive or Who Are Pregnant
or Lactating",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678336/
48314,"Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719928/
48315,SARS-CoV-2 Infection and Significance of Oral Health Management in the Era of “the New Normal with COVID-19”,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235682/
48316,Dynamics of CD4+ T-Cells and Neutralizing Antibody Responses to Three Consecutive Doses of Inactivated COVID-19 Vaccines in PLWH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166092/
48317,Parents’ Willingness to Vaccinate Their Children With COVID-19 Vaccine: Results of a Survey in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767903/
48318,SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352574/
48319,Nat Microbiol. 2022; 7(10): 1709. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483304/
48320,Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935297/
48321,"The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831023/
48322,"Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620770/
48323,"Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162782/
48324,"Willingness, refusal and influential factors of parents to vaccinate their children against the COVID-19: A systematic review and meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861629/
48325,SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779393/
48326,National Academy of Medicine of Korea (NAMOK) Key Statements on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546308/
48327,The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778387/
48328,Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19–convalescent individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779849/
48329,Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548030/
48330,Diagnostic Tools for Rapid Screening and Detection of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414050/
48331,People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636386/
48332,Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622572/
48333,"Vaccinations Against COVID-19 May Have Averted Up To 140,000 Deaths In The United States",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937640/
48334,mRNA- and Adenovirus-Based Vaccines against SARS-CoV-2 in HIV-Positive People,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031858/
48335,"Factors influencing COVID-19 vaccination intention: The roles of vaccine knowledge, vaccine risk perception, and doctor-patient communication",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450210/
48336,"Functional consequences of SARS-CoV-2 infection in pregnant women, fetoplacental unit, and neonate",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581789/
48337,Covid-19 infection in children and adolescents and its association with type 1 diabetes mellitus (T1d) presentation and management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734866/
48338,Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic Sera,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223959/
48339,"Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286709/
48340,Lancet Infect Dis. 2022 Sep; 22(9): e239. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333949/
48341,Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448314/
48342,Results of the RENAISSANCE Study: REsponse to BNT162b2 COVID-19 vacciNe—short- And long-term Immune reSponSe evAluatioN in health Care workErs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403667/
48343,"An Integrated Radiologic-Pathologic Understanding of COVID-19
Pneumonia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868683/
48344,The impact of COVID-19 vaccines on fertility-A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464596/
48345,"Liver disorders in COVID-19, nutritional approaches and the use of phytochemicals",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473593/
48346,Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056353/
48347,"Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341908/
48348,COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213508/
48349,Trust in Science as a Possible Mediator between Different Antecedents and COVID-19 Booster Vaccination Intention: An Integration of Health Belief Model (HBM) and Theory of Planned Behavior (TPB),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320855/
48350,Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715386/
48351,Biomimetic Nanotechnology for SARS-CoV-2 Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051120/
48352,An Executed Plan to Combat COVID-19 in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276922/
48353,Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease‐19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441773/
48354,Negative sentiments toward novel coronavirus (COVID-19) vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584858/
48355,Immune-Boosting Effect of the COVID-19 Vaccine: Real-World Bidirectional Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569382/
48356,Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in Healthcare Workers and COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955649/
48357,The dramatic increase in anti-vaccine discourses during the COVID-19 pandemic: a social network analysis of Twitter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993086/
48358,Cov19VaxKB: A web-based integrative COVID-19 vaccine knowledge base,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716025/
48359,A SARS-CoV-2 and influenza double hit vaccine based on RBD-conjugated inactivated influenza A virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289656/
48360,"COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795815/
48361,COVID-19 vaccine equity: a health systems and policy perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631691/
48362,SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551145/
48363,SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120039/
48364,The intersection of gender and race in older adults’ decision to receive COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485425/
48365,Optimizing COVID-19 vaccine allocation considering the target population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853449/
48366,"Association of the Magnitude of Anti-SARS-CoV-2 Vaccine Side Effects with Sex, Allergy History, Chronic Diseases, Medication Intake, and SARS-CoV-2 Infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10820381/
48367,SARS-CoV-2 vaccine uptake and reasons for hesitancy among Canadian pregnant people: a prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744265/
48368,Blood donor eligibility after COVID-19 vaccination: the current state of recommendations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783297/
48369,Acceptance of COVID‐19 booster vaccination based on the protection motivation theory: A cross‐sectional study in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348068/
48370,Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714803/
48371,The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243884/
48372,Dissecting CD8+ T cell pathology of severe SARS-CoV-2 infection by single-cell immunoprofiling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800604/
48373,The Impact of Meso-Level Factors on SARS-CoV-2 Vaccine Early Hesitancy in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341526/
48374,One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567933/
48375,"SARS-CoV-2 B.1.1.7 UK Variant of Concern Lineage-Related Perceptions, COVID-19 Vaccine Acceptance and Travel Worry Among Healthcare Workers",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187763/
48376,"Emerging manufacturers engagements in the COVID −19 vaccine research, development and supply",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287474/
48377,Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209841/
48378,"Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7651196/
48379,Factors Associated With COVID-19 Vaccine Acceptance Among Patients Receiving Care at a Federally Qualified Health Center,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291217/
48380,Factors Influencing Willingness to Be Vaccinated against COVID-19 in Nigeria,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180792/
48381,Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266930/
48382,Platforms Exploited for SARS-CoV-2 Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824029/
48383,Cost effectiveness of fractional doses of COVID-19 vaccine boosters in India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922587/
48384,"Rapamycin and inulin for third-dose vaccine response stimulation (RIVASTIM): Inulin – study protocol for a pilot, multicentre, randomised, double-blinded, controlled trial of dietary inulin to improve SARS-CoV-2 vaccine response in kidney transplant recipients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716412/
48385,T‐cell recovery and evidence of persistent immune activation 12 months after severe COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347640/
48386,Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744442/
48387,Comparison of the Immune Responses to COVID-19 Vaccines in Bangladeshi Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504987/
48388,Parents’ views on the acceptability of a COVID-19 vaccine for their children: A cross-sectional study in Abu Dhabi-United Arab Emirates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376339/
48389,"Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765452/
48390,Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528088/
48391,NPJ Vaccines. 2022; 7: 28. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885829/
48392,Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388189/
48393,Effectiveness of the WHO-Authorized COVID-19 Vaccines: A Rapid Review of Global Reports till 30 June 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708265/
48394,Current state of vaccine development and targeted therapies for COVID-19: impact of basic science discoveries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462898/
48395,Parents’ Intentions and Perceptions about COVID-19 Vaccination for their Children: Results from a National Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116994/
48396,"COVID-19 vaccine uptake and effectiveness by time since vaccination in the Western Cape province, South Africa: An observational cohort study during 2020–2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10854330/
48397,Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797829/
48398,SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991062/
48399,Strategic Planning of a Joint SARS-CoV-2 and Influenza Vaccination Campaign in the UK,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10891881/
48400,"Pemphigus during the COVID-19 Epidemic: Infection Risk, Vaccine Responses and Management Strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317200/
48401,Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932592/
48402,SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412395/
48403,In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811676/
48404,Human Stem Cell Models of SARS-CoV-2 Infection in the Cardiovascular System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349465/
48405,Stem Cell Rev Rep. 2021; 17(6): 2368. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531906/
48406,Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422807/
48407,COVID-19 vaccine acceptance in three rural communes in Haiti: A cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171132/
48408,A Bivalent COVID-19 Vaccine Based on Alpha and Beta Variants Elicits Potent and Broad Immune Responses in Mice against SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143086/
48409,"Adverse events and SARS-CoV-2 antibody responses after immunization with Sputnik V, ChAdOx1-S, and BBIBP-CorV vaccines in people with HIV",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079572/
48410,A Comprehensive Review on the Efficacy of Several Pharmacologic Agents for the Treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692303/
48411,Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705976/
48412,Harnessing the non-specific immunogenic effects of available vaccines to combat COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678415/
48413,Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604481/
48414,Acceptance of the COVID-19 vaccine based on the health belief model: a multicenter national survey among medical care workers in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481094/
48415,Immune landscape and redox imbalance during neurological disorders in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482955/
48416,"Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365313/
48417,"COVID-19: Invasion, pathogenesis and possible cure – A review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669942/
48418,Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266840/
48419,"Leveraging 13 million responses to the U.S. COVID-19 Trends and Impact Survey to examine vaccine hesitancy, vaccination, and mask wearing, January 2021-February 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559553/
48420,Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069796/
48421,"Enablers and barriers to vaccine uptake and handwashing practices to prevent and control COVID-19 in Kenya, Uganda, and Tanzania: a systematic review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11004251/
48422,Attitudes Toward COVID-19 Vaccines Among Pregnant and Recently Pregnant Individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11002697/
48423,COVID-19 outbreak in an elderly care home: Very low vaccine effectiveness and late impact of booster vaccination campaign,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531647/
48424,Potential therapeutic options for COVID-19: an update on current evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755901/
48425,Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189440/
48426,The quest for a better fight: How can nanomaterials address the current therapeutic and diagnostic obstacles in the fight against COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489264/
48427,Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781262/
48428,Selective adaptation of SARS-CoV-2 Omicron under booster vaccine pressure: a multicentre observational study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623172/
48429,A Retrospective Evaluation of Self-Reported Adverse Events Following Immunization with Different COVID-19 Vaccines in Türkiye,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964774/
48430,Willingness to receive the COVID-19 vaccine among HIV positive men who have sex with men in China: a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830605/
48431,Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520206/
48432,Correlates of uptake of COVID-19 vaccines and motivation to vaccinate among Malawian adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332229/
48433,Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961733/
48434,Ivermectin for preventing and treating COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406455/
48435,Cochrane Database Syst Rev. 2022; 2022(6): CD015017. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215332/
48436,Novel coronavirus disease (COVID-19) pandemic: A recent mini review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773542/
48437,Providing children with COVID‐19 vaccinations is challenging due to lack of data and wide‐ranging parental acceptance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653137/
48438,"COVID-19 Diagnostics, Tools, and Prevention",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344926/
48439,Global Prevalence and Potential Influencing Factors of COVID-19 Vaccination Hesitancy: A Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412456/
48440,SARS‐CoV‐2 replicating in nonprimate mammalian cells probably have critical advantages for COVID‐19 vaccines due to anti‐Gal antibodies: A minireview and proposals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404575/
48441,Integrated immune dynamics define correlates of COVID-19 severity and antibody responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862905/
48442,Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10818859/
48443,"Acceptance of COVID-19 Vaccine among the Healthcare Workers in the Eastern Cape, South Africa: A Cross Sectional Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233726/
48444,The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052681/
48445,Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135691/
48446,"Longitudinal analyses using 18F-Fluorodeoxyglucose positron emission tomography with computed tomography as a measure of COVID-19 severity in the aged, young, and humanized ACE2 SARS-CoV-2 hamster models",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105383/
48447,Protecting adults at risk of pneumococcal infection and influenza from exposure to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920219/
48448,Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272948/
48449,SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070527/
48450,Immune Imprinting and Implications for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142218/
48451,"Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768509/
48452,Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773076/
48453,The time to offer treatments for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074648/
48454,Pulmonary function testing during SARS‐CoV‐2: An ANZSRS/TSANZ position statement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539179/
48455,Molecular mimicry and autoimmunity in the time of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258587/
48456,"Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835928/
48457,A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745033/
48458,Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604136/
48459,A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298481/
48460,"A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694590/
48461,Quantifying Changes in Vaccine Coverage in Mainstream Media as a Result of the COVID-19 Outbreak: Text Mining Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631944/
48462,A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547312/
48463,"Is knowledge about COVID-19 associated with willingness to receive vaccine, vaccine uptake, and vaccine booster uptake in rural Malang, Indonesia?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282756/
48464,COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696595/
48465,DNA vaccine protection against SARS-CoV-2 in rhesus macaques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243363/
48466,Towards the development of an epitope-focused vaccine for SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513333/
48467,Temporal trends and determinants of COVID-19 vaccine series initiation after recent pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305504/
48468,Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312950/
48469,Nat Commun. 2024; 15: 2175. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10928100/
48470,Three Separate Spike Antigen Exposures by COVID-19 Vaccination or SARS-CoV-2 Infection Elicit Strong Humoral Immune Responses in Healthcare Workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317472/
48471,Are We Paving the Way to Dig Out of the “Pandemic Hole”? A Narrative Review on SARS-CoV-2 Vaccination: From Animal Models to Human Immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395838/
48472,SARS-CoV-2 vaccines for cancer patients: a call to action,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904467/
48473,Exploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: a multi-national survey study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10899622/
48474,Willingness to Accept Expedited COVID-19 Vaccine Research for Children Aged <12 Years After Adult Vaccine Approval,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639474/
48475,"SARS-CoV-2 Vaccine Uptake among Patients with Chronic Liver Disease: A Cross-Sectional Analysis in Hebei Province, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458449/
48476,Insight into the emerging role of SARS-CoV-2 nonstructural and accessory proteins in modulation of multiple mechanisms of host innate defense,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381213/
48477,Critical appraisal of the mechanisms of gastrointestinal and hepatobiliary infection by COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289353/
48478,Immune profiling of COVID-19: preliminary findings and implications for the pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108128/
48479,Animal models of mechanisms of SARS‐CoV‐2 infection and COVID‐19 pathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283621/
48480,Comparative risk of cerebral venous sinus thrombosis (CVST) following COVID-19 vaccination or infection: A national cohort study using linked electronic health records,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746546/
48481,Early cross-coronavirus reactive signatures of humoral immunity against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943686/
48482,"An insight into SARS-CoV-2 structure, pathogenesis, target hunting for drug development and vaccine initiatives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215161/
48483,"Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358642/
48484,The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880242/
48485,A novel simian adenovirus-vectored COVID-19 vaccine elicits effective mucosal and systemic immunity in mice by intranasal and intramuscular vaccination regimens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10715068/
48486,Impact of the COVID-19 pandemic on routine vaccine landscape: A global perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294763/
48487,Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376738/
48488,SARS-CoV-2 Vaccines during Pregnancy and Breastfeeding: A Systematic Review of Maternal and Neonatal Outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951373/
48489,Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742681/
48490,SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436349/
48491,"Safety and efficacy of COVID-19 vaccine immunization during pregnancy in 1024 pregnant women infected with the SARS-CoV-2 Omicron virus in Shanghai, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10826606/
48492,Antepartum SARS-CoV-2 infection and adverse birth outcomes in South African women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718447/
48493,T cell immunity to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529278/
48494,Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745767/
48495,Nat Commun. 2023; 14: 1593. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032242/
48496,Immune memory in mild COVID-19 patients and unexposed donors from India reveals persistent T cell responses after SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924292/
48497,Front Immunol. 2021; 12: 636768. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991090/
48498,Intranasal Delivery of Thermostable Subunit Vaccine for Cross-Reactive Mucosal and Systemic Antibody Responses Against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110812/
48499,Perceived Barriers and Intentions to Receive COVID-19 Vaccines: Psychological Distress as a Moderator,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967752/
48500,Hyperimmune immunoglobulin for people with COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887673/
48501,An additional dose of viral vector COVID-19 vaccine and mRNA COVID-19 vaccine in kidney transplant recipients: A randomized controlled trial (CVIM 4 study),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349825/
48502,Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402624/
48503,SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients – a comparative long term post-infection study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428854/
48504,Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950968/
48505,Universal Predictors of Dental Students’ Attitudes towards COVID-19 Vaccination: Machine Learning-Based Approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539257/
48506,"Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500019/
48507,"Acceptance of COVID-19 vaccination and influencing factors among people living with HIV in Guangxi, China: a cross-sectional survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109427/
48508,Progress with COVID-19 vaccination in the WHO African Region in 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474845/
48509,With Great Hopes Come Great Expectations: Access and Adoption Issues Associated With COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341090/
48510,"A comprehensive review of oral microenvironment changes and orofacial adverse reactions after COVID‐19 vaccination: The good, the bad, and the ugly",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10935892/
48511,"A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628628/
48512,Seasonal coronavirus–specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19 ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553556/
48513,Living Organ Donor Perspectives and Sources of Hesitancy about COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323843/
48514,COVID-19 Vaccine Education (CoVE) for Health and Care Workers to Facilitate Global Promotion of the COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775929/
48515,CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043652/
48516,Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147846/
48517,Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687490/
48518,RAGE engagement by SARS-CoV-2 enables monocyte infection and underlies COVID-19 severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694673/
48519,Cardiovascular Dysfunction in COVID-19: Association Between Endothelial Cell Injury and Lactate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984030/
48520,Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: how many booster doses do we need?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936995/
48521,Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330139/
48522,"Preceding anti-spike IgG levels predicted risk and severity of COVID-19 during the Omicron-dominant wave in Santa Fe city, Argentina",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947048/
48523,Over 1‐year duration and age difference of SARS‐CoV‐2 antibodies in convalescent COVID‐19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426830/
48524,Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427556/
48525,"Non-coding RNAs expression in SARS-CoV-2 infection: pathogenesis, clinical significance, and therapeutic targets",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10700414/
48526,“First Do No Harm”. No-Fault Compensation Program for COVID-19 Vaccines as Feasibility and Wisdom of a Policy Instrument to Mitigate Vaccine Hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540114/
48527,Effects of COVID-19 and mRNA vaccines on human fertility,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689912/
48528,The impact of vaccine hesitation on the intentions to get COVID-19 vaccines: The use of the health belief model and the theory of planned behavior model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615565/
48529,Mechanisms of SARS-CoV-2 Transmission and Pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556779/
48530,Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: A population-based register study with implications to vaccinations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023344/
48531,mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452492/
48532,"Seroprevalence in health care workers during the later phase of the second wave: Results of three hospitals in Serbia, prior to vaccine administration",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130304/
48533,"Effectiveness of COVID-19 vaccines against hospitalisation in Latin America during three pandemic waves, 2021–2022: a test-negative case-control design",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682274/
48534,COVID-19 Vaccines in Children with Cow’s Milk and Food Allergies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401713/
48535,Multiplatform analyses reveal distinct drivers of systemic pathogenesis in adult versus pediatric severe acute COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073144/
48536,Clinical Presentation of COVID-19 and Antibody Responses in Bangladeshi Patients Infected with the Delta or Omicron Variants of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694163/
48537,Implications of SARS-CoV-2 Infection in Systemic Juvenile Idiopathic Arthritis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029451/
48538,Evidence-based policies in public health to address COVID-19 vaccine hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079004/
48539,"SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242031/
48540,Front Immunol. 2023; 14: 1232965. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292686/
48541,Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020872/
48542,Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367741/
48543,"Determinants and Variations of COVID-19 Vaccine Uptake and Responses Among Minority Ethnic Groups in Amsterdam, the Netherlands",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891150/
48544,Potential for Early Noninvasive COVID-19 Detection Using Electronic-Nose Technologies and Disease-Specific VOC Metabolic Biomarkers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054641/
48545,Preclinical immunological evaluation of an intradermal heterologous vaccine against SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745378/
48546,Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057765/
48547,"Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910845/
48548,Circulating multimeric immune complexes contribute to immunopathology in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513013/
48549,Waning vaccine response to severe COVID-19 outcomes during omicron predominance in Thailand,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174527/
48550,Risk management strategies and therapeutic modalities to tackle COVID-19/SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837232/
48551,Evaluation of Antibody Response and Adverse Effects following Heterologous COVID-19 Vaccine Booster with mRNA Vaccine among Healthcare Workers in Indonesia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386191/
48552,First COVID-19 Booster Dose in the General Population: A Systematic Review and Meta-Analysis of Willingness and Its Predictors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323526/
48553,Leveraging lessons learned from the COVID-19 pandemic for HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423691/
48554,Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827020/
48555,"Persistence of protection against SARS-CoV-2 clinical outcomes up to 9 months since vaccine completion: a retrospective observational analysis in Lombardy, Italy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797009/
48556,A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366622/
48557,Determinants of COVID-19 Vaccination Decision-Making Behaviors among Pregnant Women in Sub-Saharan Africa: A Scoping Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384512/
48558,Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978449/
48559,Utility of NO and H2S donating platforms in managing COVID-19: Rationale and promise,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398942/
48560,Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic Stroke,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405641/
48561,Scale Development for COVID-19 Vaccine Hesitancy by Integration of Socio-Demographic and Psychological Factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302605/
48562,SARS-CoV-2 Variants of Concern Increased Transmission and Decrease Vaccine Efficacy in the COVID-19 Pandemic in Palembang Indonesia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972875/
48563,Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662353/
48564,"The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694140/
48565,"Neutralizing antibodies to SARS‐CoV‐2 variants of concern including Delta and Omicron in subjects receiving mRNA‐1273, BNT162b2, and Ad26.COV2.S vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353285/
48566,Correlation between COVID-19 and hepatitis B: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782843/
48567,Vaccination strategies and transmission of COVID-19: Evidence across advanced countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769883/
48568,Efficacy of Six Different SARS-CoV-2 Vaccines during a Six-Month Follow-Up and Five COVID-19 Waves in Brazil and Mexico,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142281/
48569,Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100875/
48570,The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385262/
48571,"Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135375/
48572,COVID-19: imbalanced cell-mediated immune response drives to immunopathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553190/
48573,The human genetic epidemiology of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060414/
48574,COVID-19: The Emerging Immunopathological Determinants for Recovery or Death,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736111/
48575,Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974935/
48576,Impact of COVID-19 in solid organ transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800718/
48577,Therapeutic strategies to fight COVID‐19: Which is the status artis?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239658/
48578,"Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis ",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459193/
48579,Community risks for SARS-CoV-2 infection among fully vaccinated US adults by rurality: A retrospective cohort study from the National COVID Cohort Collaborative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815650/
48580,"Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645495/
48581,PNAS Nexus. 2024 Jan; 3(1): pgad477. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10825409/
48582,Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393170/
48583,Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010731/
48584,Sci Adv. 2021 Oct; 7(43): eabj3107. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528426/
48585,A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175625/
48586,"Knowledge, attitudes, and perceptions of COVID-19 vaccine and refusal to receive COVID-19 vaccine among healthcare workers in northeastern Ethiopia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765812/
48587,"Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Randomized Control Trials in the Pre-Delta Era: A Systematic Review and Network Meta-Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608197/
48588,"Effectiveness of Whole-Virus COVID-19 Vaccine among Healthcare Personnel, Lima, Peru",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745240/
48589,Predicted B Cell Epitopes Highlight the Potential for COVID-19 to Drive Self-Reactive Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581003/
48590,Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280377/
48591,Propensity-Score-Matched Evaluation of Adverse Events Affecting Recovery after COVID-19 Vaccination: On Adenovirus and mRNA Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875227/
48592,Would COVID-19 vaccination willingness increase if mobile technologies prohibit unvaccinated individuals from public spaces? A nationwide discrete choice experiment from China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531240/
48593,Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408367/
48594,Assessment of vaccinations and breakthrough infections after adjustment of the dynamic zero-COVID-19 strategy in China: an online survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512888/
48595,"COVID-19 Complications: Oxidative Stress, Inflammation, and Mitochondrial and Endothelial Dysfunction",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573237/
48596,Update on Extracellular Vesicle-Based Vaccines and Therapeutics to Combat COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569487/
48597,Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947923/
48598,Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666329/
48599,"Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574791/
48600,COVID‐19 in gastroenterology: Where are we now? Current evidence on the impact of COVID‐19 in gastroenterology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435247/
48601,The impact of COVID-19 vaccination programme in the Republic of San Marino: Focus on effectiveness of Gam-Covid-Vac,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251905/
48602,Fusion of intelligent learning for COVID-19: A state-of-the-art review and analysis on real medical data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206574/
48603,Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Primary analysis report of a phase 3 open-label trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165021/
48604,Perspectives on administration of COVID-19 vaccine to pregnant and lactating women: a challenge for low- and middle-income countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413092/
48605,Proceedings of the Online Conference “Vaccines and Vaccination during and Post COVID Pandemics” (7–9 December 2022),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383049/
48606,Genomic Biomarker Heterogeneities between SARS-CoV-2 and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608907/
48607,Organoid and microfluidics-based platforms for drug screening in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695520/
48608,Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661524/
48609,"Exploring Determinants of COVID-19 Vaccine Acceptance, Uptake, and Hesitancy in the Pediatric Population: A Study of Parents and Caregivers in Saudi Arabia during the Initial Vaccination Phase",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094388/
48610,SARS-CoV-2 primary and breakthrough infections in patients with cancer: Implications for patient care,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526006/
48611,Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938298/
48612,Development of a novel medium throughput flow-cytometry based micro-neutralisation test for SARS-CoV-2 with applications in clinical vaccine trials and antibody screening,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688860/
48613,Longitudinal Study of DNA Methylation and Epigenetic Clocks Prior to and Following Test-Confirmed COVID-19 and mRNA Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203887/
48614,SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305493/
48615,"COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401617/
48616,Clinical drug therapies and biologicals currently used or in clinical trial to treat COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486678/
48617,A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768780/
48618,"Effectiveness of COVID-19 vaccination in healthcare workers in Shiga Prefecture, Japan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586956/
48619,Worldwide Estimation of Parental Acceptance of COVID-19 Vaccine for Their Children: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051081/
48620,To Be or Not To Be Vaccinated: That Is a Question in Myasthenia Gravis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485039/
48621,COVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166656/
48622,Public Opinions on COVID-19 Vaccines—A Spatiotemporal Perspective on Races and Topics Using a Bayesian-Based Method,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504395/
48623,Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821964/
48624,Exploring the Interaction between E484K and N501Y Substitutions of SARS-CoV-2 in Shaping the Transmission Advantage of COVID-19 in Brazil: A Modeling Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592180/
48625,CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immune responses against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348575/
48626,Potential factors influencing COVID-19 vaccine acceptance and hesitancy: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942251/
48627,Investigating the intention to receive the COVID-19 vaccination in Macao: implications for vaccination strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894128/
48628,Cross-sectional study on COVID-19 vaccine hesitancy and determinants in healthcare students: interdisciplinary trainings on vaccination are needed,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020813/
48629,Aging‐related cell type‐specific pathophysiologic immune responses that exacerbate disease severity in aged COVID‐19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844132/
48630,"Understanding COVID‐19 misinformation and vaccine hesitancy in context: Findings from a qualitative study involving citizens in Bradford, UK",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239544/
48631,Measuring Vaccine Efficacy Against Infection and Disease in Clinical Trials: Sources and Magnitude of Bias in Coronavirus Disease 2019 (COVID-19) Vaccine Efficacy Estimates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586723/
48632,"Vaccine Acceptance and Hesitancy among Hospitalized COVID-19 Patients in Punjab, Pakistan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611380/
48633,New-onset IgG autoantibodies in hospitalized patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440763/
48634,Assessing the best time interval between doses in a two-dose vaccination regimen to reduce the number of deaths in an ongoing epidemic of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986122/
48635,Parental Hesitancy on COVID-19 Vaccination for Children Under Five Years in Thailand: Role of Attitudes and Vaccine Literacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012909/
48636,"COVID-19 vaccine-taking hesitancy among Bangladeshi people: knowledge, perceptions and attitude perspective",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828157/
48637,The effects of obesity and metabolic abnormalities on severe COVID-19-related outcomes after vaccination: A population-based study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974355/
48638,Obesity and Leptin Resistance in the Regulation of the Type I Interferon Early Response and the Increased Risk for Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002648/
48639,Pannexin-1 channel opening is critical for COVID-19 pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603863/
48640,Delineating COVID-19 immunological features using single-cell RNA sequencing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299978/
48641,COVID-19 vaccine hesitancy concerns: Findings from a Ghana clinical radiography workforce survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498685/
48642,Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10879169/
48643,Cost-Effectiveness Analysis of COVID-19 Inactivated Vaccines in Reducing the Economic Burden of Ischaemic Stroke after SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224220/
48644,Animal Transmission of SARS-CoV-2 and the Welfare of Animals during the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300090/
48645,Antibody and B cell responses to SARS-CoV-2 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233571/
48646,Comparison of the immunogenicity of five COVID‐19 vaccines in Sri Lanka,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349502/
48647,Increased Interleukin 18-Dependent Immune Responses Are Associated With Myopericarditis After COVID-19 mRNA Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894592/
48648,"Intent among Parents to Vaccinate Children before Pediatric COVID-19 Vaccine Recommendations, Minnesota and Los Angeles County, California—May–September 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504557/
48649,COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738845/
48650,An Analysis of Factors Shaping Vaccine Attitudes and Behaviours in a Low-Trust Society Based on Structural Equation Modelling—The Case of Poland’s Vaccination Programme against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690255/
48651,An outlook on potential protein targets of COVID-19 as a druggable site,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256362/
48652,Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998661/
48653,Effectiveness of COVID-19 vaccination during pregnancy by circulating viral variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502365/
48654,Learning from the COVID-19 pandemic: a systematic review of mathematical vaccine prioritization models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10942533/
48655,Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243164/
48656,"Willingness to receive SARS-CoV-2 vaccine among healthcare workers in public institutions of Zhejiang Province, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381814/
48657,Longer-term effectiveness of a heterologous coronavirus disease 2019 (COVID-19) vaccine booster in healthcare workers in Brazil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311693/
48658,Expert considerations and consensus for using dogs to detect human SARS-CoV-2-infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773891/
48659,Immunity in SARS-CoV-2 Infection: Clarity or Mystery? A Broader Perspective in the Third Year of a Worldwide Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943048/
48660,COVID-19 Vaccines: Computational tools and Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830932/
48661,"Impact of national Covid-19 vaccination Campaign, South Korea",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080122/
48662,Visual Detection of COVID-19 from Materials Aspect,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358106/
48663,Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029781/
48664,Systematic Review and Meta-Analysis of COVID-19 Vaccination Acceptance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828741/
48665,Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case–control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728025/
48666,Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841214/
48667,Understanding COVID-19: From Origin to Potential Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460442/
48668,Immunogenicity and adverse events of the COVID-19 vaccines in healthy and individuals with autoimmune diseases in an Iranian population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10946076/
48669,Vesiculobullous and Other Cutaneous Manifestations of COVID-19 Vaccines: a Scoping and Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291118/
48670,A contemporary review on the important role of in silico approaches for managing different aspects of COVID-19 crisis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776350/
48671,Noninvasive nasopharyngeal proteomics of COVID-19 patient identify abnormalities related to complement and coagulation cascade and mucosal immune system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467311/
48672,Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031737/
48673,The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405756/
48674,"Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229440/
48675,Aerosol Inhalation of Chimpanzee Adenovirus Vectors (ChAd68) Expressing Ancestral or Omicron BA.1 Stabilized Pre–Fusion Spike Glycoproteins Protects Non–Human Primates against SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535855/
48676,COVID-19 vaccine candidates and vaccine development platforms available worldwide,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437828/
48677,Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719526/
48678,Intention to participate in COVID-19 vaccine clinical trials in May 2021: a cross-sectional survey in the general French population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481082/
48679,Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105364/
48680,"Anxiety disorders, COVID-19 fear, and vaccine hesitancy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233868/
48681,Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213063/
48682,The Efficacy of COVID-19 Vaccines in Chronic Kidney Disease and Kidney Transplantation Patients: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402591/
48683,Side effects of COVID-19 vaccines and perceptions about COVID-19 and its vaccines in Bangladesh: A Cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394094/
48684,"Comparison of COVID-19 Vaccine Policies in Italy, India, and South Africa",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505201/
48685,"Vaccinating Children against SARS-CoV-2: A Literature Review and Survey of International Experts to Assess Safety, Efficacy and Perceptions of Vaccine Use in Children",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862079/
48686,"SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413106/
48687,Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11054389/
48688,Effectiveness of COVID-19 Vaccines against Delta (B.1.617.2) Variant: A Systematic Review and Meta-Analysis of Clinical Studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778641/
48689,"Systematic Guidelines for Effective Utilization of COVID-19 Databases in Genomic, Epidemiologic, and Clinical Research",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059256/
48690,Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309237/
48691,"COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a preliminary assessment from a case-control study in St. Petersburg, Russia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503256/
48692,Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10914634/
48693,Public Perceptions and Acceptance of COVID-19 Booster Vaccination in China: A Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709447/
48694,Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863106/
48695,Factors and reasons associated with low COVID-19 vaccine uptake among highly hesitant communities in the US,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730806/
48696,Am J Infect Control. 2022 May; 50(5): 591. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943483/
48697,A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11068153/
48698,COVID-19 Vaccination Strategies and Their Adaptation to the Emergence of SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229267/
48699,COVID-19: A Multidisciplinary Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403483/
48700,Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440153/
48701,"Quantifying inequities in COVID-19 vaccine distribution over time by social vulnerability, race and ethnicity, and location: A population-level analysis in St. Louis and Kansas City, Missouri",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417193/
48702,In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354838/
48703,"Changes in Attitudes towards the COVID-19 Vaccine and the Willingness to Get Vaccinated among Adults in Poland: Analysis of Serial, Cross-Sectional, Representative Surveys, January–April 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402425/
48704,Gender Differences in Response to COVID-19 Infection and Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295772/
48705,COVID‐19 vaccine‐readiness for anti‐CD20‐depleting therapy in autoimmune diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405500/
48706,Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852243/
48707,Cell Rep. 2021 Jul 20; 36(3): 109414. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238659/
48708,COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in Scotland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9269984/
48709,"A critical assessment of SARS-CoV-2 in aqueous environment: Existence, detection, survival, wastewater-based surveillance, inactivation methods, and effective management of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035368/
48710,"COVID-19 Vaccination Intent, Barriers and Facilitators in Healthcare Workers: Insights from a Cross-Sectional Study on 2500 Employees at LMU University Hospital in Munich, Germany",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412572/
48711,An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829433/
48712,COVID-19 Vaccination Acceptance and Its Associated Factors among Cancer Patients in Tunisia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068194/
48713,Effectiveness of BNT162b2 and CoronaVac vaccines against omicron in children aged 5 to 11 years,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010648/
48714,Prevalence and Determinants of COVID-19 Vaccine Acceptance Among Healthcare Workers: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366855/
48715,COVID-19 Vaccine Hesitancy Among Older Adolescents and Young Adults: A National Cross-Sectional Study in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133905/
48716,"Institutional trust, scientific literacy, and information sources: What factors determine people's attitudes toward COVID-19 vaccines of different origins in China?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986272/
48717,Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952283/
48718,The presence of senescent peripheral T-cells is negatively correlated to COVID-19 vaccine-induced immunity in cancer patients under 70 years of age,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272422/
48719,Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746394/
48720,Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637626/
48721,Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671995/
48722,Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425442/
48723,In-line treatments and clinical initiatives to fight against COVID-19 outbreak,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567661/
48724,Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606260/
48725,The short-term effectiveness of coronavirus disease 2019 (COVID-19) vaccines among healthcare workers: a systematic literature review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495770/
48726,"Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145892/
48727,An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709787/
48728,Did text-based news-media coverage about the COVID-19 pandemic increase vaccine uptake? A population-based study in Alaska,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208214/
48729,"Immunogenicity, safety and clinical outcomes of the SARS-CoV-2 BNT162b2 vaccine in adolescents with type 1 diabetes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331611/
48730,Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520874/
48731,SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478654/
48732,Predicting COVID-19 pandemic waves including vaccination data with deep learning,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10757845/
48733,A Precision Adjuvant Approach to Enhance Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines Optimized for Immunologically Distinct Vulnerable Populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129145/
48734,The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11054439/
48735,SARS-COV-2 Variants: Differences and Potential of Immune Evasion,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805732/
48736,COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272971/
48737,SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503203/
48738,SARS-CoV-2 Vaccination and Clinical Presentation of COVID-19 in Patients Hospitalized during the Delta- and Omicron-Predominant Periods,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918275/
48739,COVID-19 Anti-Vaccine Sentiments: Analyses of Comments from Social Media,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622531/
48740,Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253517/
48741,Infection and transmission of SARS‐CoV‐2 depend on heparan sulfate proteoglycans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521309/
48742,The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590742/
48743,"The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214726/
48744,"Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135679/
48745,Comparative effectiveness of third doses of mRNA-based Covid-19 vaccines in U.S. Veterans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949349/
48746,"Zoonotic coronavirus epidemics: Severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834857/
48747,COVID-19 and the Differences in Physiological Background Between Children and Adults and Their Clinical Consequences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884370/
48748,"SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915969/
48749,Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000914/
48750,Lancet Respir Med. 2022 Jul; 10(7): e72. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090264/
48751,"Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865440/
48752,COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857047/
48753,"COVID-19 optimal vaccination policies: A modeling study on efficacy, natural and vaccine-induced immunity responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095066/
48754,Factors associated with COVID-19 vaccine intent among Latino SNAP participants in Southern California,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981200/
48755,Effectiveness of inactivated COVID-19 vaccines among older adults in Shanghai: retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086022/
48756,Robust humoral and cellular immune responses in long-term convalescent COVID-19 individuals following one-dose SARS-CoV-2 inactivated vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377315/
48757,Postvaccination SARS-CoV-2 Infections among Healthcare Professionals: A Real World Evidence Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024651/
48758,Booster or additional vaccination doses in patients vaccinated against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972704/
48759,"SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum, but evades most convalescent serum and therapeutic antibodies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995032/
48760,Elucidating causes of COVID-19 infection and related deaths after vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280649/
48761,Monitoring of SARS-CoV-2 Specific Antibodies after Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880181/
48762,The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384785/
48763,COVID outbreak after the 1st dose of COVID vaccine among the nursing home residents: What happened?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226105/
48764,"Changes Over Time in COVID-19 Incidence, Vaccinations, Serum Spike IgG, and Viral Neutralizing Potential Among Individuals From a North American Gaming Venue: December 2020–August 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426317/
48765,Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203880/
48766,Cardiovascular Manifestations of COVID-19 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699571/
48767,What is the role of primary care in the COVID-19 vaccine roll-out and the barriers and facilitators to an equitable vaccine roll-out? A rapid scoping review of nine jurisdictions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123853/
48768,"Animal Cell Lines
as Expression Platforms in Viral
Vaccine Production: A Post Covid-19 Perspective",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11025085/
48769,Long Noncoding RNAs as Emerging Regulators of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366413/
48770,Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716022/
48771,"COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979891/
48772,Video-based messages to reduce COVID-19 vaccine hesitancy and nudge vaccination intentions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985948/
48773,Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793865/
48774,Examining Vaccine Hesitancy in Sub-Saharan Africa: A Survey of the Knowledge and Attitudes among Adults to Receive COVID-19 Vaccines in Ghana,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402404/
48775,Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123609/
48776,Acute Cardiac Events During COVID-19-Associated Hospitalizations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901494/
48777,Effectiveness of Bivalent Omicron-Containing Booster Vaccines against SARS-CoV-2 Omicron Variant among Individuals with and without Prior SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459014/
48778,"The social experience of participation in a COVID-19 vaccine trial: Subjects’ motivations, others’ concerns, and insights for vaccine promotion",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945789/
48779,SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022340/
48780,Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399815/
48781,COVID-19 Vaccine Demand and Financial Incentives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489978/
48782,"Knowledge, Attitudes and Perception toward COVID-19 Vaccines among Adults in Jazan Province, Saudi Arabia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618661/
48783,Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574860/
48784,COVID-19 vaccine acceptance and coverage among pregnant persons in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450469/
48785,Pituitary and SARS CoV-2: An unremitting conundrum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969757/
48786,Immunogenicity of BNT162b2 Vaccination against SARS-CoV-2 Omicron Variant and Attitudes toward a COVID-19 Booster Dose among Healthy Thai Adolescents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324447/
48787,Assessment of the COVID-19 vaccine market landscape in 2021 relative to challenges in low- and middle-income countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746604/
48788,"Immunology: The science of pandemics, infectious disease and COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364330/
48789,The Side Effects and Adverse Clinical Cases Reported after COVID-19 Immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031559/
48790,Dynamics of SARS-CoV-2 Major Genetic Lineages in Moscow in the Context of Vaccine Prophylaxis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736394/
48791,COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676802/
48792,Tracking the uptake and trajectory of COVID-19 vaccination coverage in 15 West African countries: an interim analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718349/
48793,Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373608/
48794,Three doses of COVID-19 mRNA vaccine induce class-switched antibody responses in inflammatory arthritis patients on immunomodulatory therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646683/
48795,COVID-19 Virus and Vaccination Attitudes among Healthcare Workers in Michigan: A Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304020/
48796,Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381434/
48797,"Long COVID Prevalence and the Impact of the Third SARS-CoV-2 Vaccine Dose: A Cross-Sectional Analysis from the Third Follow-Up of the Borriana Cohort, Valencia, Spain (2020–2022)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611325/
48798,"National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788316/
48799,Current challenges and perspectives in lung cancer care during COVID-19 waves,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241323/
48800,Recent Developments and Future Perspectives of Vaccines and Therapeutic Agents against SARS-CoV2 Using the BCOV_S1_CTD of the S Protein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303048/
48801,An insight into the epitope-based peptide vaccine design strategy and studies against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314509/
48802,Epidemiological contemplation for a currently pragmatic COVID-19 health passport: a perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10896918/
48803,Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648672/
48804,Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934698/
48805,Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673895/
48806,Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882037/
48807,"Uncertainty and unwillingness to receive a COVID-19 vaccine in adults residing in Puerto Rico: Assessment of perceptions, attitudes, and behaviors",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437450/
48808,Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046708/
48809,COVID-19 Vaccination Intentions amongst Healthcare Workers: A Scoping Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407815/
48810,SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960624/
48811,Vascular dysfunction in COVID-19 patients: update on SARS-CoV-2 infection of endothelial cells and the role of long non-coding RNAs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652506/
48812,TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061140/
48813,COVID-19 vaccine hesitancy – reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437517/
48814,Safety and immunogenicity of inactivated COVID-19 vaccine in patients with metabolic syndrome: A cross-sectional observational study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817001/
48815,Cross-Sectional Survey on BNT162b2 mRNA COVID-19 Vaccine Serious Adverse Events in Children 5 to 11 Years of Age: A Monocentric Experience,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416594/
48816,How to model the impact of vaccines for policymaking when the characteristics are uncertain: A case study in Thailand prior to the vaccine rollout during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281228/
48817,"Morphological, cellular, and molecular basis of brain infection in COVID-19 patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436354/
48818,Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037584/
48819,Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485663/
48820,"Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836435/
48821,"Overview of anti-viral effects of probiotics via immune cells in pre-, mid- and post-SARS-CoV2 era",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10728489/
48822,The determinants of COVID-19 vaccination intention: a meta-review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291626/
48823,A First Report on Side-Effects of COVID-19 Vaccines among General Population in Sudan: A Cross-Sectional Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959007/
48824,"The existence, spread, and strategies for environmental monitoring and control of SARS-CoV-2 in environmental media",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262394/
48825,"Exposure to Misinformation, Risk Perception, and Confidence towards the Government as Factors Influencing Negative Attitudes towards COVID-19 Vaccination in Malaysia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690819/
48826,The Trilogy of SARS-CoV-2 in Pediatrics (Part 1): Acute COVID-19 in Special Populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021247/
48827,Effectiveness of Mix-and-Match Vaccination in Preventing SARS-CoV-2 Omicron Variant Infection in Taiwan: A Test-Negative Control Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535833/
48828,Leveraging T-cell receptor – epitope recognition models to disentangle unique and cross-reactive T-cell response to SARS-CoV-2 during COVID-19 progression/resolution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264683/
48829,COVID-19 and HSCT (Hematopoietic stem cell transplant),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547387/
48830,Trends in willingness to receive COVID-19 vaccines among healthcare workers in India: Findings from repeated cross-sectional national surveys,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574381/
48831,SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220855/
48832,The first year of COVID-19 vaccine roll-out in Africa: challenges and lessons learned,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474932/
48833,COVID-19 challenges and its therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339548/
48834,Adverse events following immunization of COVID-19 vaccine among children aged 6–11 years,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640945/
48835,Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259773/
48836,"The effectiveness of primary series CoronaVac vaccine in preventing COVID‐19 illness: A prospective cohort study among healthcare workers in Azerbaijan, May–November 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548024/
48837,Effect of Platform Type on Clinical Efficacy of SARS-CoV-2 Vaccines in Prime Vaccination Settings: A Systematic Review and Meta-Regression of Randomized Controlled Trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10892687/
48838,Targeting Inflammasome Activation in COVID-19: Delivery of RNA Interference-Based Therapeutic Molecules,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698532/
48839,"Comparing SARS-CoV-2 variants among children and adolescents in Germany: relative risk of COVID-19-related hospitalization, ICU admission and mortality",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925936/
48840,"SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620514/
48841,Attitudes towards COVID Vaccine and Vaccine Hesitancy in Dermatology: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459048/
48842,Accelerating research and development of new vaccines against tuberculosis: a global roadmap,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884775/
48843,How can nanotechnology help to combat COVID-19? Opportunities and urgent need,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474329/
48844,Deciphering SARS-CoV-2 Virologic and Immunologic Features,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460647/
48845,COVID-19 and obesity: fighting two pandemics with intermittent fasting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226104/
48846,Persistence and Protective Potential of SARS-CoV-2 Antibody Levels After COVID-19 Vaccination in a West Virginia Nursing Home Cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471977/
48847,BNT162b2 vaccine protection against omicron and effect of previous infection variant and vaccination sequence among children and adolescents in Singapore: a population-based cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185330/
48848,SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529056/
48849,Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated kidney transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042733/
48850,"A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486193/
48851,"COVID-19 Pandemic: Advances in Diagnosis, Treatment, Organoid Applications and Impacts on Cancer Patient Management",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039300/
48852,Hybrid Immunity Improves the Immune Response after the Fourth COVID-19 Vaccine Dose in Individuals with Medical Conditions Predisposing to Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10975123/
48853,Liver and Biliary Tract Disease in Patients with Coronavirus disease-2019 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531659/
48854,Factors associated with COVID-19 vaccination acceptance among industrial workers in the post-vaccination era: a large-scale cross-sectional survey in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903899/
48855,"Phytochemicals of Withania somnifera as a Future Promising Drug against SARS-CoV-2: Pharmacological Role, Molecular Mechanism, Molecular Docking Evaluation, and Efficient Delivery",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142625/
48856,The COVID-19 Vaccination and Vaccine Inequity Worldwide: An Empirical Study Based on Global Data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102773/
48857,Progress on COVID-19 Chemotherapeutics Discovery and Novel Technology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736643/
48858,Understanding Viral Infection Mechanisms and Patient Symptoms for the Development of COVID-19 Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915126/
48859,Incidence of SARS-CoV-2 Infection and Factors Associated With Complete COVID-19 Vaccine Uptake Among Migrant Origin Persons in Finland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189547/
48860,‘Why Should I Take the COVID-19 Vaccine after Recovering from the Disease?’ A Mixed-methods Study of Correlates of COVID-19 Vaccine Acceptability among Health Workers in Northern Nigeria,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132432/
48861,The roles of cellular protease interactions in viral infections and programmed cell death: a lesson learned from the SARS-CoV-2 outbreak and COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395814/
48862,Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619667/
48863,Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877145/
48864,Health Care Workers’ Sick Leave due to COVID-19 Vaccination in Context With SARS-CoV-2 Infection and Quarantine—A Multicenter Cross-Sectional Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047200/
48865,Association of Physical Activity With SARS-CoV-2 Infection and Severe Clinical Outcomes Among Patients in South Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130952/
48866,"The Mediating Roles of Medical Mistrust, Knowledge, Confidence and Complacency of Vaccines in the Pathways from Conspiracy Beliefs to Vaccine Hesitancy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624917/
48867,"SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308774/
48868,The role of host genetics in the immune response to SARS‐CoV‐2 and COVID‐19 susceptibility and severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404857/
48869,Vaccine Adverse Events Following COVID-19 Vaccination with Inactivated Vaccines in Zimbabwe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610510/
48870,Childhood COVID-19 vaccine acceptance and preference from caregivers and healthcare workers in China: A survey experiment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259187/
48871,Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522798/
48872,Ethnic/racial minorities’ and migrants’ access to COVID-19 vaccines: A systematic review of barriers and facilitators,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855618/
48873,Pharmacy-based immunization in rural USA during the COVID-19 pandemic: A survey of community pharmacists from five southeastern states,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988709/
48874,"Epidemiological Comparison of Four COVID-19 Waves in the Democratic Republic of the Congo, March 2020–January 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346056/
48875,Insights into SARS-CoV-2 Persistence and Its Relevance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228265/
48876,Association between health and safety perceptions of COVID‐19 vaccine and its uptake in Ghana,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874404/
48877,The Vaccination Concerns in COVID-19 Scale (VaCCS): Development and validation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920277/
48878,Innate immunity: the first line of defense against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935980/
48879,Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860243/
48880,"Ambient Temperature Stable, Scalable COVID‐19 Polymer Particle Vaccines Induce Protective Immunity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652985/
48881,Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092985/
48882,Prime-pull immunization of mice with a BcfA-adjuvanted vaccine elicits sustained mucosal immunity that prevents SARS CoV-2 infection and pathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121870/
48883,"Kidney Injury in COVID-19: Epidemiology, Molecular Mechanisms and Potential Therapeutic Targets",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877127/
48884,Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553924/
48885,Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009122/
48886,"Decoding SARS-CoV-2 Transmission and Evolution
and Ramifications for COVID-19 Diagnosis, Vaccine, and Medicine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318555/
48887,The COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153056/
48888,Measuring the effects of misinformation exposure and beliefs on behavioural intentions: a COVID-19 vaccination study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526535/
48889,Pharmaceutical Prospects of Curcuminoids for the Remedy of COVID-19: Truth or Myth,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047796/
48890,"A model of factors influencing COVID-19 vaccine acceptance: A synthesis of the theory of reasoned action, conspiracy theory belief, awareness, perceived usefulness, and perceived ease of use",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754289/
48891,Perception and willingness toward various immunization routes for COVID-19 vaccines: a cross-sectional survey in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560725/
48892,Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808747/
48893,The conundrum of COVID-19 mRNA vaccine–induced anaphylaxis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746073/
48894,Quantitative Benefit–Risk Assessment of COVID-19 Vaccines Using the Multi-Criteria Decision Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785565/
48895,Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033225/
48896,Inhibition of receptor‐binding domain—ACE2 interaction after two doses of Sinovac's CoronaVac or AstraZeneca/Oxford's AZD1222 SARS‐CoV‐2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662120/
48897,Health influence of SARS-CoV-2 (COVID-19) on cancer: a review: Health influence of SARS-CoV-2 (COVID-19) on cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828497/
48898,Potential intestinal infection and faecal–oral transmission of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883337/
48899,Pulmonary surfactant as a versatile biomaterial to fight COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605818/
48900,Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912142/
48901,Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058163/
48902,Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540788/
48903,How urban versus rural residency relates to COVID-19 vaccine hesitancy: A large-scale national Chinese study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846885/
48904,Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230332/
48905,COVID-19-Related Brain Injury: The Potential Role of Ferroptosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994634/
48906,Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734593/
48907,"Socio-Demographic Characteristics of COVID-19 Vaccine Recipients in Kwara State, North Central Nigeria",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766999/
48908,"Therapeutics for COVID-19: from computation to practices—where we are, where we are heading to",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467145/
48909,"Immunoinformatics prediction of overlapping CD8+ T-cell, IFN-γ and IL-4 inducer CD4+ T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831457/
48910,Social-political and vaccine related determinants of COVID-19 vaccine hesitancy in Tanzania: A qualitative inquiry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266599/
48911,COVID-19 and diabetes—Two giants colliding: From pathophysiology to management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437522/
48912,Personality Effects on Chinese Public Preference for the COVID-19 Vaccination: Discrete Choice Experiment and Latent Profile Analysis Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031452/
48913,Heterologous prime–boost strategies for COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754745/
48914,SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008380/
48915,COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547943/
48916,Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505554/
48917,Biosecurity risks associated with vaccine platform technologies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904460/
48918,Comparative Effectiveness of mRNA-based BNT162b2 Vaccine versus Adenovirus Vector–Based Ad26.COV2.S Vaccine for the Prevention of COVID-19 among Dialysis Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970445/
48919,CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752005/
48920,A Modular Biomaterial Scaffold‐Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS‐CoV‐2 Antigens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652677/
48921,Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231409/
48922,"Hesitancy of COVID-19 vaccines: Rapid systematic review of the measurement, predictors, and preventive strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359354/
48923,Promise and challenges in the development of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733917/
48924,Antibody-mediated neutralization of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118976/
48925,Factors associated with COVID-19 vaccine intentions during the COVID-19 pandemic; a systematic review and meta-analysis of cross-sectional studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437387/
48926,Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348632/
48927,Humoral vaccine response and breakthrough infections in kidney transplant recipients during the COVID-19 pandemic: a nationwide cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242148/
48928,Can the triumph of mRNA vaccines against COVID-19 be extended to other viral infections of humans and domesticated animals?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682868/
48929,When the clock ticks wrong with COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670202/
48930,Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162477/
48931,Drug Discovery Strategies for SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569306/
48932,"Natural killer cells in COVID-19: from infection, to vaccination and therapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013930/
48933,A prospective study of the association between SARS-CoV-2 infection and COVID-19 vaccination with changes in usual menstrual cycle characteristics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277995/
48934,Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671616/
48935,SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910743/
48936,"Knowledge and willingness to receive a COVID-19 vaccine: a survey from Anhui Province, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993089/
48937,SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999682/
48938,Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797419/
48939,COVID-19 vaccine uptake and intention during pregnancy in Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045023/
48940,"The coronavirus disease 2019 vaccine in pregnancy: risks, benefits, and recommendations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847190/
48941,Decline of Humoral and Cellular Immune Responses Against SARS-CoV-2 6 Months After Full BNT162b2 Vaccination in Hospital Healthcare Workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926062/
48942,The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612330/
48943,"Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201789/
48944,"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674972/
48945,Lancet. 2021 10-16 April; 397(10282): 1350. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054248/
48946,Lancet. 2020 Dec 19; 396(10267): 1978. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779364/
48947,The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709793/
48948,Impact of corona-phobia on attitudes and acceptance towards COVID-19 vaccine among cancer patients: a single-center study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650765/
48949,Understanding COVID-19 vaccine hesitancy in the Hispanic adult population of South Carolina: a complex mixed-method design evaluation study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685550/
48950,Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post–COVID-19 Convalescent Samples,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557674/
48951,Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746490/
48952,The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248963/
48953,The SARS-CoV-2 as an instrumental trigger of autoimmunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892316/
48954,Lymphadenopathy post‐COVID‐19 vaccination with increased FDG uptake may be falsely attributed to oncological disorders: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015520/
48955,The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832518/
48956,The impact of COVID-19 on liver transplantation programs in Austria,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651874/
48957,Autoimmune liver diseases and SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080695/
48958,Risks of catching COVID‐19 according to vaccination status of healthcare workers during the SARS‐CoV‐2 Delta variant dominant period and their clinical characteristics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088455/
48959,J Med Virol. 2023 May; 95(5): e28770. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316971/
48960,Molecular mechanisms implicated in SARS-CoV-2 liver tropism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827585/
48961,"Salivary, serological, and cellular immune response to the CoronaVac vaccine in health care workers with or without previous COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202665/
48962,"Behavioral and Cultural Insights, a Nationwide Study Based on Repetitive Surveys of WHO Behavioral Insights Tool in Greece Regarding COVID-19 Pandemic and Vaccine Acceptance",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819918/
48963,Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619776/
48964,BNT162b2 mRNA COVID-19 (Comirnaty) Vaccine Effectiveness in Elderly Patients Who Live in Long-Term Care Facilities: A Nationwide Cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059015/
48965,Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID‐19 vaccines in Hong Kong,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934254/
48966,SARS-CoV-2 testing disparities across geographical regions from a large metropolitan area in Brazil: Results from a web-based survey among individuals interested in clinical trials for COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326017/
48967,Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572694/
48968,The pigtail macaque (Macaca nemestrina) model of COVID-19 reproduces diverse clinical outcomes and reveals new and complex signatures of disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722729/
48969,Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802346/
48970,mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927305/
48971,Elucidating T Cell and B Cell Responses to SARS-CoV-2 in Humans: Gaining Insights into Protective Immunity and Immunopathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750814/
48972,"Covid-19 Vaccine Acceptance and Determinant Factors among General
Public in East Africa: A Systematic Review and Meta-Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201368/
48973,Delayed production of neutralizing antibodies correlates with fatal COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785364/
48974,Nat Med. 2021; 27(7): 1309. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212078/
48975,Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521484/
48976,Perceptions and predictors of intention to receive the COVID-19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087864/
48977,New-onset IgA nephropathy following COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450102/
48978,QJM. 2023 Jan; 116(1): 93. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620288/
48979,Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208357/
48980,"Interplay between Neutrophils, NETs and T-Cells in SARS-CoV-2 Infection—A Missing Piece of the Puzzle in the COVID-19 Pathogenesis?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304299/
48981,Detection of IFNγ-Secreting CD4+ and CD8+ Memory T Cells in COVID-19 Convalescents after Stimulation of Peripheral Blood Mononuclear Cells with Live SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402842/
48982,Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288220/
48983,Sources of COVID-19 Vaccine Promotion for Pregnant and Lactating Women in Bangladesh,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459640/
48984,An update on studies characterizing adaptive immune responses in SARS-CoV-2 infection and COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406159/
48985,"The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618229/
48986,"Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259069/
48987,The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836196/
48988,Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and without Prior COVID-19 - A Prospective Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361858/
48989,A Scoping Review of the Health Impact of the COVID-19 Pandemic on Persons Experiencing Homelessness in North America and Europe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954292/
48990,Effectiveness of COVID-19 Vaccines against Delta Variant (B.1.617.2): A Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875411/
48991,COVID-19 and hypopituitarism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363093/
48992,"Effectiveness of inactivated COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant–infected patients in Jiangsu, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769614/
48993,A Pre-Vaccination Baseline of SARS-CoV-2 Genetic Surveillance and Diversity in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778900/
48994,SARS-CoV-2-specific T cell memory with common TCRαβ motifs is established in unvaccinated children who seroconvert after infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174177/
48995,AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750884/
48996,SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840920/
48997,Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857622/
48998,"B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10805925/
48999,The effect of pandemic prevalence on the reported efficacy of SARS-CoV-2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982900/
49000,Safety and Immunogenicity of the Convacell® Recombinant N Protein COVID-19 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10821050/
49001,An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321692/
49002,Targeting COVID-19 vaccine hesitancy among nurses in Shanghai: A latent profile analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515966/
49003,SARS-CoV-2 infection and multi-organ system damage: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901898/
49004,"Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153712/
49005,Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549749/
49006,Assessment of Immediate Allergic Reactions After Immunization With the Pfizer BNT162b2 Vaccine Using Intradermal Skin Testing With the COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375246/
49007,Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127699/
49008,An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277844/
49009,Distinct In Vitro and In Vivo Neutralization Profiles of Monoclonal Antibodies Elicited by the Receptor Binding Domain of the Ancestral SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189799/
49010,"Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403331/
49011,A Case–Control Study of the 2019 Influenza Vaccine and Incidence of COVID-19 Among Healthcare Workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690338/
49012,Long follow-up of BNT162b2 mRNA vaccine in healthcare workers (2020–2022): A retrospective longitudinal SARS-CoV-2 serological surveillance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512804/
49013,"Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152308/
49014,Effectiveness of Maternal Inactivated COVID-19 Vaccination against Omicron Infection in Infants during the First 12 Months of Life: A Test-Negative Case-Control Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534404/
49015,"SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459327/
49016,COVID-19 surveillance in wastewater: An epidemiological tool for the monitoring of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854263/
49017,"The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18–59 years: A phase I randomized, double-blinded, controlled trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040531/
49018,Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501619/
49019,Use of Self-Collected Dried Blood Spots and a Multiplex Microsphere Immunoassay to Measure IgG Antibody Response to COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927373/
49020,"A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134758/
49021,COVID-19 in cancer patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992310/
49022,COVID-19 vaccination hesitancy among Iraqi general population between beliefs and barriers: An observational study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046899/
49023,Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280938/
49024,Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411261/
49025,"Unraveling the dynamics of the Omicron and Delta variants of the 2019 coronavirus in the presence of vaccination, mask usage, and antiviral treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581714/
49026,Using in vivo animal models for studying SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567288/
49027,"Inequities in the deployment of COVID-19 vaccine in the WHO Eastern Mediterranean Region, 2020–2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315235/
49028,"A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792419/
49029,The Coverage and Acceptance Spectrum of COVID-19 Vaccines among Healthcare Professionals in Western Tanzania: What Can We Learn from This Pandemic?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503367/
49030,SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452867/
49031,"A Recombinant Subunit Vaccine induces a Potent and Broadly Neutralizing, Durable Antibody Response in Macaques against SARS-CoV-2 P.1 (Gamma) Variant",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938837/
49032,Self-assembled mRNA vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837307/
49033,"Pathogenesis and Mechanisms of SARS-CoV-2 Infection in the Intestine, Liver, and Pancreas",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856332/
49034,Who is hesitant about Covid-19 vaccines? The profiling of participants in a French online cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958178/
49035,Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522707/
49036,Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640209/
49037,Reasons for being unsure or unwilling regarding intention to take COVID-19 vaccine among Japanese people: A large cross-sectional national survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324415/
49038,New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559550/
49039,"COVID-19 Vaccine Acceptance among Social Media Users: A Content Analysis, Multi-Continent Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101365/
49040,COVID-19 Vaccine Acceptance and Hesitancy in Health Care Workers in Somalia: Findings from a Fragile Country with No Previous Experience of Mass Adult Immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144151/
49041,COVID-19 vaccine misinformation in English-language news media: retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160593/
49042,Evolution of neurologic symptoms in non‐hospitalized COVID‐19 “long haulers”,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268866/
49043,Humoral and Cellular Responses to COVID-19 Vaccines in SARS-CoV-2 Infection-Naïve and -Recovered Korean Individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878120/
49044,β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105625/
49045,Real-World Effectiveness of COVID-19 Vaccine and Identification of SARS-CoV-2 Variants among People Living with HIV on Highly Active Antiretroviral Therapy in Central Kerala of India—An Ambi-Directional Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674822/
49046,"Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432840/
49047,Vaccine-induced immune thrombotic thrombocytopenia: what do we know hitherto?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227460/
49048,"Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746460/
49049,Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026643/
49050,Multiple early factors anticipate post-acute COVID-19 sequelae,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786632/
49051,A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906417/
49052,Evaluating COVID-19 vaccine hesitancy: A qualitative study from Vietnam,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656146/
49053,Factors associated to COVID-19 vaccine acceptance in Mexican patients with rheumatic diseases: A cross-sectional and multicenter study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196644/
49054,Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481074/
49055,Impact of COVID-19 Outbreak on Influenza and Pneumococcal Vaccination Uptake: A Multi-Center Retrospective Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223787/
49056,Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737069/
49057,Attitude towards COVID-19 vaccination among healthcare workers: a cross sectional study from Egypt,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667438/
49058,"Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136728/
49059,Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784160/
49060,A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829548/
49061,"Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: A cross-sectional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343757/
49062,Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787219/
49063,Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757903/
49064,A 2-month field cohort study of SARS-CoV-2 in saliva of BNT162b2 vaccinated nursing home workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053279/
49065,Factors associated with COVID-19 vaccination intentions among adults in the deep South,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744449/
49066,Comprehensive role of SARS‐CoV‐2 spike glycoprotein in regulating host signaling pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348444/
49067,Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893798/
49068,Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system–based cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333439/
49069,Attitudes and Intentions toward COVID-19 Vaccination among Health Professions Students and Faculty in Qatar ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619275/
49070,COVID-19 Vaccines: A Race Against Time in the Middle of Death and Devastation!,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286271/
49071,Increasing Antibody Responses to Five Doses of SARS-CoV-2 mRNA Vaccine in Lung Transplant Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299568/
49072,"Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61.3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339061/
49073,Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541143/
49074,"A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946892/
49075,Determining the Prevalence and Correlates of COVID-19 Booster Vaccine Hesitancy in the Singapore Population Following the Completion of the Primary Vaccination Series,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316882/
49076,SARS‐CoV‐2 infection of human‐induced pluripotent stem cells‐derived lung lineage cells evokes inflammatory and chemosensory responses by targeting mitochondrial pathways,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088312/
49077,"COVID-19 Vaccine Hesitancy among Healthcare Workers and Trainees in Freetown, Sierra Leone: A Cross-Sectional Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143387/
49078,Cell-Specific Mechanisms in the Heart of COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171292/
49079,Circ Res. 2023 Jun 23; 133(1): e18. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470426/
49080,SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570933/
49081,COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in Algeria: National Cross-Sectional Survey-Based Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031698/
49082,"Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11025474/
49083,Mitochondrial regulation of acute extrafollicular B‐cell responses to COVID‐19 severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473490/
49084,"Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681105/
49085,"Urban monitoring, evaluation and application of COVID-19 listed vaccine effectiveness: a health code blockchain study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274021/
49086,Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899862/
49087,Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532351/
49088,COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336973/
49089,"Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230758/
49090,A national survey of COVID-19 vaccine acceptance in Nigeria,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221949/
49091,Efficacy of approved vaccines to prevent COVID-19: a systematic review and network meta-analysis of reconstructed individual patient data from randomized trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942153/
49092,COVID‐19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non‐malignant haematological conditions: Australian and New Zealand Children’s Haematology/Oncology Group consensus statement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115069/
49093,Perspectives and Challenges in the Fight Against COVID-19: The Role of Genetic Variability,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005637/
49094,"SARS-CoV-2 and Emerging Variants: Unmasking Structure, Function, Infection, and Immune Escape Mechanisms",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134119/
49095,Complex Pathophysiological Mechanisms and the Propose of the Three-Dimensional Schedule For Future COVID-19 Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564179/
49096,Immune-checkpoint inhibitors from cancer to COVID-19: A promising avenue for the treatment of patients with COVID-19 (Review),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864014/
49097,COVID‐19 vaccines: What dermatologists should know?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420198/
49098,Population Immunity and Covid-19 Severity with Omicron Variant in South Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908853/
49099,"Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035359/
49100,The Occurrence of Acute Disseminated Encephalomyelitis in SARS-CoV-2 Infection/Vaccination: Our Experience and a Systematic Review of the Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385010/
49101,Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030519/
49102,The association between social media use and hesitancy toward COVID-19 vaccine booster shots in China: A web-based cross-sectional survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302496/
49103,"Long COVID: major findings, mechanisms and recommendations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839201/
49104,Nat Rev Microbiol. 2023; 21(6): 408. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408714/
49105,Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850935/
49106,Immunogenicity Evaluating of the Multivalent COVID-19 Inactivated Vaccine against the SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228943/
49107,COVID-19 vaccination in children: a public health priority,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767816/
49108,Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407425/
49109,Cochrane Database Syst Rev. 2022; 2022(5): CD013665. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/
49110,The effect of the third dose of the BNT162b2 vaccine on anti-SARS-CoV-2 spike antibody levels in healthcare workers with and without COVID-19 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970245/
49111,Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877634/
49112,Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048615/
49113,Sci Rep. 2023; 13: 13276. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427666/
49114,COVID-19: Current Developments and Further Opportunities in Drug Delivery and Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601382/
49115,Different T-cell and B-cell repertoire elicited by the SARS-CoV-2 inactivated vaccine and S1 subunit vaccine in rhesus macaques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746386/
49116,IL-6 modulation for COVID-19: the right patients at the right time?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042594/
49117,Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734735/
49118,Factors Associated with Change in SARS-CoV-2 Antibody Titers from Three to Six Months after the Administration of the BNT162b2 mRNA COVID-19 Vaccine among Healthcare Workers in Japan: A Prospective Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107982/
49119,Modeling and predicting the overlap of B- and T-cell receptor repertoires in healthy and SARS-CoV-2 infected individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075420/
49120,Take Your Best Shot: Which SARS-CoV-2 Vaccine Should I Get?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492082/
49121,Durability of Heterologous and Homologous COVID-19 Vaccine Boosts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366542/
49122,Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160963/
49123,Side Effects of COVID-19 Inactivated Virus vs. Adenoviral Vector Vaccines: Experience of Algerian Healthcare Workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149155/
49124,COVID-19 therapeutics: Challenges and directions for the future,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169797/
49125,Willingness to get vaccinated with the first‐generation vaccines against SARS‐CoV‐2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538202/
49126,Side Effects of Mixing Vaccines against COVID-19 Infection among Saudi Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028800/
49127,Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942141/
49128,Are Fear of COVID-19 and Vaccine Hesitancy Associated with COVID-19 Vaccine Uptake? A Population-Based Online Survey in Nigeria,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415607/
49129,Evaluation of protection by COVID-19 vaccines after deployment in low and lower-middle income countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703050/
49130,COVID-19 on Oral Health: A New Bilateral Connection for the Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10813615/
49131,"COVID‐19 vaccines mix‐and‐match: The concept, the efficacy and the doubts",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661746/
49132,Inhaled corticosteroids for the treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724831/
49133,Regulating the microenvironment with nanomaterials: Potential strategies to ameliorate COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941074/
49134,The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099181/
49135,Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641254/
49136,COVID-19 vaccine uptake and vaccine hesitancy in rural-to-urban migrant workers at the first round of COVID-19 vaccination in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851897/
49137,Immune system changes in those with hypertension when infected with SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183242/
49138,"Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12–17 year-old adolescents",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294745/
49139,"Does BCG provide long-term protection against SARS-CoV-2 infection? A case–control study in Quebec, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354805/
49140,Immunotherapies and immunomodulatory approaches in clinical trials - a mini review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885722/
49141,"CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464593/
49142,Fear of COVID-19 predicts vaccination willingness 14 months later,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047433/
49143,Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10817949/
49144,"Effectiveness of Inactivated and mRNA COVID-19 Vaccines Against SARS-CoV-2 Infection, Severe Disease and Mortality in the Geriatric Population",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169106/
49145,Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10996830/
49146,Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443512/
49147,Clin Sci (Lond). 2020 Sep; 134(17): 2315–2317. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484393/
49148,Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170451/
49149,"SARS-COV-2, infection, transmission, transcription, translation, proteins, and treatment: A review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552795/
49150,Immunogenic amino acid motifs and linear epitopes of COVID-19 mRNA vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428655/
49151,Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465121/
49152,Pan-American Guidelines for the treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408214/
49153,CD8+ T-cell immune escape by SARS-CoV-2 variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647062/
49154,Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863934/
49155,Impact of Local and Demographic Factors on Early COVID-19 Vaccine Hesitancy among Health Care Workers in New York City Public Hospitals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879070/
49156,"An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260597/
49157,Health Belief Model Perspective on the Control of COVID-19 Vaccine Hesitancy and the Promotion of Vaccination in China: Web-Based Cross-sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425399/
49158,Review the safety of Covid-19 mRNA vaccines: a review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087878/
49159,Patient Saf Surg. 2021; 15: 22. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130782/
49160,SARS-CoV-2 Antiviral Therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404831/
49161,SARS-Cov-2 Infection and Seroconversion Rates in Healthcare Providers Prior to COVID-19 Vaccine Rollout,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988593/
49162,Public acceptability of COVID-19 vaccines and its predictors in Middle ‎Eastern/North African (MENA) countries: a systematic review‎,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196809/
49163,A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamsters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187308/
49164,"The effect of a short, animated story-based video on COVID-19 vaccine hesitancy: A study protocol for an online randomized controlled trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448293/
49165,What Could Explain the Lower COVID-19 Burden in Africa despite Considerable Circulation of the SARS-CoV-2 Virus?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391172/
49166,SARS‐CoV‐2 Delta‐variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID‐19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088586/
49167,Review of Ribosome Interactions with SARS-CoV-2 and COVID-19 mRNA Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780073/
49168,Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444500/
49169,"COVID-19 vaccination intention and behavior in a large, diverse, U.S. refugee population",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806127/
49170,A biomaterials viewpoint for the 2020 SARS-CoV-2 vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255824/
49171,Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960989/
49172,Efficacy and Safety of COVID-19 Vaccines in Phase III Trials: A Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228087/
49173,Relationship between double COVID-19 vaccine uptake and trust in effectiveness and safety of vaccination in general in 23 Member states of the European Union: an ecological study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222347/
49174,"Opinions, Attitudes and Factors Related to SARS-CoV-2 Vaccine Uptake in Eight South American Countries",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675814/
49175,Explaining the challenges of resources management and its underlying factors in COVID-19 era in Iran: a qualitative study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612242/
49176,Neurological Complications of COVID-19: Underlying Mechanisms and Management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071289/
49177,Neurological involvement in the respiratory manifestations of COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906194/
49178,"Routine SARS‐CoV‐2 vaccination for all children
",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339529/
49179,Describing the Myths and Misconceptions Regarding COVID-19 Vaccines Among the Population of the Kingdom of Saudi Arabia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282580/
49180,Current Advances in Paper-Based Biosensor Technologies for Rapid COVID-19 Diagnosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363872/
49181,Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938315/
49182,Celiac Disease and Targeting the Molecular Mechanisms of Autoimmunity in COVID Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322892/
49183,Effectiveness of COVID-19 vaccine in preventing infection and disease severity: a case-control study from an Eastern State of India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545845/
49184,Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501874/
49185,The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272618/
49186,COVID-19 Vaccination Acceptance Among Chinese Population and Its Implications for the Pandemic: A National Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860971/
49187,Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405719/
49188,"COVID-19 and earlier pandemics, sepsis, and vaccines: A historical perspective",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130518/
49189,"Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678819/
49190,"Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288262/
49191,Virus-like Particles of Nodavirus Displaying the Receptor Binding Domain of SARS-CoV-2 Spike Protein: A Potential VLP-Based COVID-19 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001971/
49192,"COVID‐19 vaccinations and rates of infections, hospitalizations, ICU admissions, and deaths in Europe during SARS‐CoV‐2 Omicron wave in the first quarter of 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537885/
49193,Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251904/
49194,Implications of COVID-19 in pediatric rheumatology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270517/
49195,The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082447/
49196,"COVID-19 Infection in Children, Infants and Pregnant Subjects: An Overview of Recent Insights and Therapies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469368/
49197,The efficacy and effectiveness of COVID-19 vaccines around the world: a mini-review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198032/
49198,"Mandatory vaccinations, the segregation of citizens, and the promotion of inequality in the modern democracy of Greece and other democratic countries in the era of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734873/
49199,TLRs: Innate Immune Sentries against SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178469/
49200,Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442297/
49201,Associations of COVID-19 risk perception with vaccine hesitancy over time for Italian residents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788320/
49202,Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677488/
49203,Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID‐19 vaccines?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111482/
49204,Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928857/
49205,Prospects for mucosal vaccine: shutting the door on SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544966/
49206,Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894731/
49207,Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908811/
49208,Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546091/
49209,Vaccinology in the post−COVID-19 era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826410/
49210,Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758783/
49211,"Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977121/
49212,"Extracellular vesicles in COVID-19 prognosis, treatment, and vaccination: an update",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012322/
49213,SARS-CoV-2 Vaccine Effectiveness and Breakthrough Infections Among Patients Receiving Maintenance Dialysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711902/
49214,Factors Influencing COVID-19 Vaccine Uptake among Nepali People in the UK: A Qualitative Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143668/
49215,"Prevalence of antibodies against SARS‐CoV‐2 in the Norwegian population, August 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349429/
49216,Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10820583/
49217,A comprehensive update on CIDO: the community-based coronavirus infectious disease ontology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585694/
49218,Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238659/
49219,Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156796/
49220,Understanding the barriers and facilitators of vaccine hesitancy towards the COVID-19 vaccine in healthcare workers and healthcare students worldwide: An Umbrella Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096263/
49221,Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316719/
49222,A retrospective case-control study on menstrual cycle changes following COVID-19 vaccination and disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015085/
49223,Integrative network pharmacology and in silico analyses identify the anti-omicron SARS-CoV-2 potential of eugenol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937729/
49224,"Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861850/
49225,The evolution of the global COVID-19 epidemic in Morocco and understanding the different therapeutic approaches of chitosan in the control of the pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685138/
49226,Declining trends in vaccine confidence across sub-Saharan Africa: A large-scale cross-sectional modeling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294724/
49227,Factors influencing COVID-19 vaccine acceptance and hesitancy among rural community in Bangladesh: A cross-sectional survey based study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897644/
49228,Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308954/
49229,The current understanding and potential therapeutic options to combat COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207108/
49230,Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295078/
49231,Assessing COVID-19 Vaccine Uptake and Effectiveness Through the North West London Vaccination Program: Retrospective Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451961/
49232,"Effectiveness of Inactivated Vaccine against SARS-CoV-2 Delta Variant Infection in Xiamen, China—A Test-Negative Case-Control Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052085/
49233,Genomic Transcriptome Benefits and Potential Harms of COVID-19 Vaccines Indicated from Optimized Genomic Biomarkers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692407/
49234,Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896984/
49235,"Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566856/
49236,An Exploration of COVID-19 Impact and Vaccine Hesitancy in Parents of Pediatric Hematopoietic Stem Cell Transplant (HCT) Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785691/
49237,New Wave of COVID-19 Vaccine Opinions in the Month the 3rd Booster Dose Arrived,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228932/
49238,Reasons for COVID-19 Vaccine Hesitancy Among Chinese People Living With HIV/AIDS: Structural Equation Modeling Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255267/
49239,JMIR Public Health Surveill. 2022 Jul; 8(7): e40910. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377429/
49240,Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006787/
49241,Socioeconomic Differences in SARS-CoV-2 Infection and Vaccination in Germany: A Seroepidemiological Study After One Year of COVID-19 Vaccination Campaign,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538434/
49242,Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132185/
49243,Humoral immunoresponse elicited against an adenoviral-based SARS-CoV-2 coronavirus vaccine in elderly patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550251/
49244,"Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906816/
49245,Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554601/
49246,Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026957/
49247,A Systematic Review on the Safety and Efficacy of COVID-19 Vaccines Approved in Saudi Arabia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962734/
49248,Real-World Safety of COVID-19 mRNA Vaccines: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301865/
49249,Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566857/
49250,Appraisal of SARS-CoV-2 mutations and their impact on vaccination efficacy: an overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305048/
49251,The whole-of-society approach of mass COVID-19 vaccination in China: a qualitative study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802023/
49252,Analysis of Differences in User Groups and Post Sentiment of COVID-19 Vaccine Hesitators in Chinese Social-Media Platforms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177948/
49253,"“It Doesn’t Cure, but It Protects”: COVID-19 Vaccines through the Eyes of Children and Their Parents",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459681/
49254,Sustained Antibody-Dependent NK Cell Functions in Mild COVID-19 Outpatients During Convalescence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859986/
49255,Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230320/
49256,Acceptance and Risk Perception of COVID-19 Vaccination among Pregnant and Non Pregnant Women in Sub-Saharan Africa: A Cross-Sectional Matched-Sample Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964765/
49257,Microalgae as an Efficient Vehicle for the Production and Targeted Delivery of Therapeutic Glycoproteins against SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698596/
49258,An Insight Into COVID-19: A 21st Century Disaster and Its Relation to Immunocompetence and Food Antioxidants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838355/
49259,Knowledge of COVID-19 and Its Relationship with Preventive Behaviors and Vaccination among Adults in Northern Thailand’s Community,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834673/
49260,Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11015197/
49261,“The vaccination is positive; I don’t think it’s the panacea”: A qualitative study on COVID-19 vaccine attitudes among ethnically diverse healthcare workers in the United Kingdom,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462779/
49262,Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126603/
49263,Insight into the liver dysfunction in COVID-19 patients: Molecular mechanisms and possible therapeutic strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130970/
49264,COVID-19: gastrointestinal and hepatobiliary manifestations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288242/
49265,Public Perceptions of COVID-19 Vaccines: Policy Implications from US Spatiotemporal Sentiment Analytics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465389/
49266,COVID-19 Vaccine Hesitancy in South Africa: Lessons for Future Pandemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180246/
49267,COVID-19 Vaccination Response and Its Practical Application in Patients With Chronic Lymphocytic Leukemia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771252/
49268,"Allergic diseases and immunodeficiencies in children, lessons learnt from COVID‐19 pandemic by 2022: A statement from the EAACI‐section on pediatrics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538373/
49269,Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447987/
49270,Estimating SARS‐CoV‐2 infections and associated changes in COVID‐19 severity and fatality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432583/
49271,COVID-19 vaccine coverage targets to inform reopening plans in a low incidence setting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465974/
49272,Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086806/
49273,Recent Advancements on COVID-19: A Comprehensive Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713878/
49274,COVID-19 vaccine hesitancy among medical students in India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185413/
49275,Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342835/
49276,Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052472/
49277,"FcγRIIa - dependent platelet activation identified in COVID-19 vaccine-induced immune thrombotic thrombocytopenia-, heparin-induced thrombocytopenia, streptokinase- and anisoylated plasminogen-streptokinase activator complex-induced platelet activation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684751/
49278,Front Cardiovasc Med. 2023; 10: 1342177. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10731446/
49279,COVID-19 vaccine uptake and associated factors among adolescents and youths: Findings and implications for future vaccination programmes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511127/
49280,"Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517939/
49281,Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481789/
49282,Food Safety and Employee Health Implications of COVID-19: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906301/
49283,COVID-19 symptom relationship to antibody response and ACE2 neutralization in recovered health systems employees before and after mRNA BNT162b2 COVID-19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462709/
49284,Attitudes and Values of US Adults Not Yet Up-to-Date on COVID-19 Vaccines in September 2022,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299362/
49285,Recent advances in point of care testing for COVID-19 detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371983/
49286,Willingness to Accept the COVID-19 Vaccine and Related Factors among Indian Adults: A Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317945/
49287,The allocation of COVID-19 vaccines and antivirals against emerging SARS-CoV-2 variants of concern in East Asia and Pacific region: A modelling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810205/
49288,Induction of trained immunity by influenza vaccination - impact on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568262/
49289,High rates of COVID-19 vaccine refusal among Afghan pregnant women: a cross sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387420/
49290,The impact factors of social media users' forwarding behavior of COVID-19 vaccine topic: Based on empirical analysis of Chinese Weibo users,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515960/
49291,Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171754/
49292,Lack of influence of social media on vaccine decision-making by university students in Ireland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10760349/
49293,COVID-19 vaccine acceptance among pregnant women worldwide: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518917/
49294,Endoplasmic Reticulum Stress in Elderly Patients with COVID-19: Potential of Melatonin Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863214/
49295,Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380698/
49296,Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879018/
49297,"COVID-19 Vaccine Acceptance and Associated Factors Among College Students in Dessie City, Northeastern Ethiopia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384869/
49298,Predicting COVID-19 and Influenza Vaccination Confidence and Uptake in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611394/
49299,"Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102678/
49300,Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID‐19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015469/
49301,COVID-19 and the pituitary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089131/
49302,Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479327/
49303,Humoral and cellular immune responses to CoronaVac up to one year after vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634255/
49304,Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510054/
49305,Antiparasitic Drugs against SARS-CoV-2: A Comprehensive Literature Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320270/
49306,Low Prevalence of COVID-19 Vaccine Hesitancy in Students Across Health Science Disciplines in Texas,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901227/
49307,Exploring key informants’ perceptions of Covid-19 vaccine hesitancy in a disadvantaged urban community in Ireland: Emergence of a ‘4Cs’ model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715488/
49308,Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+ T cell responses post SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017386/
49309,Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244875/
49310,Projecting the Impact of SARS-CoV-2 Variants and the Vaccination Program on the Fourth Wave of the COVID-19 Pandemic in South Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306637/
49311,Longitudinal Dynamics of Cellular Responses in Recovered COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161166/
49312,Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550283/
49313,"COVID-19 in Patients with Hematologic Malignancies: Clinical Manifestations, Persistence, and Immune Response",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254311/
49314,The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972313/
49315,Lancet Infect Dis. 2021 Oct; 21(10): e302. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352492/
49316,Safety of AZD1222 COVID-19 vaccine and low Incidence of SARS-CoV-2 infection in Botswana following ChAdOx1(AZD1222) vaccination: A single-arm open-label interventional study – final study results,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714336/
49317,COVID-19: Some unresolved issues,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548072/
49318,Factors Associated With Parental Acceptance of COVID-19 Vaccination: A Multicenter Pediatric Emergency Department Cross-Sectional Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806130/
49319,Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486547/
49320,Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843151/
49321,Lymphocyte Subpopulations Associated with Neutralizing Antibody Levels of SARS-CoV-2 for COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501134/
49322,Influenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: An analysis of the Canadian Longitudinal study on Aging (CLSA),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660139/
49323,Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688562/
49324,Humoral immune mechanisms involved in protective and pathological immunity during COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245343/
49325,Hum Immunol. 2023 May-July; 84(5): 355. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082609/
49326,"Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: Data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994755/
49327,"COVID-19 Vaccine Acceptance and Hesitancy among Nurses in Thailand: Implications, Challenges, and Future Prospects for Attitudes and Vaccine Literacy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10892553/
49328,Cardiovascular manifestations secondary to COVID-19: A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065692/
49329,COVID-19 Vaccination within the Context of Reactogenicity and Immunogenicity of ChAdOx1 Vaccine Administered to Teachers in Poland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910564/
49330,"Acceptance, attitude, and factors affecting the intention to accept COVID-19 vaccine among Thai people and expatriates living in Thailand",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595590/
49331,"Impact of Health Workers’ Choice of COVID-19 Vaccine Booster on Immunization Levels in Istanbul, Turkey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223587/
49332,Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611020/
49333,MicroRNAs Derived from Extracellular Vesicles: Keys to Understanding SARS-CoV-2 Vaccination Response in Cancer Patients?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452664/
49334,Complement Factors in COVID-19 Therapeutics and Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733687/
49335,Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509317/
49336,Vitamin D: A Potential Mitigation Tool for the Endemic Stage of the COVID-19 Pandemic?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226430/
49337,Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689305/
49338,Immune thrombocytopenic purpura secondary to COVID‐19 vaccination: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880659/
49339,"Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626161/
49340,Self-reported side effects of COVID-19 vaccines among the public,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10901186/
49341,Primary Source of Information About COVID-19 as a Determinant of Perception of COVID-19 Severity and Vaccine Uptake: Source of Information and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354304/
49342,"Effects of SARS CoV-2, COVID-19, and its vaccines on male sexual health and reproduction: where do we stand?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548269/
49343,COVID-19 vaccine hesitancy: a systematic review of barriers to the uptake of COVID-19 vaccine among adults in Nigeria,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028775/
49344,"COVID-19: Transmission, prevention, and potential therapeutic opportunities",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256510/
49345,Vaccine Side Effects in Health Care Workers after Vaccination against SARS-CoV-2: Data from TüSeRe:exact Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864657/
49346,Social media use and vaccine hesitancy in the European Union,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893322/
49347,Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463842/
49348,COVID-19 vaccine response and safety in patients with cancer: An overview of systematic reviews,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707626/
49349,"Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027959/
49350,Targeting SARS-CoV-2 and host cell receptor interactions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792186/
49351,"S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921634/
49352,Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318295/
49353,Dynamics of Antibody Responses after Asymptomatic and Mild to Moderate SARS-CoV-2 Infections: Real-World Data in a Resource-Limited Country,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143231/
49354,A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668345/
49355,Analysis of B Cell Receptor Repertoires Reveals Key Signatures of the Systemic B Cell Response after SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865482/
49356,How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846337/
49357,A review of current effective COVID-19 testing methods and quality control,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189236/
49358,"Effectiveness of Inactivated COVID-19 Vaccines Against Illness Caused by the B.1.617.2 (Delta) Variant During an Outbreak in Guangdong, China: A Cohort Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819853/
49359,Innate and adaptive immune responses to SARS‐CoV‐2 in humans: relevance to acquired immunity and vaccine responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013613/
49360,"Acceptance of COVID-19 Vaccine and Determinant Factors Among Patients with Chronic Disease Visiting Dessie Comprehensive Specialized Hospital, Northeastern Ethiopia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380286/
49361,Short and mid‐term SARS‐CoV‐2 antibody response after inactivated COVID‐19 vaccine in hemodialysis and kidney transplant patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088488/
49362,The PHH-1V HIPRA vaccine: a new tool in the vaccination strategy against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586735/
49363,Microbiome Analysis for Wastewater Surveillance during COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426581/
49364,"Effectiveness of BNT162b2 and CoronaVac vaccines in preventing SARS-CoV-2 Omicron infections, hospitalizations, and severe complications in the pediatric population in Hong Kong: a case-control study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026771/
49365,Neuroprotective Agents with Therapeutic Potential for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669388/
49366,Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them!,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139532/
49367,Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402319/
49368,"Long COVID: The latest manifestations, mechanisms, and potential therapeutic interventions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732402/
49369,Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572995/
49370,Localized delivery of nanomedicine and antibodies for combating COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502448/
49371,Adjuvants for COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222622/
49372,"Acceptance of COVID-19 vaccine and associated factors among health professionals working in Hospitals of South Gondar Zone, Northwest Ethiopia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903926/
49373,Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757397/
49374,Prevalence of human pathogenic viruses in wastewater: A potential transmission risk as well as an effective tool for early outbreak detection for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352675/
49375,"SARS‐CoV‐2, Covid‐19, and the debunking of conspiracy theories",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995093/
49376,Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222305/
49377,"
Clinical and immunological outcomes of
SARS-CoV-2 infection in patients with inborn
errors of immunity receiving different brands
and doses of COVID-19 vaccines
",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10912874/
49378,Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296981/
49379,B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801326/
49380,“Is Omicron mild”? Testing this narrative with the mutational landscape of its three lineages and response to existing vaccines and therapeutic antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088584/
49381,Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479753/
49382,A dynamic mucin mRNA signature associates with COVID-19 disease presentation and severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525642/
49383,"Report of Adverse Effects Following Population-Wide COVID-19 Vaccination: A Comparative Study between Six Different Vaccines in Baja-California, Mexico",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414877/
49384,Distinct Features of Vascular Diseases in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332421/
49385,Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163696/
49386,Targeted wastewater surveillance of SARS-CoV-2 on a university campus for COVID-19 outbreak detection and mitigation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163699/
49387,"Timeline of SARS-CoV-2 Transmission in Sabah, Malaysia: Tracking the Molecular Evolution",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459040/
49388,"Cohort profile: a national, community-based prospective cohort study of SARS-CoV-2 pandemic outcomes in the USA—the CHASING COVID Cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458000/
49389,COVID-19: Has the Liver Been Spared?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866733/
49390,Curbing COVID-19 Vaccine Hesitancy from a Dermatological Standpoint: Analysis of Cutaneous Reactions in the Vaccine Adverse Event Reporting System (VAERS) Database,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361907/
49391,Impact of COVID-19 vaccine-associated side effects on health care worker absenteeism and future booster vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013647/
49392,Pivoting data and analytic capacity to support Ontario’s COVID-19 response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785247/
49393,Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511649/
49394,Prevention and treatment strategies for kidney transplant recipients in the context of long-term existence of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11021598/
49395,Attitudes toward Receiving COVID-19 Booster Dose in the Middle East and North Africa (MENA) Region: A Cross-Sectional Study of 3041 Fully Vaccinated Participants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414713/
49396,A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380544/
49397,Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949831/
49398,Immune response induced by novel coronavirus infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641212/
49399,Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936041/
49400,"Prognosis of COVID-19 in the middle eastern population, knowns and unknowns",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471247/
49401,Seroepidemiology of SARS-CoV-2 on a partially vaccinated island in Brazil: Determinants of infection and vaccine response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706255/
49402,Disparities in child and adolescent COVID-19 vaccination coverage and parental intent toward vaccinations for their children and adolescents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351440/
49403,Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525243/
49404,Characteristics and Comparison of Adverse Events of Coronavirus Disease 2019 Vaccines Reported to the United States Vaccine Adverse Event Reporting System Between 14 December 2020 and 8 October 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016134/
49405,Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969758/
49406,"COVID-19 Vaccine Acceptance and Hesitancy among Migrants, Refugees, and Foreign Workers: A Systematic Review and Meta-Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302060/
49407,Longitudinal study comparing IgG antibodies induced by heterologous prime‐boost COVID‐19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877967/
49408,SARS-CoV-2: The Monster Causes COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861077/
49409,"Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591157/
49410,Effectiveness and Safety of COVID-19 Vaccination in Patients with Malignant Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962104/
49411,Investigation of Neurological Complications after COVID-19 Vaccination: Report of the Clinical Scenarios and Review of the Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966113/
49412,The Gut Microbiome of Children during the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783902/
49413,Plant-Based Vaccines in Combat against Coronavirus Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876659/
49414,"Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926447/
49415,Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612758/
49416,Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834523/
49417,Broad-Spectrum Anti-coronavirus Vaccines and Therapeutics to Combat the Current COVID-19 Pandemic and Future Coronavirus Disease Outbreaks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940144/
49418,A hitchhiker's guide through the COVID-19 galaxy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461017/
49419,Nutrition as Personalized Medicine against SARS-CoV-2 Infections: Clinical and Oncological Options with a Specific Female Groups Overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409275/
49420,A comparison of conventional and advanced electroanalytical methods to detect SARS-CoV-2 virus: A concise review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270057/
49421,Acceptance of a COVID-19 Vaccine and Its Related Determinants among the General Adult Population in Kuwait,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089409/
49422,Association of initial COVID‐19 vaccine hesitancy with subsequent vaccination among pregnant and postpartum individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111102/
49423,A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857284/
49424,Research Progress in the Treatment of Complications and Sequelae of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674502/
49425,COVID-19 vaccine hesitancy among persons living in homeless shelters in France,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114835/
49426,A Cross-Sectional Survey on COVID-19 Vaccine Hesitancy Among Parents From Shandong vs. Zhejiang,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602062/
49427,The future of COVID-19: A vaccine review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363422/
49428,Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485669/
49429,Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568958/
49430,Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544670/
49431,Vaccine discourse during the onset of the COVID-19 pandemic: Topical structure and source patterns informing efforts to combat vaccine hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328525/
49432,Mapping global trends in vaccine sales before and during the first wave of the COVID-19 pandemic: a cross-sectional time-series analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640199/
49433,Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336035/
49434,Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569401/
49435,The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11047051/
49436,Public Perception of SARS-CoV-2 Vaccinations on Social Media: Questionnaire and Sentiment Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700913/
49437,A vaccine based on the yeast-expressed receptor-binding domain (RBD) elicits broad immune responses against SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682237/
49438,Coronavirus Disease 2019 (COVID-19) Vaccines and Pregnancy: What Obstetricians Need to Know,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884084/
49439,Neurological pathophysiology of SARS‐CoV‐2 and pandemic potential RNA viruses: a comparative analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652524/
49440,SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653322/
49441,Protection from COVID-19 disease in hamsters vaccinated with subunit SARS-CoV-2 S1 mucosal vaccines adjuvanted with different adjuvants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067881/
49442,Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797340/
49443,CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678543/
49444,Determinants of COVID-19 skepticism and SARS-CoV-2 vaccine hesitancy: findings from a national population survey of U.S. adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132354/
49445,Immune response stability to the SARS-CoV-2 mRNA vaccine booster is influenced by differential splicing of HLA genes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11026523/
49446,"Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229804/
49447,"Proposed Pathogenesis, Characteristics, and Management of COVID-19 mRNA Vaccine-Related Myopericarditis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612108/
49448,Am J Cardiovasc Drugs. 2022; 22(1): 105. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691155/
49449,"COVID-19 vaccine acceptance and perceived risk among pregnant and non-pregnant adults in Cameroon, Africa",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469991/
49450,Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399176/
49451,Leveraging South African HIV research to define SARS‐CoV‐2 immunity triggered by sequential variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349367/
49452,Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226983/
49453,Current updates on adaptive immune response by B cell and T cell stimulation and therapeutic strategies for novel coronavirus disease 2019 (COVID-19) treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076978/
49454,Are parents’ willing to vaccinate their children against COVID-19? A qualitative study based on the Health Belief Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054307/
49455,Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428332/
49456,COVID-19 and HIV infection co-pandemics and their impact: a review of the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097669/
49457,Immunogenicity of an AAV-Based COVID-19 Vaccine in Murine Models of Obesity and Aging,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026898/
49458,To clot or not to clot? Ad is the question—Insights on mechanisms related to vaccine‐induced thrombotic thrombocytopenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420166/
49459,J Thromb Haemost. 2023 Apr; 21(4): 1066. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501979/
49460,Identifying SARS‐CoV‐2 ‘memory’ NK cells from COVID‐19 convalescent donors for adoptive cell therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652867/
49461,Vaccine Communication: Appeals and Messengers Most Effective for COVID-19 Vaccine Uptake in Ukraine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967207/
49462,A population-based matched cohort study of early pregnancy outcomes following COVID-19 vaccination and SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574832/
49463,COVID-19 Vaccine Effectiveness Among Patients With Maintenance Dialysis; Observations From Population Level Cohort Studies in 2 Large Canadian Provinces,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285471/
49464,Fair-split distribution of multi-dose vaccines with prioritized age groups and dynamic demand: The case study of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116158/
49465,"COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392210/
49466,Vaccines - safety in pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992376/
49467,Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637536/
49468,"Long-term Lung Abnormalities Associated with COVID-19
Pneumonia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462591/
49469,"Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281043/
49470,SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769879/
49471,"COVID‐19: Risk Factors Associated with Infectivity and
Severity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265317/
49472,"Vaccine Willingness and Impact of the COVID-19 Pandemic on Women’s Perinatal Experiences and Practices—A Multinational, Cross-Sectional Study Covering the First Wave of the Pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038007/
49473,Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111366/
49474,Assessing humoral immune response after two doses of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786607/
49475,"Biology of COVID-19 and related viruses: Epidemiology, signs, symptoms, diagnosis, and treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723419/
49476,"Can Lactoferrin, a Natural Mammalian Milk Protein, Assist in the Battle against COVID-19?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782828/
49477,A trimeric spike-based COVID-19 vaccine candidate induces broad neutralization against SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026892/
49478,"Combining viral genomics and clinical data to assess risk factors for severe COVID-19 (mortality, ICU admission, or intubation) amongst hospital patients in a large acute UK NHS hospital Trust",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035897/
49479,Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216847/
49480,Behavioral Intention to Receive a COVID-19 Vaccination Among Chinese Factory Workers: Cross-sectional Online Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945977/
49481,Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404227/
49482,COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical Manifestations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608106/
49483,Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193775/
49484,Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158969/
49485,"COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335551/
49486,Bivalent second booster dose of the COVID-19 vaccine: Eligible populations’ reasons for receiving in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088915/
49487,Understanding COVID-19-associated coagulopathy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362465/
49488,Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678302/
49489,"SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902153/
49490,Booster Immunization Improves Memory B Cell Responses in Older Adults Unresponsive to Primary SARS-CoV-2 Immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384172/
49491,The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399171/
49492,Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960902/
49493,Clinical and genomic signatures of SARS-CoV-2 Delta breakthrough infections in New York,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323230/
49494,Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963519/
49495,"A tailored COVID-19 vaccination pathway for children 5–11 years in Victoria, Australia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106821/
49496,Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215557/
49497,EClinicalMedicine. 2021 Nov; 41: 101168. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527185/
49498,Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461570/
49499,Impact of the COVID-19 pandemic on Bordetella pertussis infections in England,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882439/
49500,Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639402/
49501,Factors associated with vaccine intention in adults living in England who either did not want or had not yet decided to be vaccinated against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903974/
49502,COVID-19 vaccine acceptance among healthcare workers in India: Results from a cross-sectional survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021553/
49503,"COVID-19 Vaccine Hesitancy and Determinants of Acceptance among Healthcare Workers, Academics and Tertiary Students in Nigeria",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032510/
49504,"Not All Conservatives Are Vaccine Hesitant: Examining the Influence of Misinformation Exposure, Political Ideology, and Flu Vaccine Acceptance on COVID-19 Vaccine Hesitancy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052187/
49505,The Role of Existential Concerns in the Individual’s Decisions regarding COVID-19 Vaccine Uptake: A Survey among Non-Vaccinated Italian Adults during the Third Wave of the Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319079/
49506,Hesitancy for receiving regular SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis from the UK-REACH study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548389/
49507,Modeling transmission of SARS-CoV-2 Omicron in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307473/
49508,Registry Systems for COVID-19 Vaccines and Rate of Acceptability for Vaccination Before and After Availability of Vaccines in 12 Countries: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872397/
49509,COVID-19 and Pediatric Asthma: Clinical and Management Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908623/
49510,Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID‐19 infection: Prospective observational study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661640/
49511,Myeloid dysregulation and therapeutic intervention in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576142/
49512,"Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127834/
49513,Role of the SphK‐S1P‐S1PRs pathway in invasion of the nervous system by SARS‐CoV‐2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014301/
49514,"Safety, immunogenicity, efficacy, and acceptability of COVID-19 vaccination in people with multiple sclerosis: a narrative review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396498/
49515,Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755486/
49516,Associations of vaccine status with characteristics and outcomes of hospitalized severe COVID-19 patients in the booster era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089907/
49517,Safety and efficacy of dendritic cell vaccine for COVID-19 prevention after 1-Year follow-up: phase I and II clinical trial final result,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315914/
49518,In vitro evidence against productive SARS-CoV-2 infection of human testicular cells: Bystander effects of infection mediate testicular injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231791/
49519,"As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730036/
49520,"Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432953/
49521,Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439210/
49522,A brief review on DNA vaccines in the era of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629371/
49523,Long COVID and its Management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305273/
49524,Predicting COVID‐19 booster vaccine intentions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111247/
49525,SARS-CoV-2 Reinfection Is a New Challenge for the Effectiveness of Global Vaccination Campaign: A Systematic Review of Cases Reported in Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535385/
49526,Tracking the progress in COVID-19 and vaccine safety research – a comprehensive bibliometric analysis of publications indexed in Scopus database,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828093/
49527,Clinical manifestations of COVID-19 infection in dialysis patients and protective effect of COVID-19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066982/
49528,Current status of coronavirus disease 2019 vaccine research based on bibliometric analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746459/
49529,Molnupiravir and Its Antiviral Activity Against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013824/
49530,Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489704/
49531,Comprehensive analysis of drugs to treat SARS-CoV-2 infection: Mechanistic insights into current COVID-19 therapies (Review),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307820/
49532,Dental Healthcare Amid the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583530/
49533,No small matter: a perspective on nanotechnology-enabled solutions to fight COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488724/
49534,Parental Vaccine Literacy: Attitudes towards the COVID-19 Vaccines and Intention to Vaccinate Their Children Aged 5–11 Years against COVID-19 in Thailand,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10747165/
49535,"COVID-19 prevention behaviors, trust, and intent to vaccinate among youth at risk for HIV",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970374/
49536,Parents’ willingness and attitudes concerning the COVID‐19 vaccine: A cross‐sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236907/
49537,Current perspectives regarding SARS‐CoV‐2 vaccination in chronic lymphocytic leukemia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087408/
49538,"Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347473/
49539,"Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570409/
49540,Decisions to Choose COVID-19 Vaccination by Health Care Workers in a Southern California Safety Net Medical Center Vary by Sociodemographic Factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412623/
49541,Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484565/
49542,Near-Complete SARS-CoV-2 Seroprevalence among Rural and Urban Kenyans despite Significant Vaccine Hesitancy and Refusal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862465/
49543,"Identifying the determinants of non-injection of covid-19 vaccine: A qualitative study in Urmia, Iran",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386546/
49544,In Vitro Exposure of Primary Human T Cells and Monocytes to Polyclonal Stimuli Reveals a Basal Susceptibility to Display an Impaired Cellular Immune Response and Develop Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289744/
49545,COVID-19 Vaccine Perspective Among University Lecturers and Students: A Qualitative Study of Pre Implementation of Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266379/
49546,Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245563/
49547,COVID-19 Vaccine Booster Hesitancy in Malaysia: A Web-Based Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058917/
49548,"Genomic surveillance, evolution and global transmission of SARS-CoV-2 during 2019–2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342790/
49549,Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463843/
49550,Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413264/
49551,Front Immunol. 2023; 14: 1274753. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469294/
49552,COVID‐19 vaccine acceptability among healthcare workers in Ethiopia: Do we practice what we preach?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115514/
49553,"SARS-CoV-2 tests, confirmed infections and COVID-19-related hospital admissions in children and young people: birth cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437731/
49554,Covid-19 deaths in Africa: prospective systematic postmortem surveillance study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887952/
49555,COVID-19 Vaccines and Immunosuppressed Patients With Cancer: Critical Considerations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713690/
49556,Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669952/
49557,Assessment of the Interferon-Lambda-3 Polymorphism in the Antibody Response to COVID-19 in Older Adults Seropositive for CMV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963200/
49558,COVID-19 vaccine hesitancy between family decision-makers and non-decision-makers among college teachers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815219/
49559,"Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351
Variant",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091623/
49560,"Understanding Factors to COVID-19 Vaccine Adoption in Gujarat, India",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909936/
49561,"SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396141/
49562,In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491932/
49563,Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513711/
49564,Environment and COVID-19 incidence: A critical review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858699/
49565,Imaging Techniques: Essential Tools for the Study of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355083/
49566,"Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568567/
49567,Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402899/
49568,Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073701/
49569,Nanotechnology-based approaches in the fight against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712532/
49570,"Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472849/
49571,Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384470/
49572,A systematic review of SARS-CoV-2 vaccine candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551521/
49573,Ethics of age de-escalation in pediatric vaccine trials: Attending to the case of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888531/
49574,COVID-19 Vaccination Intent and Willingness to Pay in Bangladesh: A Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143282/
49575,"Temporal trends and determinants of COVID-19 vaccine coverage and series initiation during pregnancy in Ontario, Canada, December 2020 to December 2021: A population-based retrospective cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894778/
49576,COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397302/
49577,Development and management of gastrointestinal symptoms in long-term COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10752947/
49578,Single‐cell transcriptome atlas reveals protective characteristics of COVID‐19 mRNA vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538852/
49579,Burden and Impact of Reactogenicity among Adults Receiving COVID-19 Vaccines in the United States and Canada: Results from a Prospective Observational Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10821469/
49580,Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481693/
49581,Potential changes in vaccine access and policy landscape in Thailand post COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746520/
49582,"COVID-19 Vaccine Acceptance is associated with Vaccine Hesitancy, Perceived Risk and Previous Vaccination Experiences",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814475/
49583,Association of laparoscopically-confirmed endometriosis with long COVID-19: a prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101545/
49584,"Developmental Aspects of SARS-CoV-2, Potential Role of Exosomes and Their Impact on the Human Transcriptome",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708617/
49585,"Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527094/
49586,"Cluster analysis of adults unvaccinated for COVID-19 based on behavioral and social factors, National Immunization Survey-Adult COVID Module, United States",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804852/
49587,Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439873/
49588,An overview of the recent findings of cell-based therapies for the treatment and management of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492917/
49589,SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906421/
49590,Review on Approved and Inprogress COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420219/
49591,Iran J Pharm Res. 2024 Jan-Dec; 23(1): e146470. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10924271/
49592,Acceptance and Preference for COVID-19 Vaccine among Japanese Residents at Early Stage of the Epidemic in Japan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861095/
49593,A Review of the Currently Available Antibody Therapy for the Treatment of Coronavirus Disease 2019 (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887598/
49594,"COVID-19 vaccination coverage among healthcare workers in obstetrics and gynecology during the first three months of vaccination campaign: a cross-sectional study in Jiangsu province, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903925/
49595,"Perceptions of COVID-19 Maternal Vaccination among Pregnant Women and Healthcare Workers and Factors That Influence Vaccine Acceptance: A Cross-Sectional Study in Barcelona, Spain",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692476/
49596,"COVID-19: Second Wave or Multiple Peaks, Natural Herd Immunity or Vaccine – We Should be Prepared",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711348/
49597,Facilitators and Barriers to Take up a COVID-19 Vaccine Booster Dose among Community-Dwelling Older Adults in Hong Kong: A Population-Based Random Telephone Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228543/
49598,A spatial and dynamic solution for allocation of COVID-19 vaccines when supply is limited,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053274/
49599,Consecutive Hits of COVID-19 in India: The Mystery of Plummeting Cases and Current Scenario ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934068/
49600,IL-15 immunotherapy is a viable strategy for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537239/
49601,Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659513/
49602,SARS-CoV-2 vaccine-induced humoral and cellular immunity in patients with hematologic malignancies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674560/
49603,Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583637/
49604,"COVID-19 vaccine hesitancy among pregnant women attending public antenatal clinics in Dar es Salaam, Tanzania",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653711/
49605,Pharmaceutical Industry’s Engagement in the Global Equitable Distribution of COVID-19 Vaccines: Corporate Social Responsibility of EUL Vaccine Developers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539183/
49606,Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease: an extension study (RESCUE 2),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990163/
49607,"Infodemic, Institutional Trust, and COVID-19 Vaccine Hesitancy: A Cross-National Survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265924/
49608,COVID-19 Vaccine Hesitancy among Arab Americans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030465/
49609,Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472862/
49610,Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929940/
49611,The COVID-19 pandemic: a threat to antimicrobial resistance containment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204817/
49612,Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403711/
49613,Global impact of the first year of COVID-19 vaccination: a mathematical modelling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225255/
49614,SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313683/
49615,"Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868348/
49616,Open Forum Infect Dis. 2023 May; 10(5): ofad252. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171106/
49617,Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551858/
49618,The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161940/
49619,"Prior SARS‐CoV‐2 infection and COVID‐19 vaccine effectiveness against outpatient illness during widespread circulation of SARS‐CoV‐2 Omicron variant, US Flu VE network",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209645/
49620,Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537178/
49621,Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639505/
49622,Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645737/
49623,COVID-19 Outbreak and BNT162b2 mRNA Vaccination Coverage in a Correctional Facility during Circulation of the SARS-CoV-2 Omicron BA.1 Variant in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315621/
49624,Comparative Assessment of the Kinetics of Cellular and Humoral Immune Responses to COVID-19 Vaccination in Cancer Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383486/
49625,"The Intersection of COVID-19 and Rheumatoid Arthritis: Shared Mechanisms, Treatment Challenges, and Potential Therapeutic Approaches",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389822/
49626,Determinants of Hesitancy Towards COVID-19 Vaccines in State of Kuwait: An Exploratory Internet-Based Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684437/
49627,How Does Severe Acute Respiratory Syndrome-Coronavirus-2 Affect the Brain and Its Implications for the Vaccines Currently in Use,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780773/
49628,Cutaneous reactions after COVID‐19 vaccination in Turkey: A multicenter study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349975/
49629,Analytical insights of COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567672/
49630,Why does COVID-19 continue to spread despite mass vaccination?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358243/
49631,Wastewater-based epidemiological surveillance to monitor the prevalence of SARS-CoV-2 in developing countries with onsite sanitation facilities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225114/
49632,Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926413/
49633,A Comprehensive Summary of the Knowledge on COVID-19 Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801274/
49634,Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266318/
49635,The Prevalence of COVID-19 Vaccination and Vaccine Hesitancy in Pregnant Women: An Internet-based Cross-sectional Study in Japan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918615/
49636,Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955932/
49637,"Jeelo Dobara (Live Life Again): a cross-sectional survey to understand the use of social media and community experience and perceptions around COVID-19 vaccine uptake in three low vaccine uptake districts in Karachi, Pakistan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884570/
49638,Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593054/
49639,Sci Rep. 2024; 14: 644. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10770061/
49640,Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case–control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619717/
49641,Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240007/
49642,Nat Commun. 2022; 13: 4798. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377300/
49643,Sequential Administration of SARS-CoV-2 Strains-Based Vaccines Effectively Induces Potent Immune Responses against Previously Unexposed Omicron Strain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224538/
49644,An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204679/
49645,The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446508/
49646,SARS-CoV-2 virus: Vaccines in development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825979/
49647,Sinovac vaccination and the course of COVID-19 disease in hospitalized patients in Turkey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167459/
49648,Histopathological and molecular links of COVID-19 with novel clinical manifestations for the management of coronavirus-like complications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150634/
49649,"Novel COVID-19 vaccine hesitancy and acceptance, and associated factors, amongst medical students: a scoping review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930839/
49650,"Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927425/
49651,One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220992/
49652,From Cell to Symptoms: The Role of SARS-CoV-2 Cytopathic Effects in the Pathogenesis of COVID-19 and Long COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179575/
49653,"Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398561/
49654,"A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663145/
49655,Cutaneous adverse events following 771 doses of the inactivated and mRNA COVID‐19 vaccines: A survey study among health care providers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350229/
49656,Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127771/
49657,Perceptions and attitudes towards Covid-19 vaccines: narratives from members of the UK public,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244123/
49658,Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354789/
49659,Key predictors of COVID-19 vaccine hesitancy in Malaysia: An integrated framework,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126375/
49660,COVID-19 vaccine hesitancy and patient self-advocacy: a statistical analysis of those who can and can’t get vaccinated,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255840/
49661,Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475962/
49662,Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729845/
49663,Serum peptidome profiles immune response of COVID-19 Vaccine administration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450691/
49664,Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423223/
49665,Sci Transl Med. 2022 Mar 29 : eabm2311. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995030/
49666,COVID-19 and Cardiovascular Disease: From Bench to Bedside,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048382/
49667,The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832653/
49668,Comparative global B cell receptor repertoire difference induced by SARS-CoV-2 infection or vaccination via single-cell V(D)J sequencing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377262/
49669,A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305344/
49670,An Update on mRNA-Based Viral Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473183/
49671,Correlation between Type I Interferon Associated Factors and COVID-19 Severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506204/
49672,A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551302/
49673,Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682481/
49674,Early Serological Response to BNT162b2 mRNA Vaccine in Healthcare Workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402545/
49675,Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275758/
49676,"Psychobehavioral Responses and Likelihood of Receiving COVID-19 Vaccines during the Pandemic, Hong Kong",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237883/
49677,COVID-19 rhapsody: Rage towards advanced diagnostics and therapeutic strategy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214321/
49678,Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126559/
49679,Next-Generation Sequencing Reveals the Progression of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991797/
49680,COVID-19 vaccine development: What lessons can we learn from TB?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702199/
49681,Update on COVID-19 and Effectiveness of a Vaccination Campaign in a Global Context,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518080/
49682,COVID-19 vaccine effectiveness against omicron (B.1.1.529) variant infection and hospitalisation in patients taking immunosuppressive medications: a retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381025/
49683,"Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995575/
49684,BMJ Open. 2022; 12(11): e056872corr1. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644317/
49685,What impact does the attitude toward COVID-19 vaccination have on physicians as vaccine providers? A cross sectional study from the German outpatient sector,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691451/
49686,"Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162476/
49687,Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604727/
49688,Immune dysregulation and system pathology in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993139/
49689,"Spotlights on the latest opinions on identification, prevention, and management of newer CoV-2 variants: A roundup appraisal on innovative ideas and designer vaccines for Omicron",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250817/
49690,"COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459044/
49691,Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248499/
49692,Retrospectively modeling the effects of increased global vaccine sharing on the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671807/
49693,Nat Med. 2023; 29(11): 2958. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041477/
49694,"Effectiveness of Inactivated COVID-19 Vaccines against Delta-Variant COVID-19: Evidence from an Outbreak in Inner Mongolia Autonomous Region, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961555/
49695,"Clinical Profile and Risk Factors for Severe COVID-19 in Hospitalized Patients from Rio de Janeiro, Brazil: Comparison between the First and Second Pandemic Waves",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094970/
49696,Nanotechnology for the management of COVID-19 during the pandemic and in the post-pandemic era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522393/
49697,"Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310416/
49698,"Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971363/
49699,Lancet Infect Dis. 2022 Jun; 22(6): e159. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993155/
49700,"Perceptions of Parents towards COVID-19 Vaccination in Children, Aseer Region, Southwestern Saudi Arabia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414894/
49701,COVID-19 Vaccine Acceptance among Low- and Lower-Middle-Income Countries: A Rapid Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950670/
49702,Development of an Oral IgA Response against SARS-CoV-2 Following Immunization with Different COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10748229/
49703,"Parental hesitancy towards vaccinating their children with a booster dose against COVID-19: Real-world evidence from Taizhou, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354386/
49704,"COVID-19 Vaccination Hesitancy among Youths in Soweto, South Africa",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223070/
49705,"Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728410/
49706,COVID-19-Related Age Profiles for SARS-CoV-2 Variants in England and Wales and States of the USA (2020 to 2022): Impact on All-Cause Mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606787/
49707,"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Dose, Infection, and Disease Outcomes for Coronavirus Disease 2019 (COVID-19): A Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524637/
49708,"SARS-CoV-2: phenotype, genotype, and characterization of different variants",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204680/
49709,Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877652/
49710,"Comparison of the Clinical and Laboratory Findings and Outcomes of Hospitalized COVID-19 Patients Who Were Either Fully Vaccinated with Coronavac or Not: An Analytical, Cross Sectional Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148084/
49711,SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322674/
49712,Postvaccination COVID‐19 infection is associated with reduced mortality in patients with cirrhosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015228/
49713,SARS-CoV-2 vaccines and myocarditis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541288/
49714,Accelerated national lot release on COVID-19 vaccines in Republic of Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160014/
49715,Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428469/
49716,Barriers and Facilitators to COVID-19 Vaccine Uptake among Polish Patients: A Qualitative Interview Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861893/
49717,"Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory Proteins",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223475/
49718,Evaluation of the Gam-COVID-Vac and vaccine-induced neutralizing response against SARS-CoV-2 lineage P.1 variant in an Argentinean cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685184/
49719,Dynamic Trends and Underlying Factors of COVID-19 Vaccine Booster Hesitancy in Adults: Cross-Sectional Observational Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395646/
49720,Global research on RNA vaccines for COVID-19 from 2019 to 2023: a bibliometric analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10902429/
49721,Factors associated with COVID-19 vaccine hesitancy among healthcare workers in Cameroon and Nigeria: a web-based cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629963/
49722,Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218332/
49723,Vaccine‐induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538323/
49724,A qualitative investigation of facilitators and barriers to accessing COVID-19 vaccines among Racialized and Indigenous Peoples in Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746392/
49725,Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686447/
49726,"COVID-19 vaccine knowledge, attitudes, and experiences of health care workers in Perth, Western Australia: A qualitative study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803204/
49727,Attitudes of Healthcare Workers in Israel towards the Fourth Dose of COVID-19 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966952/
49728,Assessment of Attitudes and Intentions towards COVID-19 Vaccines and Associated Factors among General Populations of Pakistan: A Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609017/
49729,Omicron BA.1 breakthrough infections in inactivated COVID-19 vaccine recipients induced distinct pattern of antibody and T cell responses to different Omicron sublineages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155635/
49730,Immune responses during COVID-19 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480812/
49731,"COVID-19: molecular targets, drug repurposing and new avenues for
drug discovery",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534958/
49732,Serial SARS-CoV-2 Antibody Titers in Vaccinated Dialysis Patients: Prevalence of Unrecognized Infection and Duration of Seroresponse,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542005/
49733,"The effect of COVID certificates on vaccine uptake, health outcomes, and the economy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263819/
49734,Promising use of immune cell‐derived exosomes in the treatment of SARS‐CoV‐2 infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393056/
49735,Anti‐spike IgG antibody kinetics following the second and third doses of BNT162b2 vaccine in nursing home residents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115082/
49736,Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213865/
49737,A cross-sectional study of factors associated with COVID-19 testing among people who inject drugs: missed opportunities for reaching those most at risk,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042668/
49738,Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811047/
49739,Determinants of COVID-19 vaccine acceptance in Ethiopia: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165773/
49740,Effectiveness of an inactivated SARS-CoV-2 vaccine in children and adolescents: a large-scale observational study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117174/
49741,Population-Level Effectiveness of an Inactivated Whole-Virion COVID-19 Vaccine: A Test Negative Case-Control Study in the Dominican Republic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043129/
49742,Proteomic approaches to study SARS-CoV-2 biology and COVID-19 pathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839417/
49743,Policy Endorsement and Booster Shot: Exploring Politicized Determinants for Acceptance of a Third Dose of COVID-19 Vaccine in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962357/
49744,"Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158532/
49745,Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN® induced immunity in COVID-19 exposed Indians,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502007/
49746,"Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b–2a trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584570/
49747,"Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015557/
49748,SARS-CoV-2 Infection and COVID-19 in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678836/
49749,"Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765328/
49750,COVID-19 vaccination intention and activation among health care system employees: A mixed methods study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276645/
49751,Assessment of Herpes Zoster Risk Among Recipients of COVID-19 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669817/
49752,Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334537/
49753,Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029786/
49754,Survey of pediatric transplant center practices regarding COVID-19 vaccine mandates for transplant candidates and living donors and use of COVID-19-positive deceased organs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509306/
49755,"Assessing SARS-CoV-2 vaccine hesitancy among the people living with and without HIV from May to September 2022 in Blantyre, Malawi",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332178/
49756,Calcium Signals during SARS-CoV-2 Infection: Assessing the Potential of Emerging Therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773957/
49757,The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920968/
49758,"Parents’ attitudes, knowledge and practice towards vaccinating their children against COVID-19: a cross-sectional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225601/
49759,Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10907304/
49760,Nat Immunol. 2024; 25(3): 578. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10907281/
49761,An Update on SARS-CoV-2 Clinical Trial Results—What We Can Learn for the Next Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779148/
49762,Clinical features and severe acute respiratory syndrome-coronavirus-2 structural protein-based serology of Mexican children and adolescents with coronavirus disease 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377623/
49763,The comparison of SARS-CoV-2 antibody levels in medical personnel induced by different types of vaccines compared to the natural infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189579/
49764,Autoimmune hepatitis after COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732229/
49765,Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498392/
49766,Acceptance of a Third Dose of COVID-19 Vaccine and Associated Factors in China Based on Health Belief Model: A National Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780099/
49767,Engineering viral genomics and nano-liposomes in microfluidic platforms for patient-specific analysis of SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254234/
49768,Egyptian hemodialysis patients' willingness to receive the COVID-19 vaccine booster dose: a multicenter survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979119/
49769,"The Relationship between Mental Disorders and the COVID-19 Pandemic—Course, Risk Factors, and Potential Consequences",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368061/
49770,"Vaccine development against coronavirus (2003 to present): An overview, recent advances, current scenario, opportunities and challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371592/
49771,Superspreading of SARS-CoV-2 Omicron BA.2.23 among vaccinated Finnish adults: symptomatic COVID-19 only contracted by those without recent infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368952/
49772,COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450840/
49773,Efficacy information influences intention to take COVID‐19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420419/
49774,Spike protein of SARS-CoV-2 variants: a brief review and practical implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994061/
49775,Humoral and cellular immune responses to Pfizer-BioNTech BNT162b2 SARS-CoV-2 vaccine in adolescents with liver transplantation: Single center experience,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727154/
49776,Sexual dimorphism in COVID-19: potential clinical and public health implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803381/
49777,"Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)—United States, March–June and October–December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136001/
49778,Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492402/
49779,Critical roles of cytokine storm and bacterial infection in patients with COVID-19: therapeutic potential of mesenchymal stem cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812357/
49780,NMR spectroscopy spotlighting immunogenicity induced by COVID-19 vaccination to mitigate future health concerns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393187/
49781,Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966779/
49782,mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733787/
49783,Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366625/
49784,Hypercoagulability of COVID-19 and Neurological Complications: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547944/
49785,Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143195/
49786,Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429819/
49787,COVID-19 Coagulopathy: From Pathogenesis to Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059042/
49788,Updated insight into COVID-19 disease and health management to combat the pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237642/
49789,Assessment of adjuvantation strategy of lipid squalene nanoparticles for enhancing the immunogenicity of a SARS-CoV-2 spike subunit protein against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372419/
49790,Attitude and Acceptance of COVID-19 Vaccine in Parents and Adolescents: A Nationwide Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212673/
49791,RNAi Technology and Investigation on Possible Vaccines to Combat SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024446/
49792,Advanced cardiac imaging in the spectrum of COVID-19 related cardiovascular involvement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335398/
49793,One Year of COVID-19 Vaccine Misinformation on Twitter: Longitudinal Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970010/
49794,Which vaccine attributes foster vaccine uptake? A cross-country conjoint experiment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067644/
49795,Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822409/
49796,Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220987/
49797,Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet light,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296761/
49798,The COVID-19 pandemic: diverse contexts; different epidemics—how and why?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392634/
49799,AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein–specific TH1 response with a diverse TCR repertoire,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924073/
49800,IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222767/
49801,COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920251/
49802,A lymph node–targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864572/
49803,Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301105/
49804,"Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439244/
49805,"COVID-19 Vaccine Uptake in Immigrant, Refugee, and Nonimmigrant Children and Adolescents in Ontario, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372706/
49806,The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248768/
49807,T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128286/
49808,Fomites and the environment did not have an important role in COVID-19 transmission in a Brazilian mid-sized city,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342429/
49809,Revisiting the potential role of BCG and MMR vaccines in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450304/
49810,Potential strategies for combating COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416802/
49811,"Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018410/
49812,Modifiable contributing factors to COVID-19: A comprehensive review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701571/
49813,Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929057/
49814,"No(cebo) Vax: COVID-19 Vaccine Beliefs Are Important Determinants of Both
Occurrence and Perceived Severity of Common Vaccines’ Adverse Effects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083709/
49815,The Many Faces of Innate Immunity in SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228170/
49816,COVID-19 Vaccine Hesitancy among New Jersey Teachers and Impacts of Vaccination Information Dissemination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967281/
49817,Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470303/
49818,COVID-19 therapies: do we see substantial progress?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152818/
49819,Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606233/
49820,"Recent Developments in the Understanding of Immunity, Pathogenesis and Management of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409103/
49821,"Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 – January 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169571/
49822,"COVID-19 Vaccination and Intent Among Healthcare Personnel, U.S.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710229/
49823,Factors Associated with COVID-19 Vaccine Hesitancy after Implementation of a Mass Vaccination Campaign,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879669/
49824,Molecular mechanisms and therapeutic effects of different vitamins and minerals in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297660/
49825,Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786731/
49826,Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599018/
49827,"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471804/
49828,Lancet. 2021 9-15 January; 397(10269): 98. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831759/
49829,Effect of Vaccination Time Intervals on SARS-COV-2 Omicron Variant Strain Infection in Guangzhou: A Real-World Matched Case–Control Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693306/
49830,"A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979130/
49831,"High SARS-CoV-2 Seroprevalence and Rapid Neutralizing Antibody Decline among Agricultural Workers in Rural Guatemala, June 2020–March 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323551/
49832,COVID-19 Vaccination Did Not Increase the Risk of Potentially Related Serious Adverse Events: 18-Month Cohort Study in an Italian Province,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861956/
49833,Considerations for bioanalytical characterization and batch release of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044082/
49834,Plant-based vaccines and antibodies to combat COVID-19: current status and prospects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754927/
49835,Understanding the Facilitators and Barriers to COVID-19 Vaccine Uptake Among Teachers in the Sagnarigu Municipality of Northern Ghana: A Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884702/
49836,Unveiling Vaccine Hesitancy on Twitter: Analyzing Trends and Reasons during the Emergence of COVID-19 Delta and Omicron Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458131/
49837,Predictors of COVID-19 Vaccine Hesitancy in South African Local Communities: The VaxScenes Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951818/
49838,Vaccine development and technology for SARS‐CoV‐2: Current insight,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662109/
49839,The impact of the COVID-19 pandemic on lifestyle behaviors in children and adolescents: an international overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815717/
49840,Environmental friendly micro cold storage for last-mile Covid-19 vaccine logistics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610367/
49841,A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185226/
49842,A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530591/
49843,Immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccines in healthy adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407550/
49844,"Effectiveness of 3 COVID-19 Vaccines in Preventing SARS-CoV-2 Infections, January–May 2021, Aragon, Spain",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888243/
49845,"SARS‐CoV‐2, aging, and Post‐COVID‐19 neurodegeneration",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877664/
49846,Risk stratification through allergy history: single-centre experience of specialized COVID-19 vaccine clinic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278227/
49847,"Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS-CoV-2 infection: a self-controlled case series study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665324/
49848,Predictors of Intention to Vaccinate Against COVID-19 in a Peruvian Sample,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021466/
49849,Deep Learning Analysis of COVID-19 Vaccine Hesitancy and Confidence Expressed on Twitter in 6 High-Income Countries: Longitudinal Observational Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629504/
49850,"Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816388/
49851,Comparative safety of mRNA COVID‐19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662238/
49852,"Cross-sectional analysis of COVID-19 vaccine intention, perceptions and hesitancy across Latin America and the Caribbean",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063600/
49853,Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738935/
49854,Side effects of COVID-19 vaccines: a systematic review and meta-analysis protocol of randomised trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882642/
49855,COVID-19 vaccination uptake in 441 socially and ethnically diverse pregnant women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385003/
49856,Immune recall improves antibody durability and breadth to SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097880/
49857,Pathogenesis and virulence of coronavirus disease: Comparative pathology of animal models for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10878030/
49858,A modified porous silicon microparticle potentiates protective systemic and mucosal immunity for SARS-CoV-2 subunit vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173827/
49859,"Attitude and level of COVID-19 vaccination and its determinants among patients with chronic disease visiting Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia: A cross-sectional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733868/
49860,SARS‐CoV‐2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID‐19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652790/
49861,COVID-19 Vaccine Hesitancy among Parents of Children under Five Years in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413913/
49862,"Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report—IVY Network, February 1–August 31, 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183633/
49863,New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003544/
49864,"Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676828/
49865,A Bayesian network analysis quantifying risks versus benefits of the Pfizer COVID-19 vaccine in Australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371378/
49866,"Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333264/
49867,The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529057/
49868,Exploring the vaccine-induced immunity against severe acute respiratory syndrome coronavirus 2 in healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131514/
49869,Comprehensive analyses of bioinformatics applications in the fight against COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560182/
49870,"COVID-19 vaccines: evidence, challenges and the future",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452286/
49871,Identification of an immunogenic epitope and protective antibody against the furin cleavage site of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732504/
49872,"Neutralizing Antibody Response to BBIBP-CorV in Comparison with COVID-19 Recovered, Unvaccinated Individuals in a Sample of the Pakistani Population",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171576/
49873,Systematic review of risk of SARS-CoV-2 infection and severity of COVID-19 with therapies approved to treat multiple sclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743352/
49874,Development and preclinical evaluation of virus‐like particle vaccine against COVID‐19 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653174/
49875,Vaccine Attitudes and COVID-19 Vaccine Intentions and Prevention Behaviors among Young People At-Risk for and Living with HIV in Los Angeles and New Orleans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954448/
49876,Assessing the acceptability of COVID‐19 vaccine and its booster dose,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521373/
49877,Statewide evaluation of COVID-19 vaccine hesitancy in Rhode Island,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159551/
49878,The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301107/
49879,The effects of COVID-19 on placental morphology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191727/
49880,Prevalence and factors of COVID-19 vaccine refusal among solid cancer patients in China: an application of the health belief model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435902/
49881,Correlation of antigen-specific immune response with disease severity among COVID-19 patients in Bangladesh,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554593/
49882,Light at the end of the tunnel: Influence of vaccine availability and vaccination intention on people’s consideration of the COVID-19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364891/
49883,The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021400/
49884,The COVID-19 pandemic face mask waste: A blooming threat to the marine environment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836388/
49885,Chemosphere. 2022 Jan; 287: 132411. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487163/
49886,Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385604/
49887,Frontline workers: Mediators of mucosal immunity in community acquired pneumonia and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539803/
49888,Qualitative Insights into Vaccine Uptake of Nursing Staff in Long-Term Care Facilities in Finland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056830/
49889,Characteristics and Roles of T Follicular Helper Cells in SARS-CoV-2 Vaccine Response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611968/
49890,An intranasal vaccine durably protects against SARS-CoV-2 variants in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270739/
49891,High heterogeneity on the accepted vaccines for COVID-19 certificates in European countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977214/
49892,"Distinct Adverse Reactions to mRNA, Inactivated Virus, and Adenovirus Vector COVID-19 Vaccines: Insights from a Cohort Study on Atopic and Non-Atopic Subjects in Brazil",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11054204/
49893,The Association Between Previous Influenza Vaccination and COVID-19 Infection Risk and Severity: A Systematic Review and Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920881/
49894,Am J Prev Med. 2022 Nov; 63(5): 874. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579269/
49895,Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371319/
49896,Knowledge and attitude toward the second round of COVID-19 vaccines among teachers working at southern public universities in Ethiopia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986266/
49897,Parents' Hesitancy to Vaccinate Their 5–11-Year-Old Children Against COVID-19 in Saudi Arabia: Predictors From the Health Belief Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005777/
49898,Front Public Health. 2022; 10: 914691. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199487/
49899,Comparison of Maternal–Fetal Outcomes among Unvaccinated and Vaccinated Pregnant Women with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787626/
49900,Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494913/
49901,The Role of Cyclodextrins in COVID-19 Therapy—A Literature Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918006/
49902,Lactiplantibacillus plantarum as a Potential Adjuvant and Delivery System for the Development of SARS-CoV-2 Oral Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067309/
49903,"Patient-derived monoclonal antibodies to SARS-CoV-2 nucleocapsid protein N-terminal and C-terminal domains cross-react with their counterparts of SARS-CoV, but not other human betacoronaviruses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927002/
49904,Considerations for Novel COVID-19 Mucosal Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329946/
49905,Immunogenicity and Safety of Vaccines against Coronavirus Disease in Actively Treated Patients with Solid Tumors: A Prospective Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372585/
49906,"A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823954/
49907,"I have decided about my COVID-19 vaccine, what about my child?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746399/
49908,"Protective Effect of Inactivated COVID-19 Vaccines against Progression of SARS-CoV-2 Omicron and Delta Variant Infections to Pneumonia in Beijing, China, in 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413898/
49909,Cold-adapted SARS-CoV-2 variants with different temperature sensitivity exhibit an attenuated phenotype and confer protective immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744683/
49910,A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728249/
49911,COVID-19 and Gut Injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608818/
49912,COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778857/
49913,COVID-19 vaccine decision-making among pregnant and lactating women in Bangladesh,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183608/
49914,"Prospective interpretation of Covid vaccines. A cross sectional study, Ordu province experience",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332199/
49915,Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869052/
49916,Health Professionals’ COVID-19 Vaccine Acceptance and Associated Factors in Tertiary Hospitals of South-West Ethiopia: A Multi-Center Cross- Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919101/
49917,Mouse Models for the Study of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594264/
49918,COVID-19 and comorbidities of hepatic diseases in a global perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015303/
49919,Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375068/
49920,Analysis of COVID-19 Incidence and Protective Potential of Persisting IgG Class Antibodies against SARS-CoV-2 Infection in Hospital Staff in Poland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383555/
49921,Inside the story about the research and development of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217575/
49922,Optimal COVID-19 Vaccine Sharing Between Two Nations That Also Have Extensive Travel Exchanges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387873/
49923,Extracellular Vesicle-Based SARS-CoV-2 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058598/
49924,What gastroenterologists should know about SARS–CoV 2 vaccine: World Endoscopy Organization perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242672/
49925,Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647045/
49926,Longitudinal determination of BNT162b2 vaccine induced strongly binding SARS-CoV-2 IgG antibodies in a cohort of Romanian healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339977/
49927,"Clinical Course of 53 Previously Vaccinated Patients Admitted to the National Hospital in Warsaw, Poland with COVID-19 Between November 2021 and March 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155592/
49928,Relevance of COVID-19 vaccine on the tourism industry: Evidence from China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401110/
49929,"Attitudes of COVID-19 vaccination among college students: A systematic review and meta-analysis of willingness, associated determinants, and reasons for hesitancy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235888/
49930,COVID-19: Rethinking the Lockdown Groupthink,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952324/
49931,Antibodies at work in the time of severe acute respiratory syndrome coronavirus 2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458058/
49932,"Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895919/
49933,Perceptions and Knowledge towards COVID-19 Vaccine Hesitancy among a Subpopulation of Adults in Kenya: An English Survey at Six Healthcare Facilities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147716/
49934,"Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114994/
49935,Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631592/
49936,"COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196863/
49937,Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087434/
49938,"COVID-19 Vaccine Hesitancy Among Medical Students: The Next COVID-19 Challenge in Wuhan, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564029/
49939,"A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10772081/
49940,Social Bots’ Involvement in the COVID-19 Vaccine Discussions on Twitter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835429/
49941,"A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177966/
49942,Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908846/
49943,COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910221/
49944,Factors associated with COVID-19 booster vaccine willingness among migrants from the Eastern Mediterranean living in Australia: a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706861/
49945,Neutralizing Antibody Responses to Messenger RNA Coronavirus Disease 2019 Vaccines Versus Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Pregnant Women and Vaccine-Induced Antibody Transfer to Infants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167992/
49946,Influenza-A mediated pre-existing immunity levels to SARS-CoV-2 could predict early COVID-19 outbreak dynamics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10746369/
49947,Why are we vaccinating children against COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437699/
49948,Toxicol Rep. 2021 Dec 17 ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679517/
49949,Toxicol Rep. 2021; 8: 1981. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496904/
49950,Toxicol Rep. 2022; 9: 1065. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075891/
49951,COVID-19 Vaccine Hesitancy and Its Determinants Among Adults with a History of Tobacco or Marijuana Use,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101333/
49952,Thyroid Dysfunction and COVID-19: The Emerging Role of Selenium in This Intermingled Relationship,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180529/
49953,Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135333/
49954,Broadly Reactive SARS-CoV-2-Specific T-Cell Response and Participation of Memory B and T Cells in Patients with Omicron COVID-19 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597734/
49955,A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967525/
49956,"COVID-19 vaccine acceptance and its determinants among residents of Ambo Town, West Shewa, Oromia Region, Ethiopia: cross-sectional survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291218/
49957,Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446717/
49958,BMJ. 2021; 374: n2300. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451392/
49959,Ethnic differences in SARS-CoV-2 vaccine hesitancy in United Kingdom healthcare workers: Results from the UK-REACH prospective nationwide cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287519/
49960,COVID-19: Molecular and Cellular Response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904902/
49961,COVID-19 diagnostic methods in developing countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135468/
49962,"A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108708/
49963,"Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313090/
49964,Vaccine mandates for healthcare workers beyond COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985724/
49965,"A Phase I/II Clinical Trial of Intradermal, Controllable Self-Replicating Ribonucleic Acid Vaccine EXG-5003 against SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10747308/
49966,"Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828370/
49967,Association Between What People Learned About COVID-19 Using Web Searches and Their Behavior Toward Public Health Guidelines: Empirical Infodemiology Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415385/
49968,Bioengineering of Novel Non-Replicating mRNA (NRM) and Self-Amplifying mRNA (SAM) Vaccine Candidates Against SARS-CoV-2 Using Immunoinformatics Approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723807/
49969,Prevention of Coronavirus Disease 2019 (COVID-19) by mRNA-Based Vaccines Within the General Population of California,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406879/
49970,COVID-19 Vaccines and Public Anxiety: Antibody Tests May Be Widely Accepted,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120666/
49971,COVID-19 and liver injury: An ongoing challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846934/
49972,The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286235/
49973,Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636174/
49974,Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893932/
49975,Immune Response after SARS-CoV-2 Infection with Residual Post-COVID Symptoms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535557/
49976,Long COVID: pathophysiological factors and abnormalities of coagulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113134/
49977,COVID-19 in Patients with Hematologic Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775038/
49978,Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282797/
49979,"Healthcare workers’ attitudes on mandates, incentives, and strategies to improve COVID-19 vaccine uptake: A mixed methods study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746602/
49980,Audiological and vestibular symptoms following SARS-CoV-2 infection and COVID-19 vaccination in children aged 5–11 years,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583622/
49981,Longitudinal Follow-Up of the Immunity to SARS-CoV-2 in Health Care Workers in Argentina: Persistence of Humoral Response and Neutralizing Capacity after Sputnik V Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286708/
49982,Molecular Understanding of ACE-2 and HLA-Conferred Differential Susceptibility to COVID-19: Host-Directed Insights Opening New Windows in COVID-19 Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095019/
49983,Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083569/
49984,Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809350/
49985,Prophylaxis for COVID-19: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813508/
49986,Development of COVID-19 therapies: Nonclinical testing considerations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122883/
49987,Structural biology of SARS-CoV-2: open the door for novel therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793099/
49988,Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319587/
49989,"SARS-CoV-2 epidemiology, antibody dynamics, and neutralisation capacity in Irish healthcare workers in the era of booster COVID-19 vaccinations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909389/
49990,A Perspective on COVID-19 Management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070140/
49991,Intramuscular injection of a mixture of COVID-19 peptide vaccine and tetanus vaccine in horse induced neutralizing antibodies against authentic virus of SARS-CoV-2 Delta variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580217/
49992,Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596387/
49993,"Longitudinal changes in COVID-19 vaccination intent among South African adults: evidence from the NIDS-CRAM panel survey, February to May 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889513/
49994,COVID-19 Vaccine Willingness and Related Factors Among Health Care Workers in 3 Southeast Asian Jurisdictions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396363/
49995,Impact of prenatal COVID-19 vaccination on delivery and neonatal outcomes: Results from a New York City cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749885/
49996,Comparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681846/
49997,"Determinants of COVID-19 vaccine acceptance and hesitancy among healthcare professionals in the Kintampo North Municipality, Bono East Region, Ghana",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336636/
49998,"Evaluation of the Diagnostic Performance of Two Automated SARS-CoV-2 Neutralization Immunoassays following Two Doses of mRNA, Adenoviral Vector, and Inactivated Whole-Virus Vaccinations in COVID-19 Naïve Subjects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220828/
49999,SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314866/